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An increasing demand for total hip replacement (THR) surgeries, due to an ageing population 
and an increasing number of younger patients undergoing THR surgery, has resulted in a 
proportional increase in the number of patients requiring revision surgery to remedy 
complications or failures of their THR implant components. Revision surgery of THR implants 
is expensive and time consuming and places an increasing burden on health funding and 
surgical resources. Consequently, a large emphasis has been placed on developing more 
accurate diagnostic methods which allow early diagnosis of THR implant wear and 
complications. This thesis investigates the potential of acoustic emission (AE) monitoring as a 
method for the early diagnosis of THR implant wear and complications.  
A detailed data collection protocol is presented for the use of an AE monitoring device on THR 
patients in the clinical environment (in-vivo) and on implants retrieved from THR patients in 
the laboratory environment (in-vitro). The AE monitoring device samples AEs at 100 kHz 
using ultrasonic receivers placed on the skin surface over the hip joint of THR patients. During 
in-vivo monitoring, THR study participants perform basic motions such as walking, sitting to 
standing, and stair ascents and descents. In-vitro data collection utilises the same AE sensing 
equipment to record AEs from robotic and manual manipulations of THR implants retrieved 
during the revision surgery of study participants. 
A detailed analysis was performed on the time and frequency domain characteristics of the in-
vivo AEs collected from 117 THR patients and 23 control study participants. In-vitro data was 
collected and analysed from the retrieved implants of five THR patients with ceramic implant 
bearing components. Dominant frequencies of in-vivo AE signals were found to be in the 1-4 
kHz range. In-vitro AEs from implant main bearing surface manipulations yielded dominant 
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frequency content in the same 1-4 kHz range. However, in-vitro AEs from relative motion at 
the trunnion Morse taper of the femoral implant components yielded squeaking AEs with 
dominant frequency content in the 18-22 kHz range. 
Further work developed and implemented an event detection algorithm to automate the 
detection of regions of interest (AE events) from the large dataset of AE signals. The AE events 
from patients who progressed onto revision surgery were analysed and grouped using the 
clinically identified reasons for revision of excessive noise, loosening, and excessive wear. A 
statistical analysis of AE event parameters was performed on the grouped data and the analysis 
indicated that single parameters alone were not an effective way to categorise participant AE 
data. A multidimensional analysis of the event parameters was performed, which took the form 
of two-parameter scatter plot comparisons and a principal component analysis. The 
multidimensional analyses showed that AEs were generally similar across all groups. However, 
some definite differences in the distributions of AE events from the different groups was 
apparent, particularly those within the loosening group of THR participants. The overall results 
from the AE analysis showed promise in the diagnostic potential of the AE monitoring 
technique. However, the results fell well short of being able to lead to a reliable failure 
diagnosis in their current state. 
Finally, a system to concurrently collect combined AE and gait data from THR patients was 
developed. The combined system provides the ability to continuously link the AE signals with 
the specific motion of the patient, and therefore to the motion of the implant components. The 
system itself and detailed data collection protocols were developed and combined AE and gait 
data was collected and analysed from three THR study participants. The data from the 
combined system has shown promising intra- and inter-participant consistency with substantial 
AE activity observed to occur repeatedly during a subset of the stance phase of the gait cycle. 
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Audible squeaking was also observed to occur consistently during the terminal stance phase 
for one of the participants, repeatedly occurring within the 30-40% range of the gait cycle. The 
initial testing from the combined AE and gait analysis has indicated relationships likely exist 
between AEs and particular implant motions and loadings. 
While further research is needed before the AE monitoring technique could be used as a clinical 
diagnostic method that might augment existing methods, this thesis presents some key steps 
towards this final overarching goal. Critical assessment of the current methods is made, and 
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Chapter 1 Introduction 
1.1 Total Hip Replacement Incidence 
The leading cause for primary total hip replacement (THR) surgeries in many countries is 
reported to be osteoarthritis, also known as degenerative joint disease (Australian Orthopaedic 
Association National Joint Replacement Registry, 2015; Canadian Institute for Health 
Information [CIHI], 2015; Garellick et al., 2015; Hooper, 2013; National Services Scotland, 
2016; New Zealand Orthopaedic Association [NZOA], 2015; Pivec et al., 2012). Osteoarthritis 
causes pain and loss of normal function in joints and is the most common joint disease 
worldwide with an estimated 10% of men and 18% of women over the age of 60 being affected 
(Glyn-Jones et al., 2015). When osteoarthritis is found to be at an advanced stage often the only 
effective treatment available is replacement of the joint with an artificial implant. With 
demographic ageing of the population, the incidence of osteoarthritis and consequent THR 
surgery is becoming increasingly more common in New Zealand and around the world.  
In 2016 there were 8785 primary THR surgeries in New Zealand which was 5% more than in 
2015 and more than double the amount of surgeries in 1999 when the registry began (NZOA, 
2017). Projections for the next 20 years suggest a threefold increase in the number of THR 
surgeries in the USA for patients over 65 years of age and data from several other countries 
show similar trends (Hooper, 2013; Hooper et al., 2014; Kurtz, S. et al., 2007). Additionally, 
trends from around the world show an increasing proportion of THR patients are below the age 
of 65 and this proportion is approaching or has exceeded 50% (Kurtz, S. M. et al., 2009; NZOA, 
2015). As a result of an increasing number of younger patients undergoing THR surgery, joint 
replacement implants are being required to remain in service longer and withstand a more 
active patient lifestyle. 
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An initial THR surgery to implant an artificial joint, known as primary surgery, has a high 
success rate returning patients to pain-free activities. In New Zealand THR implants have a 15 
year survival rate of 87.3% and data from the UK and USA shows a greater than 80% survival 
rate after 25 years (NZOA, 2015; Pivec et al., 2012). However, despite a high survival rate, the 
increase in the number of primary THR surgeries means that the number of patients who 
develop implant complications or failures is also increasing substantially. As a consequence, 
the demand for revision surgery (a new operation where a component is exchanged or 
manipulated in a previously replaced hip joint) is continuing to increase proportionately. 
Revision surgery is expensive and time consuming and places an increasing burden on health 
funding and surgical resources: The cost of a THR revision can be up to four times that of the 
primary procedure (Wyatt et al., 2014). With the knowledge of an ever increasing number of 
revision surgeries, an emphasis is being placed on improving reliability and survivorship of 
joint replacement prostheses (Kurtz, S. M. et al., 2009). 
1.2 Research Motivation 
One step towards the goal of improving the reliability and survivorship of joint replacement 
implants is by placing emphasis on developing more accurate diagnostic methods which allow 
early diagnosis of THR prosthesis wear and complications (Hayter et al., 2012; Rodgers et al., 
2014). If the condition of THR prostheses can be easily and reliably monitored more frequently, 
it is hoped that many major revision surgeries can be avoided or reduced in complexity through 
the early detection of complications and wear. As a consequence, the overall cost and resource 
burden for the health system can be reduced and implant manufacturers may gain better insight 
into implant factors that initiate failure.  
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Whilst many implant complications will require surgery to remedy the situation, early detection 
can often lead to a less invasive surgery where components interfacing with bone are left in 
place and only bearing surface component exchanges occur. A less invasive surgery is 
advantageous for patient recovery and improves the chance of long term success of the implant. 
If failing implants are not detected, wear debris from bearing surface degradation causes 
osteolysis (pathological destruction of bone around the implant from the body’s reaction to 
foreign wear particles). The degree of osteolysis increases with time, reducing the bone stock 
available for future implant fixation, significantly complicating the revision surgery and 
reducing the chance of success (Dattani, 2007). Early diagnosis can also provide further 
valuable information to surgeons and prosthesis manufacturers and allow them to improve 
surgical procedures and prosthesis designs in an attempt to reduce the need for revision surgery. 
There are many techniques that can be used in the diagnosis of THR complications, all with 
various advantages and disadvantages. There is much literature to suggest that no current single 
technique provides a definitive clinical diagnosis for all of the different THR complications. 
Therefore, emphasis is currently placed on using outcomes from sequential changes in 
radiographs and multiple imaging techniques coupled with detailed patient histories and 
physical examinations (Burge, 2015; Clohisy et al., 2009; Miller, 2012). It is evident that X-
ray imaging is the most common diagnostic technique currently used in THRs (outside physical 
examination) due to its relative low cost, ease to produce, and its ability to provide good 
preliminary insight into prosthesis condition. If further diagnostic information is required CT 
and/or MRI are usually employed and, if necessary, other techniques can also be used such as 
fluoroscopy (a technique which displays real-time X-rays to allow viewing of moving 
structures radiographically). 
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However, the major concern with the use of X-ray imaging, CT scanning, and fluoroscopy is 
the potential for tissue damage by ionizing radiation. Hence, research into new diagnostic 
techniques that are non-invasive, inexpensive, simple to conduct, and free from ionizing 
radiation has great importance. One such technique of particular interest, and the subject of this 
thesis, is the detection and analysis of acoustic emissions from hip replacement implants. This 
technique is not currently employed clinically in orthopaedics and there is limited literature on 
the subject. 
 The remainder of this chapter will briefly introduce the technique of acoustic emission 
monitoring and then go on to explain the previous work surrounding acoustic emission 
monitoring of THR implants that has been conducted at the University of Canterbury and the 
University of Otago Christchurch. This previous work forms the basis for the work that was 
conducted for the present thesis. The final sections will outline the research objectives and 
provide a chapter overview of this thesis. 
1.3 Acoustic Emission Monitoring 
An acoustic emission (AE) is considered a mechanical elastic wave that propagates through a 
medium, or multiple mediums, as a result of dynamic local rearrangements at an atomic scale 
caused by strain in the material from which the wave originated (Baranov et al., 2007; Eitzen 
& Wadley, 1984; Kohn, 1995; Scruby, 1987). The atomic rearrangements are a result of the 
conversion of elastic or kinetic energy, from an applied stimulus, to thermal energy through 
the local deformation, or atomic vibration and rearrangement, of a material in order to dissipate 
the energy (Akay, 2002). It then stands to reason that, because an AE concerns vibrations at an 
atomic level, AEs will be present in all physical or dynamic interactions of a substance and 
knowledge of the presence of AEs is only limited by the sensitivity of equipment used to detect 
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them (Baranov et al., 2007). AEs are typically detected using transducers attached to the surface 
of the material in question. The transducers detect the surface motion, which is a result of the 
mechanical vibration of the AE, and convert it to a voltage-time waveform allowing the 
characteristics of the AE to be investigated (Eitzen & Wadley, 1984). 
AE monitoring has been considered an ideal damage monitoring technique due to its sensitivity 
to deformation processes and its ability to be applied continuously (Kohn, 1995). It can be used 
to non-invasively and non-destructively monitor both surface and subsurface deformation, 
fatigue, and fracture of various materials, including soft tissues and metal or ceramic 
components. The AE technique can also provide insight into the materials’ failure mechanisms 
and over the past half century the technique has advanced considerably. Literature indicates 
the technique has produced some promising results in orthopaedics by attempting to diagnose 
various prosthesis complications such as loosening, osteolysis, and infection with varying 
degrees of success. However, the literature on the subject is both fragmented and limited: most 
of the studies generally do not have the aim of using the AE data to make a clinical diagnosis 
and the studies that do have uncorroborated results. A detailed review of the existing literature 
specifically surrounding the use of AE monitoring in orthopaedics, including findings and 
limitations, is presented in Section 2.3.2. 
1.4 Previous Work 
1.4.1 Overview 
Previous work at the University of Canterbury has developed an AE prototype diagnostic tool 
for joint replacement assessment and clinical trials have been conducted, in conjunction with 
the University of Otago Christchurch School of Medicine and the Canterbury Orthopaedic and 
Bone Research Association (COBRA), to gather AE data from THR patients in the clinical (in-
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vivo) environment (Rodgers et al., 2014). In addition to this, data has also been collected from 
laboratory (in-vitro) testing using THR implants retrieved from patients who have undergone 
revision surgery and were also previously monitored for AEs in-vivo. To our knowledge, the 
study is the first to be utilising both in-vivo and in-vitro AE data from the same THR implant 
components. The study therefore has the advantage of attempting to replicate implant specific 
in-vivo AE responses in the laboratory, as well as physically examining the condition of the 
implant components. By doing this, a more clinically relevant database of THR AE 
characteristics can be developed and a greater understanding of inter-patient variability can be 
gained. These factors should ultimately lead to an instrument with greater diagnostic potential 
than is currently available. 
1.4.2 Acoustic Emission Device & Signal Processing 
A simple sensing device had been developed which recorded AE data signals using National 
Instruments (NI) data acquisition hardware (CompacDAQ and NI-9222 analogue module) and 
LabVIEW software. The device utilised four passive ultrasonic receivers (Prowave 328ER250 
sensors) each with a resonant frequency of 32.8 kHz. Each of the four data signals were 
recorded simultaneously at 100 kHz, giving AE signals with a maximum observable (Nyquist) 
frequency of 50 kHz. The LabVIEW software program output the recorded AE signal data as 
text files which were saved for post-processing.  
Software code had been developed in MATLAB to import and organise the recorded AE 
signals to allow further analysis to be performed. Additionally, the MATLAB program had 
been designed to filter any unwanted signal noise from the data using a Daubechies wavelet 
filter. The software programming up to the point of producing organised and filtered AE data 
signals was considered both necessary and reliable and therefore will be used within the current 
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research and will not be modified. Some programming work had also been carried out on AE 
categorisation (‘event detection’) and spectral analysis but had yielded limited results. It had 
however allowed for some interesting findings relating to squeaking of THR implants and had 
demonstrated the generally varied nature of biological data. It was evident that more work was 
needed to effectively categorise the AE data. Long term, it would be desirable to develop real-
time processing algorithms to process data and provide immediate feedback to an orthopaedic 
surgeon. However, this thesis will focus on developing reliable post-processing algorithms and 
hence real-time processing is considered outside of the scope. 
1.4.3 Acoustic Emission Data Collection 
A protocol for in-vivo AE data collection using the AE sensing device had been developed 
where the four sensors are attached against the skin surface of the participant from the iliac 
crest to the upper-femur. Ethical approval for in-vivo AE data collection was granted from the 
New Zealand Upper South A regional ethics committee under approval number 
URA/10/11/075. The participant performs a range of prescribed motions and any AEs that are 
produced which reach the skin surface are recorded. The study had previously collected AE 
data for 80 THR study participants, 39 of which have undergone subsequent revision surgery 
with 19 of those making their implant components available for in-vitro examination. AE data 
for 22 natural hips with no known previous joint problems or trauma had also been collected 
for use as control data. 
An in-vitro test rig had been developed whereby a robotic arm is used to manipulate retrieved 
prosthetic joints in a reliable and repeatable manner. Prior to the inclusion of the robotic arm 
the in-vitro testing was carried out by hand and thus the robotic arm was incorporated in order 
to replicate the in-vivo movements in a more realistic way. The in-vitro testing set-up had not 
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been designed to replicate implant fixation to bone structures nor did it include any 
representation of soft tissues surrounding the implant. The main purpose of the in-vitro testing 
had been to investigate the interactions at the main bearing interface and the modular 
connections of the implant components. The AE sensing device had been adapted to record 
AEs generated by the implant components during in-vitro testing and to monitor unwanted 
external AE sources such as the actuating robot arm. 
1.4.4 Surface Analysis 
A number of the retrieved implant components, in particular some ceramic femoral heads, 
showed considerably worn surfaces. To investigate this wear more closely a surface analysis 
had been conducted at a microscopic level using scanning electron microscopy (SEM). Four 
ceramic implant components, which had been AE monitored both in-vivo and in-vitro, had 
subsequently been carbon coated and examined with a SEM. The analysis found a previously 
unobserved failure mechanism of inter-granular failure of the ceramic material which had been 
identified across all four components.  
1.4.5 Modal Analysis 
THR implant vibration modes had also been investigated using finite element analysis (FEA) 
software. A complete set of a THR implant had been laser scanned to yield solid models for 
use with ANSYS FEA software. A simple modal analysis had been carried out for each 
component to investigate the first three vibration modes and their frequencies. It became 
evident from the results that boundary conditions were an important factor in determining the 
modal properties and hence it was not expected that the FEA analysis frequencies would align 
accurately with the frequencies of the AEs. However, the results did show that the modal 
frequencies of the femoral head were considerably higher than those of the femoral stem, 
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acetabular cup, and acetabular liner. The modal frequencies of the stem, shell, and liner were 
more closely aligned with the main frequency content of in-vivo AEs as well as in-vitro AEs 
from the main bearing interface. 
1.5 Research Objectives 
The primary objective of this project was to use previously collected AE data from THR 
implants, along with any new data collected using the existing prototype diagnostic tool, to 
identify AE characteristics that are indicative of specific implant complications such as 
loosening or excessive wear. By identifying specific AE characteristics and correlating them 
with clinical reasons for revision, a significant step towards implant condition diagnosis can be 
made. In conjunction with this, the project was to continue building the existing AE database 
through ongoing clinical and laboratory data collection. A more representative and robust 
dataset was to be established to aid in clinical diagnosis through the collection of additional 
data. 
A further objective was to design and implement a simple, quantitative, in-vivo gait analysis 
technique, using IMUs and 3D motion capture, to couple temporal planar implant joint angle 
data with corresponding AEs and, in turn, implant surface analysis. The existing in-vivo data 
collection protocol was limited in that it allowed only broad representation of the joint’s motion 
over time during AE monitoring. For example, in a particular AE recording where a patient 
was walking, the general motion of the implant components was known but no temporal 
information of the implant orientations was recorded. Without any temporal implant orientation 
information the AE data cannot be associated with any specific implant positions. The 
additional information of temporal joint angles could offer further insight into the mechanisms 
and occurrence of AEs in joint replacements. 
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The hypothesis of this research is that THR implant complications have unique and identifiable 
AE characteristics that could be used to assist orthopaedic surgeons in making more informed 
and prompt implant complication diagnoses. From this hypothesis, and analysis of previous 
work, the following research questions were formulated: 
1) Can both intra and inter-patient AEs from THR implants be reliably categorised using 
time and frequency domain characteristics? 
2) If so, do these categories correspond to clinical reasons for revision such as loosening, 
noise, infection, or excessive wear? 
3) Can any correlations be seen between implant joint angles and audible AEs? 
4) If so, do these correlations allow more definitive conclusions to be drawn with respect 
to research questions 1) and 2)? 
1.6 Chapter Overview 
Chapter 2 presents the relevant background information and literature on three key topics: 
anatomical terminology and hip replacement implant components, AEs in medicine, and 
technical aspects of the AE technique and AE signals. 
Chapter 3 presents the details of the AE monitoring hardware and data collection protocols for 
the in-vivo and in-vitro AE testing. 
Chapter 4 presents the initial results of AE testing and familiarises the reader with the basic 
time and frequency domain appearances of the recorded AE signals from both the in-vivo and 
in-vitro testing. 
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Chapter 5 presents the AE event detection algorithm and subsequent evaluation. The chapter 
then goes on to show the results from the comparisons of the detected AE events of the control, 
noise revision, loosening revision, and excessive wear revision participant groups. 
Chapter 6 presents the methodology and initial results for the developed technique of combined 
AE monitoring and gait analysis. 
Chapter 7 presents the overall conclusions of the thesis and identifies future works related to 
the research. 
1.7 Summary 
This chapter presented the motivation for the research and introduced the concept of AE 
monitoring as a possible diagnostic tool for THR implants. An increasing number of primary 
THR surgeries are being performed due to ageing populations and an increase of younger 
patients undergoing THR surgery. This has resulted in a proportional increase in the number 
of THR patients experiencing implant complications and subsequent revision THR surgeries. 
Therefore, much emphasis is being placed on research into more accurate diagnostic methods 
that allow early indications of THR prosthesis wear and complications. Early diagnosis of 
implant complications can result in the avoidance of many major revision surgeries or 
reductions in their complexity. Consequently, the overall cost and resource burden for the 
health system can be reduced and recovery times for the patient could be improved. Implant 
manufacturers may also gain better insight into implant factors that initiate failure. 
Furthermore, diagnostic methods that are non-invasive, inexpensive, simple to conduct, and 
free from ionizing radiation are most desirable, such as the detection and analysis of AEs. 
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Literature on AEs in THR patients is limited but outcomes from the few published studies 
indicate the AE technique has produced some promising results in orthopaedics by attempting 
to diagnose various prosthesis complications such as loosening, osteolysis, and infection with 
varying degrees of success. However, most of the studies in the literature generally do not have 
the aim of using the AE data to make a clinical diagnosis and the studies that do have this aim 
have uncorroborated results. Therefore, the main objective of this thesis is to investigate AEs 
from a large number of THR patients and determine if the AEs have unique and identifiable 
AE characteristics that could be used to assist orthopaedic surgeons in making more informed 
and prompt implant complication diagnoses. 
This chapter also presented the previous work that had been carried out to develop the current 
AE monitoring device and conduct initial data collection. A simple sensing device had been 
developed which recorded AE data signals at 100 kHz using ultrasonic receivers attached to 
the skin surface of THR study participants. Following ethical approval, AE data had been 
collected from 80 THR study participants and 22 control hips. In-vitro testing, on implants 
previously tested in-vivo, had also been conducted on implant components that were retrieved 
during revision surgery and subsequently made available for testing through informed consent 
by the associated study participants.  
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Chapter 2 Background & Literature Review 
2.1 Introduction 
In this chapter, relevant background information is presented on three key topics: anatomical 
terminology and the THR implant; literature of AEs in medicine; and technical aspects of the 
AE technique and AE signals. The information presented on the aforementioned topics lays the 
foundation for understanding the AE analysis that follows in the remainder of the thesis. The 
first sections of this chapter cover some relevant anatomical terminology that will be used 
throughout this thesis. Furthermore, an introduction to the hip joint and the THR implant 
equivalent is presented. Additionally, an explanation of some common THR implant failure 
modes and their associated prevalence is presented. The middle sections of this chapter present 
the literature concerning AEs in medicine and more specifically, the AE technique in the field 
of orthopaedics. The final sections of this chapter cover some technical background of the AE 
monitoring technique in general. In addition, some background concerning AE propagation 
and signal parameters is presented. 
2.2 Medical Background Information 
2.2.1 Anatomical Terminology & Hip Movements 
To more effectively communicate particular aspects of this thesis it is useful to introduce some 
medical terminology that is used to describe the position and movements of parts of the human 
body. Figure 2.1a shows a diagram depicting three planes that are commonly used as references 
to describe relative positions or directions. In the context of this thesis, the sagittal plane is an 
important plane to note; the sagittal plane is a vertical plane that divides the body (or organ) 
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into left and right sides. The sagittal plane that divides the body into equal left and right sides 
is called the midsagittal plane. Figure 2.1b shows a diagram depicting the directional reference 
terminology used when referring to relative positions of body parts. The definitions of the 
directional terms that are useful to know are summarised in Table 2.1. 
 
Figure 2.1: a) Planes of the Body by OpenStax (2017, p. 6) licensed under CC BY 4.0, 
b) Directional References by Blausen.com staff (2014) licensed under CC BY 3.0. 
Table 2.1: Definitions of body directional terms. 
Directional Term Definition 
Anterior Toward or at the front of the body 
Posterior Toward or at the back of the body 
Superior Toward the head, or the upper part 
Inferior Away from the head, or the lower part 
Medial Toward or at the midline (the midline is a line on the midsagittal plane) 
Lateral Away from the midline 
Proximal Toward or at the end of a limb where it attaches to the body 
Distal Away from or the end of a limb where it attaches to the body 
Specific terminology is used for common movements that occur at particular joints of the body 
to indicate the form and direction of the motion. Figure 2.2 depicts the main movements of the 
hip joint and the associated terminology. A description of each of the possible hip movements 
is summarised in Table 2.2. 
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Figure 2.2: Movements of the hip. This work is a derivative of “Human body, front and side” by Nanoxyde used under 
CC BY-SA 3.0 licensed by A. J. FitzPatrick under CC BY-SA 3.0. 
Table 2.2: Summary of hip joint movements. 
Hip Movement Description 
Flexion Moving the thigh bone (femur) forward (anteriorly) 
Extension Moving the femur in the opposite direction to flexion 
Hyperextension 
Moving the femur backward (posteriorly) from the anatomical 
position (i.e. the position depicted in Figure 2.2) 
Abduction Movement of the femur away from the midline 
Adduction Movement of the femur towards the midline 
Circumduction 
Movement of the distal end of the femur in a circle through a 
sequential combination of flexion, adduction, extension, and 
abduction at a joint (OpenStax, 2013e) 
Medial rotation 
Rotating femur about its longitudinal axis so that the anterior 
surface turns toward the midline 
Lateral rotation 
Rotating femur about its longitudinal axis so that the anterior 
surface turns away from the midline 
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2.2.2 The Hip Joint 
The skeletal system of the adult human body consists of 206 individual bones; all but one of 
the bones articulate or form a joint with at least one other bone of the body (Tortora et al., 
2016). The hip joint is the articulation of the femur (thigh bone) with the hip bone of the pelvis 
and is an example of a synovial joint. Figure 2.3 shows the lateral and medial views of the right 
hip bone and Figure 2.4 shows the anterior and posterior views of the femur bone. For the 
current study, the important features to note of the hip bone are the iliac crest, anterior superior 
iliac spine (ASIS), and the acetabulum. The important features to note of the femur are the 
head, neck, and greater trochanter. 
 
Figure 2.3: The hip bone. This work is a derivative of “The hip bone” by OpenStax (2013c, p. 3) used under CC BY 4.0 
licensed by A.J. FitzPatrick under CC BY 4.0. 
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Figure 2.4: The femur bone. This work is a derivative of “The femur bone” by OpenStax (2013b, p. 2) used under CC BY 
4.0 licensed by A. J. FitzPatrick under CC BY 4.0. 
As identified previously, the hip joint is an example of a synovial joint. A synovial joint is 
defined functionally as a freely moveable joint (diarthrosis); these types of joint have 
characteristics that allow considerable movement between the articulating bones. There are six 
different structural forms of synovial joint, each form allows a different type of movement: 
pivot, hinge, saddle, ball-and-socket, condyloid, and plane (Tortora et al., 2016). Figure 2.5 
shows a diagram with an example for each type of structural classification of synovial joint. 
The figure depicts that the hip joint (Figure 2.5f) is a ball-and-socket joint. A ball-and-socket 
joint comprises one bone with a ball-like end fitting into a cup-like socket of another bone. In 
the hip joint, the proximal end of the femur is ball-like and is called the femoral head. The 
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socket of the hip joint is a cup-like depression in the hip bone called the acetabulum. The ball-
and-socket joint allows movement around three axes: flexion-extension, abduction-adduction, 
and rotation. (Tortora et al., 2016) 
 
Figure 2.5: Types of synovial joints by OpenStax (2013d, p. 6) licensed under CC BY 4.0. 
A synovial joint has four important characteristics that contribute to the joint being freely 
moveable but also remaining structurally stable: articular cartilage, an articular capsule, a 
synovial cavity (joint cavity), and synovial fluid. Figure 2.6a shows a cross-sectional diagram 
of the synovial joint of the hip identifying the important characteristics of the joint. The 
articulating bones of a synovial joint are each covered with a separate layer of articular 
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cartilage. The purpose of the articular cartilage is to reduce friction between the bones and help 
absorb shock; it does not bind the bones together (Tortora et al., 2016). It is this cartilage that 
is damaged or degraded in some way in a hip joint affected by osteoarthritis leaving the 
performance of the joint motion reduced and even causing pain during movement (Rabiei, 
2009). 
 
Figure 2.6: Hip joint schematic. Hip Joint by OpenStax (2013a, p. 12) licensed under CC BY 4.0. 
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The synovial joint is surrounded by an articular capsule which connects the bones together with 
a fibrous outer membrane and is reinforced by ligaments. The fibrous membrane and ligaments 
are flexible, allowing significant movement, and they have a high tensile strength which resists 
dislocation of the bones (Tortora et al., 2016). In the hip joint the fibrous membrane is 
reinforced by three ligaments (identified in Figure 2.6b-c): the iliofemoral, pubofemoral, and 
ischiofemoral ligaments. The inner membrane of the articular capsule, the synovial membrane, 
forms the boundary of the joint cavity between the bones and secretes synovial fluid into the 
cavity (Tortora et al., 2016). Synovial fluid is a viscous fluid which has a number of functions 
including: providing lubrication of the joint, absorbing shocks, supplying the necessary 
nourishment to the articular cartilage whilst also removing waste products, and removing 
microorganisms and debris resulting from the normal wear of the joint (Tortora et al., 2016). 
2.2.3 Hip Implant Components 
A THR implant takes the place of the natural femoral head and acetabulum to form a new 
artificial ball-and-socket joint. Therefore, a THR implant consists of both a femoral component 
and an acetabular component, creating the ball and the socket sides of the joint respectively. 
Figure 2.7a shows a diagram of the components that make up a typical THR implant prosthesis 
and their positioning in the body and Figure 2.7b shows an exploded view of the THR implant 
components. The femoral component usually consists of two modular components: a femoral 
stem and a femoral head. The femoral stem is inserted into a void prepared in the top of the 
femur after the natural femoral head has been removed. The stem is either cemented in place 
with bone cement or it is uncemented. An uncemented stem is press-fit into the femur and relies 
on bone growth into a porous surface on the stem (known as osseointegration) which 
consequently fixes the stem in place. The femoral head is spherical and contains a Morse taper 
recess which is press-fit onto a Morse taper trunnion at the neck of the femoral stem. 
  22 
 
Figure 2.7:  a) Components of a hip prosthesis by Mikael Häggström licensed under CC BY-SA 4.0 b) Exploded view of THR 
implant components. 
The acetabular component also consists of two modular components: the acetabular shell or 
cup, and the acetabular liner. The acetabular shell is inserted into the acetabulum of the hip 
bone after the acetabulum has been prepared by removing the articular cartilage and shaped to 
accept the acetabular shell. Similar to the femoral stem, the fixation of the acetabular shell is 
either cemented or uncemented. The acetabular shell will usually contain a Morse taper socket 
of which a Morse taper on the outer surface of the acetabular liner is press-fit into. The 
acetabular liner contains a spherical depression in which the femoral head mates. Hence, the 
main articulating or bearing interface of the implant is between the femoral head and the 
acetabular liner. In some cases, when a cemented acetabular shell is used, an acetabular liner 
is not required because the shell itself contains the spherical depression that accepts the femoral 
head.  
a) b) 
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The acetabular shell and femoral stem are typically made from titanium or cobalt-chromium 
alloys due to the excellent biocompatibility of these materials. The acetabular liner and femoral 
head are usually made from one of either polyethylene (PE), alumina (ceramic), or cobalt-
chromium-molybdenum alloy (metal) which creates a number of possible bearing surface 
combinations (Hutchings, 2003; Rabiei, 2009). Some of the bearing surface combinations used 
in practise are known as hard-on-soft and consist of a metal femoral head on a PE acetabular 
liner (MoP) or a ceramic femoral head on a PE acetabular liner (CoP). Other combinations are 
known as hard-on-hard and consist of either a ceramic femoral head on a ceramic acetabular 
liner (CoC), a ceramic femoral head on a metal acetabular liner (CoM), or a metal femoral head 
on a metal acetabular liner (MoM). The latter of these bearing surface combinations, MoM, is 
becoming more uncommon as there is increasing evidence of undesirable effects on patient 
health due to metal-ion debris (Browne et al., 2010). Conversely, advances in material design 
has produced highly cross-linked polyethylene bearing surfaces which has been shown to have 
significantly lower wear rates than conventional polyethylene and hence hard-on-soft bearing 
surfaces using highly cross-linked polyethylene are considered the gold standard (Liu et al., 
2015; Pivec et al., 2012). 
2.2.4 Hip Implant Failure Modes 
The most common cause of late failure of THR has been aseptic loosening as a result of particle 
debris from the articulating surfaces of the replacement (Abu-Amer et al., 2007; CIHI, 2015; 
Delaunay et al., 2013; Garellick et al., 2015; NZOA, 2015; Pivec et al., 2012; Ulrich et al., 
2008). Aseptic loosening is a loosening of an implant component’s bond with the bone in the 
absence of any infection. The New Zealand Orthopaedic Association (2017) reported that in 
New Zealand 33% of THR revisions in 2016 were for aseptic loosening (acetabular 17.8%, 
femoral 15.2%). The implication for a patient with aseptic loosening is that loading forces 
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cannot be effectively transferred and micromotion will occur between the implant and 
surrounding bone leading to production of wear and debris particles (Drees et al., 2007). Hence, 
loosening is likely to cause pain and increase the potential for breakdown of the bone or 
periprosthetic bone fractures (fractures of bone in close proximity to an implant) and ultimately 
total implant failure. Surgical intervention is necessary to treat aseptic loosening and will 
involve the exchange of either the femoral stem or acetabular cup, or both of these components. 
Any surgical intervention which involves the exchange of components interfacing with the 
bone will be more time consuming, more expensive, and increase the recovery time of the 
patient. Early detection and intervention of osteolysis and implant loosening can mean less 
invasive surgery and is therefore beneficial in terms of both the patient outcomes and use of 
health resources. 
Implant instability and dislocations are another major cause for revision of THR implants 
(CIHI, 2015; Garellick et al., 2015; NZOA, 2015; Pivec et al., 2012). Instability in a joint is 
when there is greater than normal movement of the joint in any direction causing dissociation 
of the articular surfaces. Implant malpositioning and abductor deficiency (weakness of 
abductor muscles supporting the hip joint) are the two most common factors influencing THR 
instability and recurrent dislocations. Other factors include component sizing, patient 
compliance to rehabilitation strategies, patient age, and component wear among others (Parvizi 
et al., 2008; Pivec et al., 2012). The vast majority of dislocations after THR surgery are solitary 
occurrences and can be treated non-operatively. However, recurrent dislocations usually 
require surgical intervention. Surgical intervention in these cases generally involves the 
exchange of the implant acetabular liner with a constrained version or the use of a larger 
diameter femoral head (Parvizi et al., 2008). In 2016, 16.9% of THR revisions in New Zealand 
were for implant dislocation (NZOA, 2017). 
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Another reason for revision of THR components is implant squeaking in patients who have 
implants with hard-on-hard bearing surfaces such as ceramic-on-ceramic or metal-on-metal. 
Squeaking typically begins fourteen to twenty-six months after surgery (Keurentjes et al., 2008; 
Restrepo et al., 2008; Walter et al., 2007) and can be disconcerting and embarrassing for 
patients, impeding their quality of life (Jarrett et al., 2009; Owen, D. et al., 2014). The origin 
of squeaking is controversial and has been repeatedly reported as multifactorial; dependent 
upon implant and surgical factors. Implant factors relate to friction at the bearing surface 
(Brockett et al., 2013; Restrepo et al., 2008; Taylor et al., 2007; Walter et al., 2011; Walter et 
al., 2007; Walter et al., 2008; Weiss et al., 2010), femoral stem design (Restrepo et al., 2010), 
third body wear (Brockett et al., 2013; Chevillotte et al., 2010) and micro-separation between 
the ceramic head and liner (Nevelos et al., 2000) whereas surgical factors include acetabular 
orientation (Sexton et al., 2011; Walter et al., 2007; Walter et al., 2008), neck length 
(Keurentjes et al., 2008) and rim impingement (Ecker et al., 2008; Parvizi et al., 2011). Some 
researchers believe patient characteristics also influence squeaking as those who are younger, 
taller and with a higher body mass index experience increased rates (Sexton et al., 2011; Walter 
et al., 2007), suggesting that implants in these patients would be subject to greater forces and 
stresses (Walter et al., 2007).  
A recent meta-analysis found the incidence of squeaking in ceramic-on-ceramic THRs to be 
4.2%, of which the incidence of subsequent revision for squeaking was 0.2% (Owen, D. H. et 
al., 2014). Even though the literature shows that there are much more common reasons for 
implant revision than squeaking, squeaking has the unique characteristic of being identifiable 
to the naked ear. Hence, the phenomenon of implant squeaking offers a unique opportunity to 
investigate implant AEs, with some certainty that the emissions are induced by the presence of 
the implant, to aid in implant condition monitoring and diagnostics. 
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Periprosthetic bone fracture, especially of the femur, is also a relatively common cause of THR 
revision. Fractures in close proximity to the implant can cause a range of complications which 
would generally lead to joint instabilities and/or implant loosening and hence early intervention 
is necessary to prevent total failure of the implant. The New Zealand Orthopaedic Association 
(2017) reported that in New Zealand 14.4% of THR revisions in 2016 were due to a fractured 
femur. Pain and infection are also two other common reasons for revision of THR implants. In 
2016, 13.5% of THR revisions in New Zealand were indicated to be due to pain and 13.1% due 
to infection (NZOA, 2017). It is important to note that the statistics given for the revision 
reasons may be inflated due to the fact that it is common for multiple revision reasons to be 
specified for a given implant and all reasons are included in the analysis (NZOA,2017). 
One final failure mode that is worth mentioning is fracture of the implant components 
themselves. Due to advances in material design and manufacturing technologies, fracture of 
modern implant components is uncommon (e.g. third generation ceramic femoral heads have 
an approximate fracture rate of 0.004% as opposed to a rate of 13.4% for early generation 
ceramics (Sivananthan et al., 2014)). Nevertheless, revisions for fractured implants still occur 
in THR patients with early generation ceramic components or occasionally in patients with 
implants that have been in service for many years. 
2.3 Acoustic Emissions in Medicine 
2.3.1 Acoustic Emissions in the Human Body 
One of the most recognisable symbols identifying a doctor is the presence of a stethoscope 
around their neck. The modern stethoscope has played an important and incredibly useful role 
in patient diagnoses ever since it’s invention by the French physician, Rene Theophile 
Hyacinthe Laënnec, in 1819 (Roguin, 2006). Laënnec discovered that the use of a stethoscope 
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(mediate auscultation) meant that heart sounds (or any sounds in the chest cavity) could be 
heard with a greater clarity than by placing his ear directly to the chest (immediate auscultation) 
(David & Dumitrascu, 2017; Roguin, 2006). Immediate auscultation was a diagnostic 
technique known in ancient times (for example, it was used by figures such as Hippocrates in 
ancient Greece) but it was well known that the technique was less than ideal for reasons such 
as modesty, bad hygiene, and attenuation in obese patients (David & Dumitrascu, 2017; 
Roguin, 2006). The modern stethoscope has contributed greatly to the field of medicine (and 
continues to do so) in terms of advancements in the knowledge and accuracy of heart and lung 
disease diagnoses through the study of sounds emanating from the human body (David & 
Dumitrascu, 2017; Kaniusas, 2015; Roguin, 2006). 
Internal body sounds are generally initiated from mechanical vibrations of tissues, blood, 
muscles, and air in the airways and are particularly prevalent in the thorax of the body 
(Kaniusas, 2015). Sounds generated from the heart are arguably the most recognised body 
sounds and are commonly used to aid in diagnosis of heart problems due to the repeatability 
observed in normal heart sounds. Lung sounds are another prominent body sound which allow 
information on the condition of the airways to be observed. Lung sounds are more variable 
over time and have been explained by Laënnec as easier to distinguish than to describe 
(Kaniusas, 2015). Lung sounds tend to be continuous in nature and normal lung sounds 
generally do not have recognisable features in the time domain (Kaniusas, 2015). Abnormal 
lung sounds can be continuous and have a seemingly musical character, or they can be 
discontinuous and have an explosive or bubbling character usually heard as crackling 
(Kaniusas, 2015). Heart sounds have been observed to have a frequency range up to 400 Hz, 
with lung and snoring sounds having frequencies from approximately 100 Hz up to 1000 Hz 
and 2000 Hz respectively (Kaniusas, 2015).  
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Another common internal body sound that can occur is clicking as a result of the movement of 
joints. Non-symptomatic clicking is common in the general population (Guillin et al., 2012). 
These non-symptomatic clicks can be induced from tendons, ligaments, muscles, or even bone 
impinging with, and then subsequently moving rapidly over, bony prominences ("Any 
questions?," 1969; Chandran Suja & Barakat, 2018; Guillin et al., 2012; Kawchuk et al., 2015). 
When tendons, ligaments, or muscles are tight they are more likely to impinge on each other 
or on bones during joint movement. When the increasing tension overcomes the friction of the 
impingement, the tendon, ligament, or muscle can rapidly move past the impingement to 
relieve tension and consequently releases vibrational energy that can be heard as a click. 
A further mechanism that is thought to induce non-symptomatic clicking of joints is the rapid 
separation of joint surfaces, known as articular release (Protopapas & Cymet, 2002). Clicking 
of this type is commonly identified as the noise that occurs when “cracking” one’s knuckles or 
back. There is still much debate as to the exact cause of clicking resulting from articular release 
but it is generally thought to be a result of either the formation of a gas bubble (cavitation) in 
the joint cavity or the subsequent rapid collapse of the cavitation (Castellanos & Axelrod, 1990; 
Chandran Suja & Barakat, 2018; Kawchuk et al., 2015). Regardless of the exact mechanism, 
the clicking from articular release is generally not believed to be detrimental to the health of 
the joint (Castellanos & Axelrod, 1990; Protopapas & Cymet, 2002). 
Symptomatic clicking of joints is commonly a result of problems in the direct vicinity of the 
joint such as foreign or loose bodies, labral tears, cartilage defects, or torn ligaments and usually 
has associated pain (Guillin et al., 2012; Lewis, 2010; Protopapas & Cymet, 2002; White et al., 
2004). Continual clicking as a result of the aforementioned problems can result in further 
damage to the tissue concerned or surrounding tissue. Hence, if pain is associated with joint 
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clicking then it is advised that clinical investigation occurs to properly diagnose any 
abnormalities (Guillin et al., 2012). 
It is evident from the literature that the range of sounds that emanate from various internal 
regions of the human body are widely used to aid clinical examinations and diagnoses. The 
study of these sounds by medical practitioners is common due to the ease at which they can be 
identified and monitored. The sounds propagate to the skin surface and can therefore be non-
invasively detected with an instrument as simple as a stethoscope. Additionally, sometimes the 
body sounds have enough intensity to propagate past the skin surface and all the way to an 
external observers ears without the need for amplification. Hence, it would be unwise to ignore 
such obvious and easily monitored sounds when assessing the health of patients. It is apparent 
from the literature that many sounds that are generated from the human body are considered 
normal and can, in many cases, indicate good health. Conversely, some body sounds offer no 
diagnostic assistance as they are seemingly occurring randomly or they are not yet well 
understood. Nevertheless, it is obvious that internal body sounds are common and the study of 
these sounds plays an important role in the identification of various medical conditions. 
2.3.2 Acoustic Emission Technique in Orthopaedics 
Primitive AE analysis on human joints, primarily the knee joint, has been carried out by 
medical practitioners since the early 1900’s using stethoscopes and without the use of signal 
capture and processing techniques. These early experiments provided promising evidence of 
the usefulness of AE monitoring in joint injury characterisation and early diagnosis. The 
development of data acquisition and signal processing techniques over the past half century 
have also allowed significant advancement in the analysis of AE signals (Glaser, 2008). A 
study conducted over four years from 1985 analysed the main frequency content of AEs from 
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a number of total hip replacements in patients in the clinical environment (in-vivo) and 
concluded that there was good correlation between the main frequency content and implant 
fixation condition (Gao et al., 1990). Other in-vivo studies in the 1980’s concluded that an 
increase in the number of AE events was related to clinical symptoms and radiolucency at the 
bone/cement interface of total knee replacements (Kohn, 1995).  
Gao et al. (1990) used two AE transducers, with a frequency range up to 1 kHz, attached to the 
skin of the patient during walking, sitting down, and standing up motions. The study found that 
the main frequency content of the AEs from patients with apparently loose implants were either 
below 50 Hz or above 500 Hz and those for patients showing no signs of loose components 
were between 200 and 350 Hz. Additionally, the study found that no AEs were detected from 
participants with natural joints while the occurrence of AEs from THR patients had good 
reproducibility. The study also indicated the AE technique could detect very early stage 
loosening that X-ray inspection could not despite using only the main frequency component as 
a diagnostic metric of loosening. Abnormal AEs were detected in some patients where X-rays 
showed no signs of abnormalities. These patients were re-monitored after a time of rest-cure 
and were found to have an improved clinical condition.  
The conclusions from the study by Gao et al. (1990) show great promise for the diagnostic 
potential of the AE technique in orthopaedics. However, the study limited its AE analysis to 
frequencies below 1 kHz and subsequent studies have shown AEs from THR implants to have 
more notable content occur with frequencies higher than 1 kHz (Currier et al., 2010; Khan-
Edmundson et al., 2012; Sariali et al., 2012; Walter et al., 2008). A study, carried out at the 
University of Canterbury, used AE monitoring to investigate the attenuation characteristics of 
the soft tissue surrounding THRs (Khan-Edmundson et al., 2012). It was found that the 
maximum vibration frequencies that were present at the skin surface were approximately 20 
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kHz and that there was noticeable attenuation of signals above 10 kHz. It should be noted 
however that this study was not comprehensive and made broad conclusions only and therefore 
its conclusions should be considered with caution. 
A study at the University of Tennessee combined AE monitoring of THRs with vibration and 
video fluoroscopy gait analysis (Glaser et al., 2008). Video fluoroscopy is a technique which 
records a series of successive X-rays to allow viewing of moving structures radiographically. 
Glaser et al. (2008) conducted the study in order to correlate AEs and vibrations with in-vivo 
joint kinematics through the video fluoroscopy. The study investigated 24 patients, with 
various implant bearing interface combinations. It was found that separation and subsequent 
meeting of the implant’s main bearing interface correlated well with AE generation and that 
the various interface materials produced characteristic AE profiles (Glaser, 2008; Glaser et al., 
2008, 2010). Since the study focussed primarily on the relationship between AEs and the 
separation of the implant bearing surfaces, it did consequently relate the implant separation 
over time to stages of the gait cycle. Hence, the time domain signals of the observed AEs were 
indirectly related to the stages of the gait cycle. However, in terms of indicating how consistent 
any trends were between the AE signals and gait cycle stages, Glaser et al. (2008) only went 
so far as to state that a “knocking sound was observed when the femoral head contacted the 
acetabulum” and that “squeaking and rolling sounds were detected when intensive back-and-
forth movement of the femoral head occurred.” This conclusion regarding “knocking,” 
“squeaking,” and “rolling” sounds indicates that there is likely a valuable relationship between 
implant AEs and stages of the gait cycle but this was not the general conclusion of the study. 
Furthermore, the study did not attempt to relate the observed AEs to the condition of the 
participants’ implants since the participants all were clinically evaluated to have excellently 
functioning implants.  
  32 
Many of the in-vivo studies to date have contributed important findings with regard to the 
validity of AE monitoring of joint replacements but few have assessed AEs from large and 
representative cohorts. It is evident from published studies that the AE monitoring technique 
has a place in orthopaedics; it has been shown that in-vivo AE signals from different THR 
patients show varied behaviours but seem to correlate with various clinical diagnoses and 
implant motions. However, many of the recent studies which assess AEs of THR patients and 
relate them to clinical diagnoses use only a small number of patients, sometimes less than ten, 
and hence the validity of these relations is difficult to confirm. 
There has also been a significant amount of in-vitro studies on the AEs of joint replacements. 
This research has been done in an attempt to gain further insight into the AE source as well as 
AE characteristics of implant loosening, loadings, and failures. In-vitro studies carried out at 
the University of Southampton have investigated bone cement damage, stress development 
during cement cure, and failure processes of carbon fibre reinforced plastic (CFRP) prosthesis 
components (Browne et al., 2010; Browne et al., 2005). It was found from these studies that 
AE monitoring could; locate and monitor damage in bone cement, monitor crack development 
in curing cement, and assist the understanding of failure in CFRP components. Another in-
vitro study investigated the effect on the incidence of squeaking of various component designs 
as well as bearing clearances and loading (Hothan et al., 2011). It was found that component 
design had an important effect on the squeaking characteristics and that load increases caused 
corresponding increases in the squeaking frequencies. Further in-vitro literature investigates 
such things as; AE characteristics of bone (Kohn, 1995), AEs of implant loosening in porcine 
limb specimens (Ruther et al., 2013), and diagnosis of loosened THRs using induced vibrations 
in an in-vitro hip model (Rieger et al., 2013).  
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Hothan et al. (2011) conducted in-vitro AE testing on un-lubricated THR components to 
determine the influence of cup and stem designs on squeaking incidence and characteristics. 
Eigenfrequencies of the assembled femoral components were found to be good predictors of 
squeaking frequencies and higher axial loads caused an increase in these squeaking 
frequencies. Brockett et al. (2013) investigated the potential causes of squeaking of hard-on-
hard hip bearings in-vitro and concluded that squeaking correlates well with increased friction 
at the bearing interface. However, the study used a simplified model of the gait cycle and short 
test periods on unworn implants and so the effect of long term wear was not tested. 
Additionally, the study was not extended to include any in-vivo testing.  
Rashid and Pullin (2014) critically review AE testing research in a variety of Orthopaedic 
applications. They found well-conducted in-vitro studies that validate the use of AEs for early 
detection of aseptic loosening in femoral components of THR (Davies et al., 1996; 
Mavrogordato et al., 2011; Sugiyama et al., 1989). Piriou et al. (2016) investigated a finite 
element analysis (FEA) model that can reproduce squeaking frequencies seen in-vivo and 
verified it using an in-vitro hip simulator. The study found that modal frequencies from the 
FEA and the in-vitro AE frequency content were consistent with each other. When soft tissues 
were included in FEA analysis the observed frequencies lowered to be a closer match to 
squeaking frequencies recorded in-vivo. 
2.4 Technical Background Information 
2.4.1 Traditional Damage Monitoring Using Acoustic Emissions 
The AE monitoring technique is well established in the non-destructive testing (NDT) of 
engineering components and materials as it is effective at detecting fracture and fatigue in a 
range of materials and applications. Early application of the AE technique had a focus on 
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detecting and monitoring crack growth in engineering structures (Eitzen & Wadley, 1984; 
Scruby, 1987). Crack growth causes a sudden change in stress and a subsequent displacement 
within the material resulting in an elastic (stress) wave radiating through the material away 
from the crack; commonly known as a primary AE event (Ohtsu et al., 2016; Scruby, 1987). 
Additionally, AEs can be caused by friction between any surfaces (e.g. friction between the 
crack faces, known as crack fretting). When a system has more kinetic energy than the 
associated friction can dissipate, vibration instabilities are normally introduced which can 
result in the production of AEs (Akay, 2002). AEs induced by friction processes are commonly 
known as secondary AE events and do not necessarily indicate crack growth (Ohtsu et al., 
2016; Scruby, 1987). 
The presence of secondary AE events has allowed the AE technique to be extended for use in 
monitoring and control of production processes and in the testing of engineering materials. The 
technique has the ability to continually monitor the normal AEs (generally secondary AE 
events) from manufacturing processes (such as welding, cutting, forming, turning, milling, 
grinding, and drilling) and detect when abnormal emissions occur (Baranov et al., 2007; Ohtsu 
et al., 2016; Scruby, 1987). Abnormal AEs from manufacturing processes are generally 
identified as a significant primary AE event which is uncharacteristic of the normal process or 
a secondary AE event where a sustained change has occurred in what is considered the normal 
properties of the AEs (for example, the noticeable presence of a new frequency in the typical 
frequency profile of the process). The presence of abnormal AEs can indicate damaged or loose 
tools and components, and specific locations can usually be identified if multiple sensors are 
used (Gholizadeh et al., 2015; Ohtsu et al., 2016; Scruby, 1987). AEs can also distinguish 
between specific failure mechanisms of various materials and help advance the understanding 
of material deformation and fracture (Gholizadeh et al., 2015; Scruby, 1987). 
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A review of the AE technique by Gholizadeh et al. (2015) identified the value of using the 
technique in the structural health monitoring of civil structures through the detection of 
cracking early. AE monitoring can be employed to detect the initial formation of cracks and 
can follow their progression. Therefore, the technique provides real-time information about the 
integrity of a structure allowing an immediate response to be made. AE monitoring also 
provides information across a wide range of materials and hence has been applied to monitor 
the structural integrity of concrete, steel, or wooden civil structures, in addition to pressure 
vessels and piping systems (Gholizadeh et al., 2015). The AE technique has also been 
employed extensively in aerospace applications because of its ability to effectively monitor 
damage and failure of composite materials in real-time. Specifically, the AE technique has been 
used in aircraft damage monitoring to detect fatigue cracks, barely visible impact damage, 
delamination, and corrosion (Staszewski et al., 2004). The technique has also demonstrated the 
ability to differentiate between different mechanisms of composite failure such as matrix 
cracking, fibre-matrix debonding, and delamination (Gholizadeh et al., 2015). 
2.4.2 Acoustic Emission Propagation 
As stated in Section 1.3 an AE is a mechanical elastic wave that propagates through a medium. 
This propagation occurs due to the fact that when a particle is excited by an AE it vibrates in 
its location but dynamically interacts with adjacent particles (Ohtsu et al., 2016). The particle 
interaction results in energy being transferred between particles and hence the wave propagates. 
The elastic wave is classified from considering the direction of propagation in relation to the 
direction of the particle vibration (Kohn, 1995; Ohtsu et al., 2016).  
A primary wave (P-wave) is a longitudinal wave where the particles vibrate in the direction of 
the wave propagation. A secondary wave (S-wave) is a transverse wave (sometimes called a 
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shear wave) where the particles vibrate in the direction perpendicular to the wave propagation. 
Figure 2.8 shows a schematic of transverse and longitudinal waves as a visual aid. Other waves 
that occur in a solid are Rayleigh waves and Lamb waves (Kohn, 1995; Ohtsu et al., 2016; 
Scruby, 1987). These other waves occur when a P- or S-wave reach the boundary or surface of 
the propagation medium. Rayleigh waves result in an elliptical motion of the particles near the 
surface of the medium as shown in Figure 2.9. Lamb waves occur in thin specimens and cause 
the whole specimen to vibrate in either a symmetric or anti-symmetric mode as shown in Figure 
2.10. 
 
Figure 2.8: Schematic of transverse and longitudinal waves by Zappys Technology Solutions licensed under CC BY 2.0. 
 
Figure 2.9: Rayleigh wave propagation by MPasternak at Polish Wikipedia licensed under CC BY 2.5. 
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Figure 2.10: Lamb wave schematic showing a symmetric mode vibration (top) and an anti-symmetric mode vibration 
(bottom). Lamb wave schematic by Michael Schmid licensed under CC-BY-SA-3.0 and GFDL. 
P-waves propagate with a greater velocity than S-waves and the wave velocity is determined 
by the elastic modulus, density, and Poisson’s ratio of the propagation medium (Ohtsu et al., 
2016). A Rayleigh wave has a velocity approximately 10 percent slower than a transverse wave 
in the same medium and the velocity of a Lamb wave is dependent on the dimensions of the 
medium, and the frequency and vibration mode of the wave (Ohtsu et al., 2016). The 
differences in wave speed can influence how an AE will be detected by a sensor. In general, an 
AE sensor would detect longitudinal waves first, followed by transverse waves. However, 
when waves (longitudinal or transverse) meet a boundary in the medium, additional 
longitudinal and transverse waves will be generated as a result of refractions and reflections 
(Kohn, 1995; Ohtsu et al., 2016; Scruby, 1987). These additional waves can result in an AE 
sensor detecting reflected or refracted longitudinal waves before the originally generated 
transverse wave is detected. Furthermore, the occurrence of reflected and refracted waves is 
likely to mean many vibrations detected by an acoustic sensor are the result of wave 
superposition and hence the detected AE signal is likely to include distortions. 
Attenuation of acoustic waves also occurs during propagation and will influence the vibrations 
detected by an acoustic sensor. Viscous damping in a material causes temporal attenuation of 
vibrating particles and the greater the distance of a particle from the AE source the greater the 
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damping of the vibration amplitude (Ohtsu et al., 2016). Additionally, the attenuation of AEs 
increases noticeably as the vibration frequency increases (Khan-Edmundson et al., 2012; Ohtsu 
et al., 2016). As a result of AE attenuation, the extent of the aforementioned wave superposition 
and associated distortion may be reduced when the waves reach the acoustic sensor thus 
distortions may be less significant. Furthermore, when acoustic sensors are on the surface of 
an object, Rayleigh waves tend to dominate the detected acoustic waveforms due to the fact 
that they propagate in two dimensions, as opposed to three-dimensions, hence Rayleigh waves 
experience less attenuation (Scruby, 1987). 
The propagation characteristics outlined above are important to remember when considering 
the propagation of AEs in the THR system. If the joint components of a THR are the source of 
an AE then the acoustic waves must travel through a number of various different substances to 
reach an AE sensor on the skin surface. Gao et al. (1990) presented a transfer function (TF) for 
the propagation of an acoustic wave from the source to a sensor located at either the posterior-
superior iliac spine or femoral lateral condyle. The overall TF for a system is the product of the 
specific TFs of each different material along the propagation path. The TF presented by Gao et 
al. (1990) is likely the most simple that could be applied to the THR system yet it included nine 
individual TFs for various components along the propagation path. Some of the components 
that make up the propagation path of AEs in the THR system are: the prosthesis, bone, 
numerous types of soft tissues (such as fibrous tissues, tendons, ligaments, muscles, and skin), 
and even acoustic coupling gel that is used between the skin and the sensor membrane. 
Given that the overall TF is a product, it is obvious that any output signal detected at a sensor 
on the skin surface is highly influenced by the components that constitute the specific 
propagation path of the acoustic wave. Determining the specific transfer function for THR AEs 
detected on the skin surface is outside the scope of the current thesis. However, it is important 
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to bear in mind the greater complexity of the wave propagation paths in biological systems 
compared to those of AEs in industrial applications where commonly only one or two different 
materials may be involved. The increased complexity of the biological system is likely to affect 
comparisons of AEs across different sensor locations and severely limit the ability to 
triangulate the location of AE sources. Nevertheless, differences in the bone and soft tissues of 
THR patients with and without implant complications will consequently result in differences 
in the overall TFs. Hence, differences in detected AEs should be observed between patients 
with and without implant complications.  
2.4.3 Acoustic Emission Parameters 
An AE wave or signal that is detected by an acoustic sensor can be characterised by a number 
of parameters that describe the detected waveform. There are parameters based on the intensity 
and frequency of the waveform (such as peak amplitude, root-mean-squared (RMS) amplitude, 
acoustic counts, and main frequency content) and the shape of the waveform (such as duration, 
rise time, and the measured area under the rectified signal envelope (MARSE)). Generally, any 
acoustic signal measured by an acoustic sensor has a base level of noise greater than zero. 
Therefore, an arbitrary amplitude threshold greater than the noise level is used to determine the 
presence of an AE event. An AE event is usually defined as an AE pulse that exceeds the given 
threshold and then decays back to the noise level (Baranov et al., 2007; Ohtsu et al., 2016; Rao, 
1990; Scruby, 1987; Shark et al., 2010). Consequently, parameters such as duration, rise time, 
MARSE, and acoustic counts are highly dependent on the threshold value. The AE activity of 
an AE signal is defined as the total number of discrete AE pulses (i.e. AE events) per unit time.  
As stated above, an AE event is identified when the acoustic signal exceeds the arbitrarily 
chosen amplitude threshold. Figure 2.11 shows a typical waveform with annotations 
identifying the common signal parameters which are generally defined as follows: 
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 Duration – the time span from the first crossing of the threshold to the last crossing of the 
threshold before the signal amplitude returns to the base noise level. 
 Peak amplitude – the maximum absolute voltage value within the duration of the AE. 
 Rise time – time span from the first crossing of the threshold to time of the peak amplitude. 
 RMS amplitude – the voltage defined by 𝐴𝑅𝑀𝑆 = √[∑ 𝑥𝑖
2𝑁
𝑖=1
] 𝑁⁄  where 𝑥𝑖 is the voltage 
of the 𝑖th sample from the first threshold crossing of the AE event and 𝑁 is the total number 
of samples within the duration of the AE event. 
 MARSE – the integral of the rectified signal envelope over the duration of the AE event. 
 AE counts – the total number of times a signal crosses the amplitude threshold in the 
positive voltage direction. 
 Main frequency content – the frequency corresponding to the greatest magnitude in the 
frequency domain of the AE event (i.e. the frequency that corresponds to the peak 
magnitude of the Fourier transform of the AE signal). 
 
Figure 2.11: Typical waveform and its basic characteristics. 
The duration, peak amplitude, rise time, RMS amplitude, and main frequency content 
parameters are important to note. The aforementioned five parameters are important to keep in 
mind for the following chapters of this thesis since they will form the basis of the analyses that 
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are presented in Chapter 4 and Chapter 5. The MARSE and AE counts parameters will not be 
used since the equivalent information will be available from the RMS amplitudes and main 
frequency content respectively. The MARSE of a signal will be correlated with the RMS 
amplitude as both measures are related to the energy of the signal. The AE counts of a signal 
is related to the average frequency content since the AE counts is a measure of the number of 
cycles per total duration of the event. 
2.4.4 Acoustic Emission Event Detection 
Recorded AE signals from THR patients generally contain large regions of signal with 
amplitudes that do not exceed the background noise. Consequently, the AE recordings contain 
only small regions of interest (i.e. AE events) within much longer signals. Therefore, AE event 
detection was employed in the analyses presented in this thesis and methods for event detection 
are reviewed here. The most common technique used to detect events in voltage signals is to 
identify when the signal exceeds a set voltage threshold. In this technique, an arbitrary voltage 
threshold is chosen that distinguishes the signal from noise. An event is generally defined as 
the region between the first and last crossing of the threshold before the signal amplitude 
returns to the noise level (Baranov et al., 2007; Ohtsu et al., 2016; Rao, 1990; Scruby, 1987; 
Shark et al., 2010). A voltage threshold for event detection has good discrimination of events 
for signals with a high signal-to-noise ratio. However, the method does not perform well when 
the signals are weak as it can be difficult to determine an appropriate voltage threshold value 
which accurately detects events. The thresholding method can be modified to use a variance 
signal where the variance of a sliding window over the signal is used instead of the original 
voltage signal. Applying the thresholding method to the variance signal can result in better 
discrimination of events since random fluctuations in the noise level are smoothed out allowing 
a lower threshold value to be used to detect events. 
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An alternative event detection method investigated by Rodgers et al. (2017) used the statistical 
variation in sound intensity. Given the AE data collection hardware and methodology of 
Rodgers et al. (2017), the statistical variation in sound intensity method assumes the sound 
intensity is proportional to the voltage squared. Therefore, given that the sound intensity of 
ambient noise remains relatively constant, AE events can be defined as the outliers in the sound 
intensity when plotted over time. The outliers/events were determined by splitting the sound 
intensity values into 0.1 second time windows and checking if the maximum value for a 
window exceeded three standard deviations above the mean for the entire signal. To further 
refine the detection of events to capture low energy events, an iterative process was used where 
the standard deviation was recalculated after removing any time windows with detected events 
from the signal and checking for new outliers. The iterative process was carried out until no 
new outliers were detected. Rodgers et al. (2017) concluded that the sound intensity method 
performed well but further research was required to properly assess the effectiveness of the 
method. One key disadvantage with this method is that the AE events were effectively defined 
as constant duration windows in time. Despite removing the need for an arbitrary voltage 
threshold, this definition of an event limits the ability to effectively compare AE event 
parameters since most of the parameter definitions of Section 2.4.3 are dependent on using a 
voltage threshold. 
Wavelet transform event detection has been used by a number of studies in literature with 
varying success (Ahadi & Bakhtiar, 2010; He et al., 2010; Kadambe & Boudreauxbartels, 1992; 
Ng & Qi, 2001; Rodgers et al., 2017). The wavelet method utilises a short oscillating signal 
known as a mother wavelet which has a non-zero amplitude for a finite time period. A series 
of additional wavelets are created by shifting and scaling the mother wavelet with respect to 
time. The correlation between each created wavelet in turn and the AE signal can then be 
calculated and output as a wavelet coefficient. The larger a wavelet coefficient value, the better 
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the associated wavelet matches the AE signal. Therefore, if the shape of the mother wavelet 
closely matches the waveform of specific AE events, large wavelet coefficient values will 
indicate the presence of an AE event at the corresponding time in the signal. However, if the 
shape of the mother wavelet does not match the waveform of an event well the wavelet 
coefficients may remain small and no event would be able to be identified. Consequently, the 
wavelet event detection method is limited by the ability to select a mother wavelet that closely 
matches the shape of the signal that needs to be detected. Given that the shape of THR AE 
event signals is not initially known and multiple types of AE event waveforms may be present, 
multiple wavelet analyses would need to be conducted to both determine the mother wavelets 
to be used and to detect all types of events. 
A further event detection method investigated by Rodgers et al. (2017) used the root-mean-
squared (RMS) amplitude of the AE signals. This method created an RMS amplitude signal by 
calculating the RMS amplitude of a small signal window as the window was moved over the 
entirety of the AE signal. AE events were determined by applying an amplitude threshold to 
the RMS amplitude signal and identifying the regions where the RMS amplitudes exceeded the 
threshold. Different methods for determining the threshold value were investigated such as 
user-selected, using the RMS value during noise-only regions, and using the mean value of the 
RMS amplitude signal. Rodgers et al. (2017) concluded that the RMS amplitude event 
detection method with the threshold set by using the mean value of the RMS amplitude signal 
was less robust than using a user-selected threshold but it performed well for analysing large 
patient datasets since it was efficient to implement. 
Teague et al. (2016) used a signal envelope detection algorithm to perform event detection of 
knee joint sounds. The method used a short time Fourier transform (STFT) with two 
millisecond time windows and defined the envelope as the logarithmic amplitude of the STFT 
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coefficients for each time window in turn. A moving mean and standard deviation of the 
envelope was calculated using a 1000 sample window. The occurrence of an event was 
determined by thresholding the envelope using a value of 3.3 standard deviations from the 
moving mean. The method performed well at locating the occurrence of knee clicks. However, 
the method stopped short of defining event start and end points. 
Another method for event detection is the use of pattern recognition and machine learning 
algorithms (Grzeszick et al., 2017; Rao, 1990). In general, pattern recognition and machine 
learning algorithms that are applied for AE event detection rely on using short time windows 
of the AE signals. Various signal time and frequency parameters, such as those presented in 
Section 2.4.3 (excluding duration dependent parameters), can be calculated for each short time 
window. The signal parameters as a function of time can then be passed through machine 
learning algorithms, such as clustering or neural networks, to identify patterns in the data. If 
repeated signal patterns are identified by the algorithms they are likely to indicate the 
occurrence of similar AE events. However, the accuracy of machine learning algorithms is 
called into question if the nature of the input data does not effectively capture the parameters 
that characterise different AE events. This is difficult to determine without processing a large 
number of input parameters and visually verifying their results. Furthermore, any supervised 
machine learning techniques would require large training data sets of identified AE events 
which is impractical to obtain for the THR AE dataset.  
Of the event detection methods outlined above, all methods have their advantages and 
disadvantages but no single method has an obvious advantage over the others when considering 
the scope of this thesis. With respect to the detection of AE events without having the 
subjectivity of using arbitrary thresholds, machine learning algorithms are an obvious choice. 
However, the development and implementation of a machine learning algorithm for AE event 
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detection is outside the scope of this thesis. While AE event detection forms an important part 
of this research, emphasis is placed on implementing a simple AE event detection algorithm 
that allows an initial investigation into the basic time and frequency domain characteristics of 
the regions of interest of the AE signals. For this reason, a simple event detection algorithm 
based on thresholding of the variance of the AE signal will be employed in the analysis of this 
thesis. 
2.5 Summary 
This chapter presented relevant background information for three key topics: anatomical 
terminology and the THR implant; literature of AEs in medicine; and technical aspects of the 
AE technique and AE signals. Section 2.2.1 presented important terminology regarding the 
planes of the human body (Figure 2.1a), body directions (Figure 2.1b and Table 2.1), and hip 
joint motions (Figure 2.2 and Table 2.2) that is used throughout the remainder of this thesis. 
An introduction to the anatomy of the natural hip joint was presented accompanied by an 
explanation of the THR implant and its components. The four main components of a THR 
(femoral stem, femoral head, acetabular liner, and acetabular shell) were presented in Figure 
2.7. Additionally, the common failure modes of the THR implant (aseptic loosening, 
dislocation, excessive noise, periprosthetic bone fracture, pain, infection, and implant fracture) 
and their corresponding prevalence were outlined in Section 2.2.4. 
Section 2.3 provided an overview of literature covering AEs in the human body and specifically 
AEs in the orthopaedic field. The literature demonstrated that, experimental results from in-
vitro implant tests have provided further understanding of the AE behaviour of joint 
replacements. However, in-vitro experimental results from the literature have not yet directly 
contributed to the in-vivo diagnosis of total hip or knee replacement complications. No clear 
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diagnostic method or clear indication of signal characteristics that can reliably predict specific 
failure modes currently exists. Some promising initial results have been observed in the 
literature but more research is needed into larger patient groups and more in-depth signal 
processing analyses to better understand how AEs relate to clinical outcomes. Furthermore, the 
inclusion of gait analysis and other sensing methods has shown promise of being able to 
provide additional insight into in-vivo implant mechanics. However, the literature concerning 
THR AEs combined with gait analysis is extremely sparse. 
The final sections of this chapter presented technical background of the AE monitoring 
technique, AE signal characteristics, and AE event detection methods. It was shown from 
literature that AE monitoring is usually employed in traditional damage monitoring situations 
to detect large discrete AEs that indicate crack growth or identify abnormal emissions in 
processes where the normal AEs are predictable and well-defined. Additionally, in many 
traditional damage monitoring applications the AEs can be detected from the same material 
that they originated in. However, it was explained that the propagation characteristics are much 
more complex for AEs travelling from inside the human body to the skin surface since they 
potentially pass through many different materials (such as the implant components, bone, 
fibrous tissues, tendons, ligaments, muscles, and skin). Therefore, the increased complexity of 
the biological system is likely to affect the characteristics of the AEs. Nevertheless, differences 
in the bone and soft tissues of THR patients with and without implant complications is 
hypothesised to result in detectable differences in AE characteristics. The hypothesis of 
detectable differences from AEs with different implant complications is the foundation of the 
subsequent research presented in this thesis.  
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Chapter 3 Data Collection Protocols 
3.1 Introduction 
This chapter presents the details of the AE monitoring hardware and formalises the data 
collection protocols for the in-vivo and in-vitro AE testing. First, the specific hardware and 
associated parameters of the AE monitoring device is explained. A statement of ethical 
approval is then presented. Following that, the formalised data collection protocol for the in-
vivo AE monitoring is explained. Finally, the in-vitro test apparatus and associated testing 
protocol is presented. A condensed version of this chapter forms the methods section of the 
published work FitzPatrick et al. (2017b). 
3.2 Acoustic Emission Device 
The AE detection device that was used for data collection utilised four passive ultrasonic 
receivers/sensors (Prowave 328ER250) each with a resonant frequency of 32.8 kHz. The 
signals from the sensors were amplified by a circuit mounted within each sensor housing in 
order to prevent additional noise adding to the low voltage signal during transmission to the 
data acquisition (DAQ) system. The sensors were connected to a National Instruments 
CompacDAQ through a NI-9222 analog module. The CompacDAQ was connected via USB to 
a computer running LabVIEW software where the voltage signals from the four sensors were 
recorded simultaneously at 100 kHz. The 100 kHz sampling rate provided a maximum practical 
frequency of 50 kHz by the Nyquist theorem which was well in excess of the typical 
frequencies observed during prior in-vivo and in-vitro implant testing (Khan-Edmundson et al., 
2012).  
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The sensors were cylindrical in shape and had a diaphragm diameter of 25.1 mm. Each sensor 
was mounted in a custom built housing to allow the attachment of the signal amplification 
circuit and to increase the robustness of the device. The sensor housings were constructed from 
acetal plastic and were cylindrical in shape with an overall diameter of 40 mm and a height of 
33 mm. Figure 3.1a shows an image of one of the sensors assembled inside its housing with 
the diaphragm of the sensor visible. The design of the sensor housing meant the diaphragm of 
the sensor was recessed into the housing by approximately 1.5 mm. The recessing of the sensor 
meant reducing the chance of damaging the diaphragm and restricting vibration through direct 
contact with hard objects such as the implant components during in-vitro testing for example. 
Instead, during all testing scenarios, standard ultrasound transmission gel was used to cover 
the sensor diaphragms and create a reliable transmission path for AEs to the sensors from either 
the skin surface (during in-vivo testing) or the implant components (during in-vitro testing). 
The combination of the recess and ultrasonic gel also avoided undesirable DC voltage offsets 
which would have resulted from constant contact pressure of a hard object against the sensor 
diaphragm. Figure 3.1b shows the acoustic sensors, organised in an array ready for in-vivo 
testing, and the CompacDAQ with analog module. Also identified in the Figure is a signal 
breakout box which was used to create an input point for the sensors’ power source. 
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Figure 3.1: a) Assembled acoustic emission sensor and housing. Note the sensor diaphragm (visible inside the white housing) 
has a diameter of 25.1 mm. b) Image of data acquisition hardware which consists of four ultrasonic sensors 
arranged in an array, signal breakout box for external power input, and National Instruments CompacDAQ (A 
ball-point pen of length 140mm has been included at the left of the image for scale). 
3.3 Ethical Approval & Participant Recruitment 
Ethical approval for in-vivo AE data collection was granted from the New Zealand Upper South 
A regional ethics committee under approval number URA/10/11/075. The ethics approval 
allowed the recruitment and AE monitoring of persons who had THR implants along with a 
control group of 20 people with healthy, natural hips (allowing data for 40 control hips). AE 
monitoring was nominally performed at the Canterbury Orthopaedic and Bone Research 
Association (COBRA) unit at Burwood Hospital in Christchurch but alternate locations could 
be used subject to additional locality agreements. 
Following the ethics approval, a cohort of THR patients were recruited for in-vivo monitoring. 
The recruitment criteria included patients scheduled for revision surgery in Christchurch with 
identified implant problems, such as loosening or audible squeaking, as well as those identified 
through routine questionnaires or consultations. The patients had a range of age, implant type, 
and implant conditions. Additionally, a second cohort of participants who had healthy natural 
hip joints with no history of hip joint trauma or injury were recruited to establish a control 
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database of AEs from natural hip joints. Prior to commencement of the AE monitoring of a 
participant, an informed consent process was carried out to ensure each participant understood 
the purpose of the study and what the AE monitoring procedure involved. If the participant 
agreed to partake in the study the appropriate consent form was completed. 
3.4 In-Vivo Data Collection 
3.4.1 Sensor Configuration & Attachment 
For in-vivo testing, the four sensors were arranged in a linear array using a closed cell foam 
pad to position the sensors. The foam pad had four evenly spaced holes for the sensors to locate 
into where the distance between the centres of adjacent holes was 70 mm. The holes in the 
foam pad had diameters approximately 2 mm smaller than the sensor housings to provide an 
interference fit with the sensors. The interference fit meant that the sensors were held in 
position tightly and their positions relative to each other would not change. Figure 3.2 shows a 
photograph of the sensor pad array with the 70 mm spacing identified. 
 
Figure 3.2: Sensor pad array used for in-vivo AE monitoring. 
The sensor array was placed against the skin surface of the participant from the iliac crest to 
the upper-femur. The positioning of the sensors relative to the in-situ implant are illustrated in 
Figure 3.3. Note that, while the photograph in Figure 3.3 shows the sensor array on the outside 
of the clothing, this is only to demonstrate the position on the patient. During actual in-vivo 
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testing the sensor pad is directly against the skin of the patient not outside the clothing as shown 
in Figure 3.3. Each sensor was numbered in ascending order from one through four starting 
from the highest placed sensor on the participant and concluding with the lowest placed sensor 
(see Figure 3.3). This numbering scheme of the sensors remained consistent for all in-vivo 
testing so as to allow comparisons of AEs from particular sensors across different participants. 
As mentioned in Section 3.1, ultrasound transmission gel was used on each sensor to ensure a 
reliable sound transmission path by filling the space between the skin and the sensor 
diaphragms. The sensor array was held in place using crepe bandages around the waist of the 
participant. This method of fastening the sensor array to the participant was simple, efficient, 
and reliably ensured continuous contact of the sensors with the skin during testing.  
 
Figure 3.3: Schematic showing the positioning of the four ultrasonic sensors relative to the in-situ implant and surrounding 
skeletal system (Note that during actual in-vivo testing the sensor pad is against the skin of the patient not above 
the clothes as shown in the Figure here). This work is a derivative of “Total Hip Replacement” by BruceBlaus 
used under CC-BY-SA 4.0 licensed by A. J. FitzPatrick under CC-BY-SA 4.0. 
 
3.4.2 Test Motions 
Following attachment of the sensor array, each participant was asked to perform a number of 
basic motions. The main purpose of the test motions was to subject the hip joint of the 
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participant to a number of dynamic everyday ranges of motion and loadings whilst concurrently 
measuring any AEs that occurred from or near the joint. The participants were free to perform 
each prescribed motions in a way that best suited their health and mobility. The full range of 
motion for different patients varied due to their mobility. Participants were not placed at risk 
by pushing them outside their comfortable range of motion. Therefore, the specific execution 
of each motion varied from one participant to the next. However, the movement of the hip joint 
still remained broadly similar between participants. Additionally, if a participant was not able 
to, or did not wish to, perform a particular motion then that motion was left out of their test 
procedure all together.  
The first of these motions was a squatting motion where the participant performed a standard 
squat from a standing position. The participant typically held onto the back of a chair in front 
of them help maintain their balance during the squat in the interest of safety. The illustration 
of Figure 3.4 shows the basic squatting motion, the position of the person portrayed in the 
figure is considered a shallow squat as opposed to a deep squat where the hips would drop 
below the knees. In general most of the participants performed very shallow to shallow squats 
since they moved only as far as they felt comfortable. Enforcing a deep squat in patients with 
identified problems that were scheduled for revision surgery would place them at high risk of 
pain and/or potential injury and/or dislocation of their implant. While it introduces a limitation 
to this study, patient safety had to take priority over obtaining a larger range of motion. A 
typical AE recording for the squatting motion began with the participant standing and recorded 
a single squat and finished once the participant was standing upright again. Each participant 
performed approximately six squats. 
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Figure 3.4: Illustration of squatting motion. Kniebeuge by Marcel Kollmar licensed under CC-BY-SA 3.0 DE. 
The second motion that the participants were asked to perform was standing from, and 
lowering/sitting into, a seated position. The participants began seated on a chair and moved to 
a standing position in their own time. Once standing, the participants moved back into a seated 
position on the chair. Some participants could not perform these motions easily unassisted and 
therefore used a walking stick or the back of another chair in front of them to help stabilise and 
pull themselves up and to steady themselves as they sat back down. Typically, each standing 
and sitting motion were recorded as separate AE recordings. However, on some occasions both 
a standing and sitting motion were recorded as part of the same AE recording. Generally, each 
participant repeated the stand and sit motion at least three times. 
The third motion that the participants were asked to perform was a stair ascent and descent. 
For practical reasons a step-ladder was used in place of a staircase to perform this motion. The 
participants were asked to walk up the step ladder one step at a time as far as they felt 
comfortable and to use the step-ladder handles in front of them for balance and support. In 
general, each participant had both feet on one step before they continued onto the next. 
Typically, one AE recording captured the ascent steps of the participant and a second recording 
captured the descent steps. However, on some occasions the ascent and descent steps were 
contained within one recording. Generally, at least three repetitions of the stair ascent and 
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descent motion was performed by each participant. The participants were not asked to lead 
their steps with a specific leg and hence a mixture of leading with the implanted leg and the 
opposite leg occurred. However, some participants voluntarily alternated their leading leg for 
each repetition of the motion. This combination provides both loaded and unloaded motion of 
the monitored hip joint. 
The fourth motion was basic walking. The participants were asked to simply move around the 
testing room by walking as normally as possible. The tethered AE sensors and the size of the 
testing room meant that the participants were limited to an area of approximately six square 
metres to walk. The limited walking area meant that only three to five paces could be performed 
in a straight line and hence the walking motion generally included participants walking in arcs 
as they turned around. The AE recordings for the walking motion always included multiple 
paces and typically recorded for three seconds or more. Generally, three or four AE recordings 
of three to six seconds or more were recorded for the walking motion. 
The final prescribed motion that the participants were asked to perform was heel strikes. From 
a normal standing position the participant was asked to repeatedly strike their heel against the 
ground by lifting and lowering their entire leg in a stomp-like motion. The purpose of the heel 
strikes was to determine how any heel impact was transmitted to the implant and/or 
surrounding tissue. The heel strikes were carried out using only the leg that contained the hip 
implant being monitored. The participants struck the ground with only as much force as they 
felt was comfortable. Hence, the force at which the heel struck the ground varied considerably 
between some participants. The AE recordings for the heel striking motion included multiple 
repeated heel strikes and typically recorded for three seconds or more. On average, three AE 
recordings of three or more seconds were recorded for the heel strike motion. 
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The participants were also given the opportunity to perform any other motion which they 
believed induced unique acoustic events from their prosthesis, such as squeaking. These 
motions ranged from bending over at the hips, to leg extensions from a seated position, to 
lunges. The additional motions were repeated at least three times and, depending on the motion, 
the AE recordings captured either a single repetition or multiple repetitions. 
3.5 In-Vitro Data Collection 
3.5.1 Overview 
A portion of the patients whose implants were monitored in-vivo went on to have subsequent 
revision surgery of all or some of their implant components. A number of these revision 
patients gave consent for their implant components that were removed during revision surgery 
to be used for in-vitro testing. The in-vitro testing involved manipulating the retrieved implant 
components in the laboratory environment to replicate the typical joint motions of 
flexion/extension and rotation. Any in-vitro AEs generated during these motions would be 
compared to the in-vivo AEs from the same implant components. A further purpose of the in-
vitro testing was to investigate and compare the AEs generated from the different component 
interfaces of the implant. 
Two different methods of implant manipulation were used for the in-vitro testing; robot arm 
manipulation and manual manipulation. The robot arm manipulation was employed to provide 
repeatable and reliable imitation of basic hip joint flexion/extension and rotation motions of 
the implant. Therefore, the robot arm manipulations were primarily concerned with main 
bearing interface interactions of the implants and the associated AEs. Whereas, the purpose of 
the manual manipulation was to investigate AEs generated from the trunnion Morse taper 
interactions of the femoral components that the robot arm test apparatus was unable to perform.  
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It should also be noted that in many revision cases only the bearing components (femoral head 
and acetabular liner) of the implant were replaced during revision surgery, i.e. the femoral stem 
and acetabular cup remained in the patient and were fitted with a new femoral head and 
acetabular liner respectively. Hence, in these cases, the patient’s acetabular cup and femoral 
stem could not be tested in-vitro. Therefore, when only the femoral head and acetabular liner 
were available for testing, these retrieved bearing surfaces were mated with alternative, but 
closely matched, unused acetabular cup and femoral stem components for the in-vitro testing.  
3.5.2 Robot Arm Test Apparatus 
The robot arm test apparatus utilised a 4-axis Epson RC20 robot arm to manipulate the retrieved 
implant components. The robot arm end effector was a cylindrical shaft with the shaft axis 
aligned in the vertical direction. The end effector was able to be moved in the three Cartesian 
coordinate directions x, y, and z where the x and y axes were in the horizontal plane and the z 
axis was in the vertical plane. Additionally, the end effector could be rotated about the vertical 
shaft axis (z-axis). A coordinate system is shown in-set on Figure 3.5. 
Figure 3.5 shows an image of the robot arm with an implant ready for in-vitro testing. It can be 
seen from Figure 3.5 that the components were arranged in the in-vitro apparatus in an inverted 
orientation; i.e. the implant was orientated with the femoral stem pointing upwards. The 
inverted orientation was used to allow manipulation of the femoral stem with the robot end 
effector, while the acetabular cup remained stationary, was considered to be the simplest 
method of reproducing realistic joint motions with the robot arm.  
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Figure 3.5: Robot arm in-vitro test apparatus showing implant ready for testing. 
It can also been seen from Figure 3.5 that an additional coupling was used to connect the end 
effector to the femoral stem of the implant. The additional coupling included a ball joint 
connection (known as a rose bearing) which allowed the movement of the robot end effector 
to change the orientation of the femoral stem while the femoral head remained in contact with 
the acetabular liner. Figure 3.6a shows the in-vitro test setup with the end effector positioned 
so the femoral stem is at the maximum flexion position. It can be observed from the figure that 
the additional coupling is necessary as the end effector must remain vertical and the femoral 
head must remain in contact with the acetabular liner concurrently. As a result, there is a need 
to allow relative rotation between the robot end effector and the femoral stem, which is 
provided by the rose bearing. 
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Figure 3.6: a) Robot arm in-vitro test apparatus showing implant in maximum flexion position. b) Close-up of ball joint 
coupling with Sorbothane covering removed. 
The testing apparatus employed Sorbothane (an industrial grade vibration isolation material) 
to allow force transfer but isolate the implant from any unwanted external vibrations produced 
by the robot arm actuators. Initial testing showed that the vibrations produced by the robot 
spanned the same range of frequency as the implant emissions and that this prevented simple 
low-pass or high-pass filtering to remove the robot vibrations. To isolate the acetabular 
components from vibrations propagating through the robot bed, a mounting plate with four 
Sorbothane mounts was screwed to the robot bed. The acetabular cup was secured to a steel 
mounting block which was attached to the centre of the mounting plate. To isolate the femoral 
components from vibrations propagating through the robot arm, Sorbothane was incorporated 
into the coupling between the end effector and the femoral stem. 
A close-up view of the coupling with the Sorbothane covering removed is shown in Figure 
3.6b. A layer of 5 mm thick Sorbothane was wrapped around the end of the femoral stem which 
was inserted into a tube with a 3 mm wide split running the length of the tube. Once the femoral 
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stem and Sorbothane were in place inside the tube, a hose clamp was used to compress the tube 
until the split closed up and the femoral stem was held in place. Another layer of Sorbothane 
was then clamped to the outside of the split tube and to the attachment above the ball joint. The 
purpose of the outer layer of Sorbothane was to stop the femoral stem freely rotating due to the 
rose bearing connection and to transmit torque from the end effector to the femoral stem.  
The in-vitro testing utilised the same sensing hardware as the in-vivo patient testing but 
alternative sensor locations were required due to the different setup involved. As shown in 
Figure 3.5a, one of the ultrasonic receivers was attached directly to the femoral stem and a 
second was attached to a steel block mounted directly below the acetabular cup. The two 
additional sensors were mounted to the robot arm and bed to monitor external vibrations, such 
as those initiating from the robot arm actuators, and to verify the effectiveness of the 
Sorbothane at preventing these external vibrations from being transferred to the implant and 
contaminating the signals at the implant sensors. Ultrasound transmission gel was used on each 
sensor to ensure a reliable sound transmission path by filling the space between the sensor 
diaphragms and the component each sensor was attached to. 
The in-vitro test setup was designed to simply reproduce squeaking noises without 
incorporating bone or soft tissues into the apparatus. The exclusion of bone and soft tissues is 
an obvious limitation of the in-vitro test method since any damping or attenuation of vibrations 
induced by the implant will not be replicated. Therefore, it is important to note that any 
vibrations recorded during the in-vitro testing will likely have dominant frequency content that 
differs from that of the in-vivo AEs. Literature has shown frequencies of squeaking from similar 
in-vitro test setups to range between approximately 2.4-4.4 kHz and in-vivo squeaking to range 
between 0.5-2.5 kHz (Piriou et al., 2016). Numerical modelling has shown that the inclusion 
of bone and muscle around the implant components increases the stiffness of the system and 
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can account for the differences seen in vibration frequencies between in-vitro and in-vivo 
implant vibrations in the literature (Piriou et al., 2016). Consequently, it is not expected that 
the frequency content from any AEs detected in-vitro will exactly match that of AEs detected 
in-vivo. However, any squeaking AEs will be expected to have frequency content within the 
0.5-4.4 kHz range. Furthermore, it is likely that the mechanism that induces squeaking is 
independent of the presence of bone and soft tissues since it is widely suggested by the literature 
that high friction between implant components is responsible for inducing squeaking (Currier 
et al., 2010; Hothan et al., 2011; Piriou et al., 2016). 
3.5.3 Robot Arm Test Motions 
The acetabular cup inclination was fixed at 45° to the horizontal to roughly approximate the 
inverse of the orientation of the pelvis, and the components were tested with two motion types; 
flexion-extension (FE) and rotation. Figure 3.7 shows a schematic of in-vitro setup with 
indicated FE and rotation ranges of motion. The FE angle was cycled sinusoidally between 
±30° in the x-z plane from the vertical position shown in Figure 3.5. The cycling was performed 
at three different rates of approximately 1 Hz, 1.25 Hz, and 1.33 Hz to broadly replicate typical 
gait frequency. The rotation angle was cycled between ±80° from the +30° FE angle position, 
to simulate extreme movement, at a rate of approximately 1 Hz. 
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Figure 3.7: Schematic of in-vitro implant setup showing flexion-extension and rotation ranges of motion. 
Prior to testing, the bearing surfaces of the femoral head and acetabular liner were wiped with 
acetone to remove any dust or oils present. Vertical offset of the robot end effector was used 
to ensure bearing surfaces were in good contact and a small load applied through the prosthesis. 
Due to the limitations in the robot, only low vertical loads up to 5kg were able to be applied to 
the implant. The low maximum implant loading provided by robot arm used was a limitation 
of this study but was unavoidable given the facilities available at the time of testing. Lubrication 
was not used during these tests as initial investigations found squeaking could not be reliably 
produced under lubricated conditions indicating the in-vivo occurrence of audible squeaking 
could be related to a loss of thin-film lubrication and increased friction as is suggested in the 
literature (Currier et al., 2010; Hothan et al., 2011; Piriou et al., 2016; Sariali et al., 2012; 
Walter et al., 2008; Weiss et al., 2012). In a lubricated implant in the human body, a high axial 
load may lead to the loss of the thin-film lubrication and increased friction. In the in-vitro 
testing, the complete absence of lubrication may offset the low loads applied by the robot arm. 
As with in-vivo testing, the sensor response from each motion (and different cycle rate) were 
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recorded separately to enable comparisons between the acoustic content for each specified 
motion. 
3.5.4 Manual Implant Manipulation 
The purpose of the manual manipulation was to investigate AEs generated from the trunnion 
Morse taper (TMT) interactions of the femoral components. Since the femoral head of the 
implants had only a press/impact-fit onto the cylindrical TMT of the femoral stem (see 
Section 2.2.3), it was hypothesised that the components could rotate relative to each other in-
vivo if the femoral head had not been installed with sufficient impact force. Figure 3.8 shows 
a schematic of the femoral components and depicts the direction of rotation of the femoral head 
relative to the femoral stem. 
 
Figure 3.8: Schematic of femoral components indicating axis and direction of rotation. 
To produce in-vitro AEs from the femoral TMT connection the femoral head was rotated back 
and forth by hand (in the direction depicted in Figure 3.8), while still connected to the femoral 
stem. To do this the femoral stem was held in one hand and the femoral head was rotated with 
the other hand. Both small and large rotation angles were tested with the small rotations being 
less than approximately ±5 degrees and the large rotations being up to ±45 degrees. 
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Additionally, both tight and loose fits of the femoral head were tested. Tight fits meant a large 
amount of friction was present between the Morse tapers of the components (simulating a 
femoral head installed with sufficient force) and hence a large amount of effort was required 
to rotate the femoral head. Loose fits meant the friction at the Morse tapers was greatly reduced 
and only little effort was required to rotate the femoral head thus simulating a femoral head 
installed with insufficient impact force. AEs were recorded during the rotations using a single 
sensor attached to the femoral stem in the same way that a sensor was attached to the femoral 
stem for the robot arm testing. 
The rotation of the implant components was performed manually since an effective method to 
grip the femoral head and femoral stem with the robot arm to apply the desired rotations was 
not available within the timeframe of the testing. The manual manipulation introduces 
inconsistencies to the applied force, speed, and rotation of the implant components. Therefore, 
it is important to keep in mind that AEs recorded during the manual manipulations will be 
expected to have less consistency with respect to signal parameters when compared to AEs of 
the robot arm manipulations.  
3.6 Summary 
This chapter presented the details of the AE monitoring hardware and the data collection 
protocols that were developed for the in-vivo and in-vitro AE testing. The AE monitoring 
hardware utilises four ultrasonic sensors which, through the use of National Instruments data 
acquisition hardware, interface with LabVIEW software to record AEs on a laptop computer. 
In-vivo testing was conducted on consenting THR patients, with ethical approval from the New 
Zealand Upper South A regional ethics committee (URA/10/11/075). The in-vivo testing 
required study participants to perform basic motions (such as squatting, moving from standing 
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to sitting and vice versa, stair ascents and descents, walking, heel strikes, etc.) with the 
ultrasonic sensors attached to the skin surface from the iliac crest to the upper-femur. In-vitro 
testing was conducted on retrieved implants from study participants who had previously 
undergone in-vivo testing. The in-vitro testing utilised a 4-axis Epson RC20 robot arm to 
manipulate the retrieved implant components in motions that broadly replicated hip flexion-
extension and rotation. Furthermore, in-vitro testing was conducted manually by rotating the 
femoral head about its rotational axis on the femoral stem (as shown in Figure 3.8) to 
investigate AEs from the interactions of the femoral components. 
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Chapter 4 General Analysis of Acoustic Emissions 
4.1 Introduction 
This chapter presents a summary of the demographics of the study participants and the initial 
results from the analysis of the recorded AE data. The primary focus of the chapter is to provide 
an introduction of the basic time and frequency domain appearances of the recorded AE signals 
from both the in-vivo and in-vitro testing. Figures showing visual representations of the signal 
waveforms are presented to assist in understanding the overall nature of the AE signal types. 
Since the AE technique has not been widely applied to the orthopaedic field, it is worth 
introducing the basic signal waveforms and associated frequency behaviour before attempting 
to analyse any diagnostic potential of the technique. However, this chapter will also explore 
some preliminary quantitative comparisons of the general frequency characteristics of in-vivo 
and in-vitro AEs. More specifically, comparisons of the general frequency behaviour of 
squeaking in-vivo and in-vitro AEs will be presented. This initial presentation of key 
characteristics and overall trends was deemed necessary before any more detailed analyses are 
undertaken in subsequent chapters. The clinical implications of the results of the comparisons 
will also be discussed. A subset of the results presented in this chapter have also been published 
in FitzPatrick et al. (2017b), Roffe et al. (2017) and FitzPatrick et al. (2017a). 
4.2 Participant & Database Summary 
The database of AE recordings continually increased as additional in-vitro testing was 
undertaken on implants and additional revision patients were recruited for in-vivo testing. At 
the time of writing, in-vivo data had been collected from 23 natural hips, for use as control AE 
data, and 117 total hip replacement (THR) patients. Of the hip replacement participants, 49 had 
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undergone subsequent revision surgery of their implants. Table 4.1 summarises the body mass 
index (BMI), participant age, and age of implants for the hip replacement participant cohort of 
the study. Table 4.2 provides the equivalent BMI, and participant age information for the 
control participant cohort.  
Table 4.1: Summary of BMI, age, and implant age for hip replacement study participants. 
 All Male Female 
 Average St.dev. Range Average St.dev. Range Average St.dev. Range 
BMI 
(kg/m2) 
28.7 5.1 (18.5 - 52.8) 29.8 4.7 (21.8 - 52.8) 26.5 5.2 (18.5 - 35.4) 
Age (yrs) 67.8 10.6 (23.9 - 91.4) 69.7 8.6 (48.6 - 91.4) 64.6 12.6 (23.9 - 82.7) 
Implant 
Age (yrs) 
10.6 6.1 (0.4 - 27.9) 10.9 6.3 (0.4 - 27.9) 10.0 5.5 (1.4 - 24.2) 
 
 
Table 4.2: Summary of BMI and age for study control participants 
 All Male Female 
 Average St.dev. Range Average St.dev. Range Average St.dev. Range 
BMI 
(kg/m2) 
23.8 2.1 (20.2 - 27.3) 25.1 0.7 (24.5 - 26.0) 23.3 2.3 (20.2 - 27.3) 
Age (yrs) 30.7 14.3 (21.0 - 58.6) 21.6 0.5 (21.0 - 22.1) 34.2 15.5 (21.2 - 58.6) 
 
The purpose of the control participants was to provide AE data from persons with healthy 
natural hip joints with no history of hip joint trauma or injury in order to gain a reference for 
AEs that might occur from surrounding parts of the body. The summary of Table 4.2 shows 
the control participant cohort was made up of participants who were considerably younger than 
those participants of the hip replacement cohort. However, this age discrepancy of the control 
and hip replacement participant cohorts is not considered to impact the validity of AE 
comparisons between the cohorts as the purpose of the control AE data was met. The key 
underlying concept was to obtain a baseline for AEs produced by healthy natural hip joints. 
The two groups of control participants and hip replacement participants were not intended to 
be matched cohorts.  
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The hip replacement participants had five different bearing interface material combinations 
between them; ceramic-on-ceramic (CoC), metal-on-metal (MoM), metal-on-polyethylene 
(MoP), ceramic-on-polyethylene (CoP), and ceramic-on-metal (CoM). Furthermore, for 35 of 
the 117 THR participants the specific bearing surface material combination was unknown at 
the time of writing. The source of the implant bearing surface information was the participants’ 
clinical notes and for the 35 unknown combinations the clinical notes had not been examined 
at the time of writing. Table 4.3 shows the number of artificial hips in each of the different 
bearing interface material combination categories for both the revised participants and those 
yet to undergo revision surgery. 
Table 4.3: Number of artificial hips of each bearing interface material combination for both the participants who had 
undergone revision surgery and those that had not yet had revision surgery. 
Bearing Interface Number Revised Number Unrevised Total 
CoC 11 30 41 
MoM 5 1 6 
MoP 23 0 23 
CoP 7 1 8 
CoM 1 3 4 
Unknown 2 33 35 
Total 49 68 117 
 
The reason for revision was determined from the surgical notes of the 49 participants who had 
undergone revision surgery, and hence those participants were able to be grouped by revision 
reason. Table 4.4 presents the total number of artificial hips that had been revised for each of 
the revision reasons that were identified in the participant clinical notes. It should be noted that 
any participant can have multiple reasons for revision (such as having excessive wear, 
loosening, and pain) and therefore can be included in multiple categories. Hence, the sum of 
the categories in the Table 4.4 (72) is greater than the total number of participants/hips which 
had undergone revision surgery (49). Consequently, the possibility of participants having 
multiple reasons for revision needed to be considered in subsequent analysis. 
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Table 4.4: Number of artificial hips that were revised for each revision reason. Note participants can fall into multiple 








Fractured Component 4 
Dislocation 2 
Infection 1 
Sum of Categories 72 
Total Number of 
Unique Revised Hips 
49 
 
The following analysis of AE data did not include the infection, dislocation, and fractured 
component categories due to the low number of hips in these categories. Furthermore, 11 of 
the 12 participants in the pain revision reason category were in at least one of the noise, wear, 
loosening, or fractured component categories. As a result, it was decided not to compare AE 
data in the pain category with the other categories as any trends in the pain category data were 
likely to be a combination of trends from the other categories.  
4.3 In-vivo Acoustic Emissions 
4.3.1 Overview 
Initial examination of the in-vivo AE data involved the visual inspection of both time and 
frequency domain responses. Recall that the general definition of an AE event, as stated in 
Section 2.4.3, is an AE pulse that exceeds an arbitrary voltage threshold that is above the noise 
level and then decays back to the noise level. Furthermore, the AE event duration is generally 
defined as the time span from the first crossing of the arbitrary voltage threshold to the last 
crossing of the threshold before the signal amplitude returns to the base noise level. Upon visual 
inspection of the AE recordings it was found that the base noise level of the AE signal 
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recordings was very low, on the order of ±0.1 millivolts, relative to distinct AE pulses, some 
of which were on the order of ±2 Volts. Therefore, it was generally easy to visually identify 
that AE events had occurred without explicitly quantifying a voltage threshold. Chapter 5 
presents a quantitative AE event signal analysis where an event detection algorithm was 
employed to identify distinct AE events and quantify their associated signal parameters across 
the entire AE dataset. However, the AE analysis presented in this chapter does not aim to 
quantitatively define the occurrence of specific AE events. Instead, this chapter presents 
observations from visually identified AE events that broadly represent the general behaviour 
of the AE signals. The primary focus of this chapter is to familiarise the reader with the basic 
time and frequency domain appearances of the recorded AE signals from both the in-vivo and 
in-vitro testing. In addition, a further focus of this chapter is to explore the broad frequency 
characteristics of the AE signals. 
With that being said, it is useful to introduce two main initial observations at this point and 
verify them with a quantitative result from the analysis of Chapter 5. The first important 
observation from visual inspection of the time domain responses of the AE recordings was that 
the responses mostly contained short duration acoustic events, which were typically a few 
milliseconds (ms) in duration. However, it was observed that a small number of long duration 
acoustic events occurred, which were typically much greater than 20 ms in duration. To 
quantitatively verify the observation that the AE recordings contained mostly short duration 
(<20 ms) AE events, Figure 4.1a (from the analysis of Chapter 5) shows the empirical 
cumulative distribution functions (CDFs) of AE event durations of all identified in-vivo AE 
events for the THR participant and control groups. 
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Figure 4.1: Empirical cumulative distribution functions (CDFs) of a) event durations and b) event main frequency content 
for the THR participant and control groups. 
It was observed from the empirical CDF data of Figure 4.1a that approximately 95% of AE 
events identified in both the THR participant and control data sets had durations less than 
20 ms. The long duration events, which made up only approximately 5% of observed acoustic 
events, were mainly considered to be audible squeaking events. Additionally, audible 
squeaking was only observed in participants with either ceramic-on-ceramic or metal-on-metal 
implant bearing surfaces which was consistent with literature (Imbuldeniya et al., 2013; Levy 
et al., 2015). Conversely, the short duration events were generally unnoticed by the naked ear 
during testing but were occasionally associated with ‘clicking’ or ‘popping’ sounds. 
The second important initial observation was that the Fourier transform of the AE signals 
revealed broadly consistent main frequency content for the in-vivo data. For this initial analysis 
the Fourier transform for each signal was calculated using MATLAB’s Fast Fourier Transform 
(FFT) algorithm applied to each AE signal separately. Recall from Section 2.4.3, the main 
frequency content corresponded to the frequency that had the greatest magnitude of the Fourier 
transform of an AE signal.  Figure 4.1b (from the analysis of Chapter 5) shows the empirical 
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cumulative distribution functions (CDFs) of AE event main frequency content of all identified 
in-vivo AE events for the THR participant and control groups. It was observed that 
approximately 80% of all AE events identified in both the THR participant and control data 
sets had main frequency content between 1.7 and 3.4 kHz. The observed frequency range was 
in agreement with in-vivo fundamental frequencies of THR AEs found in similar studies. 
Walter et al. (2008) observed fundamental frequencies of in-vivo squeaking AEs in the range 
of 0.4-7.5 kHz for a cohort of 31 THR participants with a mean age and body mass index (BMI) 
of 54 years and 27 kg·m-2 respectively. Sariali et al. (2012) observed main frequency content  
between 1.45 kHz and 2.46 kHz from four participants with a mean age and BMI of 60.5 years 
and 22.4 kg·m-2 respectively. Currier et al. (2010) observed in-vivo squeaking of one male and 
one female participant to have fundamental frequencies of approximately 1.5 kHz and 2.5 kHz 
respectively.  
As already stated, the results shown in Figure 4.1 were produced from the AE event analysis 
which is presented in Chapter 5. However, Figure 4.1 was included here to broadly introduce 
two general characteristics of the AE signals before the specific quantitative details of the event 
detection method are discussed in detail. The remainder of this chapter investigates the 
waveforms of some representative long and short duration AE event signals that were recorded 
from the THR study participants, control participants, and during the in-vitro testing. 
Additionally, the frequency characteristics of the AE signals in general (as opposed to the 
frequency characteristics of identified AE events) are explored and some clinical implications 
of these characteristics are discussed.  
4.3.2 In-vivo Squeaking Events 
The long duration events which were identified as squeaking usually had frequency responses 
showing a strong presence of harmonic frequencies. However, it was also observed that some 
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identified squeaking events had frequency responses that exhibited broad and noisy frequency 
peaks where harmonic frequencies were not so easily identified. Figure 4.2 shows the time and 
frequency domain magnitude responses of an in-vivo squeaking AE event from a select 
participant (Participant 1). It was observed that the event duration was approximately 110 ms 
and the overall magnitude trend of the waveform over time was symmetric: increasing for the 
first half of the duration and decreasing for the second. Additionally, the frequency response 
was observed to have a very large relative magnitude and narrow bandwidth peak at 
approximately 1 kHz with three additional lower magnitude peaks at the associated harmonic 
frequencies of approximately 2, 3, and 4 kHz.  
 
Figure 4.2: (a) Time-domain and (b) frequency-domain response plots of an in-vivo AE event from Participant 1, 
recording 6. 
Conversely, Figure 4.3 shows the time and frequency domain magnitude responses of a second 
squeaking event from the same select participant as that of Figure 4.2. It was observed that the 
event duration was approximately 570 ms which was over five times longer than that of the 
event of Figure 4.2. The overall magnitude trend of the waveform was observed to be much 
less consistent than that of Figure 4.2 but the peak magnitude occurred near the centre of the 
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event duration as it did in Figure 4.2. The frequency response was observed to have a very 
large relative magnitude and narrow bandwidth peak at approximately 1 kHz, similar to Figure 
4.2. The same presence of lower magnitude peaks at the associated harmonic frequencies of 
approximately 2, 3, and 4 kHz was also observed in Figure 4.3 but the harmonics are not as 
clear as they were in Figure 4.2. An additional peak at the fourth harmonic frequency of 
approximately 5 kHz was also observed. 
 
Figure 4.3: (a) Time-domain and (b) frequency-domain response plots of a second in-vivo AE event from Participant 1, 
recording 6. 
The AEs shown in Figures 4.2 and 4.3 show broadly similar behaviours. However, these two 
AEs do have a number of marked differences. In general, the voltage amplitude of the AE event 
of Figure 4.3 is approximately 10 times larger than that of the AE event of Figure 4.2. As 
mentioned previously, the AE event of Figure 4.3 is approximately five times longer in duration 
than that of Figure 4.2. Furthermore, the time domain response of Figure 4.3 indicates less 
consistent voltage amplitudes over time compared to that of Figure 4.2. The frequency domain 
response of Figure 4.3 has its main frequency peak at approximately 1 kHz and an additional 
and broad magnitude peak centred at approximately 1.25 kHz which was not present in Figure 
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4.2. This additional frequency magnitude peak has the second greatest magnitude of the 
frequency peaks of Figure 4.3 and is clearly not a harmonic peak. Hence, the presence of this 
additional peak indicates a secondary vibration was simultaneously present during the 
recording presented in Figure 4.3. 
Figure 4.4 shows the time and frequency domain responses of an in-vivo squeaking AE event 
from a different participant (Participant 27). It was observed that the main event duration of 
Figure 4.4 was approximately 190 ms and the signal waveform contained distinct pulses 
towards the end of the event which were not present at the beginning. These distinct pulses 
observed from the signal may indicate a stick-slip type friction motion at the implant main 
bearing interface. The frequency response was observed to have three very broad and noisy 
magnitude peaks at approximately 1, 2, and 3 kHz with the greatest magnitude occurring at the 
2 kHz peak. Given the approximate 1 kHz spacing of the frequency peaks, it is likely that the 
event of Figure 4.4 contains harmonic frequencies. However, since the frequency response was 
observed to have relatively noisy magnitude peaks it was possible the signal contained 
superposition or interference of AE signals. Figure 4.4b shows much less clearly defined peak 
frequencies and a broader range of frequency content than those seen in Figures 4.2 and 4.3. 
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Figure 4.4: (a) Time-domain and (b) frequency-domain response plots of an in-vivo AE event from Participant 27, 
recording 1. 
Superposition of AE signals or changes in the properties of the generated acoustic waveform 
could result from AEs emanating simultaneously from different sources, reflections and 
refractions of AEs from a single or multiple sources, or changes in the properties of an AE 
source over time. Further analysis of the signal was necessary to investigate the possibility of 
signal superposition of multiple AE signals or temporal changes in observed acoustic 
waveform properties. One method for further analysis of the signal was to investigate the 
frequency behaviour of the signal over time by performing short time Fourier transforms 
(STFTs). 
The STFT of a signal splits the AE data recording into short time windows (of 0.01 seconds in 
this case) and shows the frequency response for each of these time windows on one plot. The 
STFT was found by applying MATLAB’s FFT algorithm to each short time window and 
plotting the resulting FFT against time yielding a three-dimensional plot known as a 
spectrogram. Each individual time window had a 10% duration overlap with the previous 
window and a Hanning windowing function was applied to each window prior to performing 
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the FFT. The magnitude of each frequency at each window in time is represented by the colour 
of the plot and is expressed in decibels (dB) given by the corresponding colour bar. Figure 4.5a 
and 4.5b show the time domain response and the spectrogram respectively of the same AE 
event as shown in Figure 4.4. 
 
Figure 4.5: a) Time-domain response and b) spectrogram plots of same in-vivo AE recording from Figure 4.4. 
From Figure 4.5b it was observed that the magnitude of the frequency response of the AE signal 
changed over time. It can be observed from Figure 4.5b that the main frequency content of the 
signal (i.e. largest magnitude peak within that time window), indicated by the red dots, ranges 
between approximately 0.8 kHz at the beginning of the signal and approximately 3.2 kHz 
towards the end of the signal. Furthermore, at the beginning of the signal the main frequency 
content was observed to fluctuate around approximately 1 kHz. The main frequency content 
then shifted to fluctuate between approximately 1.8-2.2 kHz for the majority of the signal 
duration. Finally, towards the end of the signal, the main frequency content shifted again to 
fluctuate around approximately 3 kHz. Thus, these main frequency content observations from 
the spectrogram are, to some extent, consistent with the average frequency response of the 
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whole signal, which was shown in Figure 4.4b. From Figure 4.4b three broad frequency 
magnitude peaks were observed to be centred on approximately 1, 2, and 3 kHz, with the 2 kHz 
peak being considered the main frequency content of the signal because it had the largest 
magnitude of the three peaks. The spectrogram confirmed the observations of Figure 4.4b but 
additionally was able to identify that the main frequency content of the signal changed over 
time and that all three of the identified peaks corresponded to the main frequency content at 
separate windows in time. This example shows that a single FFT of an entire event may mask 
the varying behaviour throughout an event. Conversely, the spectrogram provides additional 
information about shifting frequencies throughout a recording as implant load, articulation 
angles, and other variables change as the participant moves. 
Another observation from Figure 4.5b was the presence of harmonic frequencies. The harmonic 
frequencies were indicated by increased frequency magnitude values (bright yellow regions) 
occurring at frequency multiples in a specific time window. For example, in Figure 4.5b at the 
time window that included 2.25 seconds, an increased frequency magnitude was observed that 
occurred at approximately 1 kHz, indicating the fundamental or 1st harmonic frequency, with 
additional bright yellow regions at the multiples of 2 and 3 kHz, indicating the 2nd and 3rd 
harmonic frequencies respectively (see annotations in Figure 4.5b). It was observed from 
Figure 4.5b that, for some of the time windows, up to five or more harmonic frequencies were 
present in the signal. Furthermore, it was evident from the spectrogram of Figure 4.5b that the 
fundamental frequency began at approximately 1.2 kHz at the start of the signal and then 
decreased in frequency approximately linearly over time until it was around 0.4 kHz towards 
the end of the signal. Consequently, the higher harmonic frequencies also exhibited decreases 
in frequency over time. This observation of decreasing harmonic frequencies over time is 
important because it helps to explain the broad frequency magnitude peaks that were seen in 
the average frequency response of the whole signal in Figure 4.4b. 
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The average frequency response of the signal (Figure 4.4b) showed noticeable frequency 
magnitude content from approximately 0.5 kHz through to almost 5.0 kHz. From observing the 
bright yellow regions of the spectrogram of Figure 4.5b it is evident that the spectrogram does 
support the observation of noticeable frequency content across the range of 0.5-5.0 kHz, but 
not for every moment in time. In addition, as identified previously, the spectrogram makes it 
evident that over the duration of the AE the main frequency content fluctuated around either 1, 
2, or 3 kHz with 2 kHz being the main frequency for the highest proportion of the duration. 
Hence, it follows that the average frequency response showed a general increase of frequency 
content in the 0.5-5.0 kHz range, greater frequency magnitudes around 1, 2, and 3 kHz, and the 
greatest frequency magnitude occurring at 2 kHz.  
In general, similar behaviours of harmonic frequencies changing over time were also seen when 
observing the spectrograms of other audible squeaking AEs. One important factor reported in 
literature that has been shown to cause changes in the frequency behaviour of squeaking AEs 
was implant loading. Hothan et al. (2011) demonstrated from in-vitro testing that increasing 
the axial load on THR implants between 200 Newton (N) and 1800 N caused an increase in the 
squeaking frequency from approximately 3.1 kHz to approximately 4.4 kHz. Given that the in-
vivo squeaking AEs occurred during dynamic participant motions, it is likely that the THR 
implants undergo significant changes in loading as a participant moves during squeaking 
events. The load on a hip joint during normal gait is in the approximate range of 0-400% body 
weight (Brinckmann et al., 2002). However, while the general motion of the participant was 
known (i.e. walking, stand from sit, stair ascent, etc.) for each squeaking event, the specific 
stage of the motion was not known (e.g. percentage of gait cycle for walking tests). Hence, for 
AEs collected using the protocol of Section 3.4, it was not possible to accurately determine a 
loading profile of the THR implants during squeaking AEs to verify any influence of implant 
loading on the observed squeaking frequencies. Nevertheless, the additional insight that the 
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spectrogram provided concerning the temporal frequency behaviour of the AE squeaking 
signals was useful as it demonstrated that average frequency responses could be misleading. 
Therefore, metrics such as main frequency content that have been acquired from the average 
frequency response of a squeaking AE should be used with caution in any further analyses. 
4.3.3 Method for Determining Squeak Fundamental Frequency 
The previous section identified that squeaking acoustic emission events generally exhibited 
harmonic frequencies. It was also observed that the main frequency content of the squeaking 
AEs often fluctuated between different harmonic frequencies over the duration of a squeak.  
These fluctuations in main frequency content result in average main frequency content values 
that can misrepresent the frequency behaviour of an AE event. Therefore, for squeaking AE 
events it would be more advantageous to find and compare fundamental frequency content 
when harmonic frequencies are present. One technique to identify the fundamental frequency 
of squeaking AE events was to employ a cepstrum. This section briefly introduces the concept 
of a cepstrum and presents results of the cepstrum technique applied to squeaking AEs. For a 
more detailed analysis of the cepstrum technique see the published conference proceeding 
covering this work (FitzPatrick et al., 2017a) in Appendix A. 
The cepstrum method is a variation on traditional frequency domain analyses, with some 
advantages when multiple strong harmonics are present. Bogert et al. (1963) defined the power 
cepstrum of a signal as “the power spectrum of the logarithm of the power spectrum” (Randall, 
2013). The concept of a cepstrum was developed while trying to identify echoes in seismic 
signals. Oppenheim and Schafer (2004) showed that a signal containing an echo can be 
represented as the summation of the original signal with a scaled and time delayed version of 
the original signal. The Fourier transform of the signal containing the echo is then equal to the 
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Fourier transform of the original signal multiplied by a periodic function that is the spectrum 
contribution of the echo (Oppenheim & Schafer, 2004). Then, by the rules of logarithms, the 
logarithm of the Fourier transform becomes the summation of the log spectrum of the original 
signal and a periodic component which has a ‘fundamental frequency’ of the echo delay 
(Oppenheim & Schafer, 2004). See Appendix A for the associated equations. 
Given that periodic components appear as sharp peaks in the spectrum of a signal, if the Fourier 
transform of the aforementioned logarithm is computed it will contain a peak at the position 
corresponding to the time that the echo occurred in the original signal (Oppenheim & Schafer, 
2004). However, the resulting spectrum, although a Fourier transform of a signal, is not in the 
frequency domain, as it has a unit of time as the independent variable, but it is also not in the 
time domain as the signal is different to the original waveform. Thus, Bogert et al. (1963) 
named this domain the quefrency domain and the spectrum of logarithm as the cepstrum since 
they found they were “operating on the frequency side in ways customary on the time side and 
vice versa” (Oppenheim & Schafer, 2004). 
While finding the presence of echoes is useful in some applications it is not immediately useful 
for AE analysis of THR implants. However, cepstrum analysis has another property which is 
of more immediate use for analysing THR AEs. Cepstrum analysis has the ability of identifying 
the fundamental frequency of a vibration when multiple harmonics are present. Consider a 
sinusoid with decayed first and second harmonics of the following form:  
𝑥(𝑡) = 𝛽1 sin(2𝜋𝑓1𝑡) + 𝛽2 sin(2𝜋𝑓2𝑡) + 𝛽3 sin(2𝜋𝑓3𝑡)    (4.1) 
where 𝛽1 = 1, 𝛽2 = 0.3, 𝛽3 = 0.1, 𝑓1 = 2𝐻𝑧, 𝑓2 = 4𝐻𝑧, and 𝑓3 = 6𝐻𝑧. Figure 4.6a shows the 
log-magnitude Fourier power spectrum of a Hanning windowed version of the signal defined 
in Equation (4.1). As expected, it can be observed from Figure 4.6a that three frequency peaks 
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are present at the appropriate frequencies of 2, 4, and 6 Hz. By taking the inverse Fourier 
transform of the log-magnitude signal in Figure 4.6a the cepstrum in Figure 4.6b is produced. 
However, the signal in Figure 4.6b does not immediately appear useful and so Figure 4.6c was 
created by replotting the data of Figure 4.6b using inverse quefrency values. By using the 
inverse quefrency values the horizontal axis of Figure 4.6c has units of Hz and it can be 
observed that a sharp peak is present at 2 Hz. Hence, the cepstrum has successfully identified 
the fundamental frequency present in Equation (4.1) of 2 Hz, despite the strong presence of 
harmonics. 
 
Figure 4.6: a) Log-magnitude Fourier power spectrum of a Hanning windowed sinusoid containing two harmonic 
frequencies, b) cepstrum of the sinusoid, and c) alternative representation of the cepstrum to show units of Hz 
on the horizontal axis. 
The ability to identify the fundamental frequencies of a signal containing harmonics is a useful 
property of the cepstrum analysis. As mentioned in Section 4.3.2, some squeaking AE signals 
from THR participants show a strong presence of harmonic frequencies. Therefore, the 
cepstrum analysis can be applied to assist in the comparison and correlation of squeaking AE 
signals of THR participants. Additionally, throughout the duration of audible squeaking, the 
position of the fundamental frequency tended to show a gradual shift of up to 1 kHz in some 
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cases. As a result, a short-time (ST) cepstrum analysis was applied to better reflect the transient 
frequency content of the AEs. 
The existing THR AE signals have been sampled at a rate of 100 kHz giving a signal time-step 
of 0.01ms. To perform the ST cepstrum analysis MATLAB software was used to apply an 
algorithm to individual THR AE signals to generate corresponding ST cepstrum signals. The 
algorithm to compute a ST cepstrum signal was as follows: 
1. Divide the signal array into 10ms windows of time and treat each time window as a 
separate signal between 0 and 10ms (That is, each signal window’s time axis array will be 
from 0 to 10ms in steps of 0.01ms.). 
2. Perform a Fast Fourier Transform (FFT) on the first time-domain window signal and 
compute the modulus of the resulting signal. Note that this new signal array is the 
frequency-domain response of the time-domain signal and has a corresponding frequency 
value array from 0 to 100 kHz in steps of 100 Hz (𝑑𝐹 = 100𝑘𝐻𝑧/1000𝑠𝑎𝑚𝑝𝑙𝑒𝑠 =
100𝐻𝑧). 
3. Compute the natural logarithm of FFT result from Step 2.  
4. Perform an inverse FFT of the result from Step 3. 
5. Compute the modulus of the result from Step 4. This new signal array is the quefrency-
domain response and because a FFT and consequent inverse FFT have been performed, 
the corresponding quefrency value array is the same as the time-domain time-step values 
from 0 to 10ms with a quefrency-step of 0.01ms. 
6. Repeat Step 2 to 5 for each of the remaining time-domain signal windows. 
7. Calculate the array of equivalent frequency values by taking the inverse of the quefrency 
value array (i.e. 1/quefrency).  
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To present the results, a 3-dimensional ST frequency-domain plot (known as a spectrogram) 
and 3-dimensional ST cepstrum plot were created for each AE signal. The spectrogram was 
created by plotting each frequency magnitude result array (Step 2 of the algorithm) on the z 
(out-of-page) axis against the corresponding frequency values on the y (vertical) axis and at 
the appropriate window position in time on the x (horizontal) axis. The window positions on 
the x-axis corresponded to the time at the centre of each window from the original time-domain 
AE signal (for example, the result arrays for the first, second, and third signal windows were 
placed at 5, 15, and 25ms on the x-axis respectively). The ST cepstrum was created by plotting 
each quefrency magnitude result array (Step 5 of the algorithm) on the z-axis against the 
corresponding equivalent frequency values (Step 7 of the algorithm) on the y-axis and at the 
appropriate window position in time on the x-axis. The resulting 3D plots are shown here as 
2D colormaps. 
Figure 4.7a shows the time-domain response of an audible squeak from a THR participant.  
Figure 4.7b shows the ST frequency-domain response (spectrogram) of the AE signal from 
Figure 4.7a with lighter colours representing higher magnitude of frequency content and red 
dot markers indicating the largest magnitude frequency content. The spectrogram shows the 
frequency content of the time-domain signal over time and hence any transient frequency 
behaviour can be identified. For the purpose of this cepstrum analysis the absolute magnitudes 
of the frequency responses (and quefrency responses) are not important and therefore the 
absolute magnitude scale (colorbar) has been included only to indicate the relative magnitude 
of one colour to the next; this analysis is primarily concerned with the locations of peak 
frequency content and fundamental frequencies which can be found by considering relative 
magnitudes. 
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Figure 4.7:  a) Time-domain response of an AE audible squeak 
from a THR patient; b) corresponding Frequency-
domain and c) quefrency-domain responses 
showing lighter colours representing higher 
magnitude and peak magnitudes denoted by red 
dot markers. 
 
Figure 4.8:   (a) Time-domain plot of an audible AE squeak 
from a second THR patient; (b) corresponding 
frequency-domain and (c) quefrency-domain 
responses. Lighter colours represent larger 
magnitude and red dots denote peak magnitudes. 
It was observed from Figure 4.7b that there was a strong presence of harmonics in the signal 
and the fundamental frequency changes substantially over time (having a range of 
approximately 1 kHz from approximately 0.7 to 1.7 kHz). The frequency of largest Fourier 
magnitude (indicated by red dot markers) in Figure 4.7b was observed to move from the 
fundamental frequency to the first harmonic for a short time and then return to the fundamental 
frequency. This shifting of the largest magnitude frequency between the fundamental and 
associated harmonics was observed in a number of the THR AEs when audible squeaking was 
present. This shifting between harmonics creates difficulties in the identification of both the 
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frequency of the fundamental vibration mode and the associated variation in this frequency 
over time. 
Figure 4.7c shows the ST cepstrum response of the same AE of Figure 4.7a and 4.7b, again 
with lighter colours representing larger magnitudes. Figure 4.7c shows that the peak 
magnitudes, indicated by red dot markers, compared very well with the fundamental frequency 
peak of the corresponding spectrogram of Figure 4.7c during the period when strong harmonics 
were present. During the time windows where the harmonics were less pronounced or non-
existent the cepstrum peak magnitudes appeared to demonstrate much higher variability. 
Figure 4.8a shows the time-domain response for an AE audible squeak from a second THR 
patient and Figure 4.8b shows the corresponding spectrogram. The spectrogram shows that the 
majority of the peak frequency content (indicated by the red dot markers) was scattered 
between 2 to 3 kHz. However, between 2.2 and 2.4 seconds the spectrogram shows the 
fundamental frequency linearly decreases from approximately 1.2 kHz to approximately 
0.2 kHz with the presence of a number of harmonics. Therefore the frequency of largest Fourier 
magnitude in Figure 4.8b alone does not necessarily give an accurate representation of the 
frequency behaviour of the AE, as illustrated by the scattered red dot markers. 
Figure 4.8c shows the ST cepstrum response of the AE from Figure 4.8a. It was observed that 
for regions of the signals where harmonics were not strong or well-defined, the peak cepstrum 
magnitudes appeared scattered across the quefrency axis. However, in the region between 
approximately 2.25 and 2.35 seconds the peak cepstrum magnitudes showed a linear decrease 
from approximately 1 kHz to approximately 0.5 kHz. Figure 4.9a shows the time-domain 
response for an AE audible squeak from a third THR patient and Figure 4.9b shows the 
corresponding spectrogram. It was observed from the spectrogram that the largest magnitude 
  88 
frequency between approximately 0.7 and 0.9 seconds was approximately 3 kHz but showed a 
small increasing trend with time. The main frequency content from 0.9 seconds dropped to 
approximately 1.7 kHz and was steady for the remainder of the squeak. Figure 4.9c shows the 
ST cepstrum response of the AE from Figure 4.9a. It was observed that between approximately 
0.8 and 0.9 seconds the peak cepstrum magnitudes were approximately 1.5 kHz and showed a 
similar shallow increasing trend to that of the peak spectrogram frequencies during the same 
time period. 
 
Figure 4.9: a) Time-domain plot of an audible squeak from a third THR patient, (b) corresponding frequency-domain and 
(c) quefrency-domain plots. Red markers are peak magnitudes. 
The spectrogram results of the three different THR patient’s audible squeak signals (Figure 
4.7b, Figure 4.8b, and Figure 4.9b) had peak frequency content that varied substantially. Some 
of the variation in peak frequency content was observed to be due to peak magnitudes switching 
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between the fundamental frequency mode and various harmonics over time. This behaviour 
can be explained by considering that a larger amount of energy would be required to excite a 
higher vibration mode of a component and hence if different amounts of vibrational energy are 
present at different stages of the squeak different vibration modes would be excited more 
strongly. To support this idea, Figure 4.9a and Figure 4.9b show that the period of time after 
the peak frequency content drops from the 1st harmonic (which was approximately 3 kHz) to 
the fundamental frequency (which was approximately 1.5 kHz), the time-domain amplitude is 
significantly reduced and hence less vibrational energy is present. 
During the time periods when the peak frequency content of the AE signals was consistently 
identifying either the fundamental or a given harmonic, some variation in the peak frequency 
was still observed. This variation was generally limited to a maximum of 200 Hz between time 
windows. One possible explanation for this additional variation is the influence of implant 
positioning, muscle forces and associated implant loads during the patient gait cycle. The 
squeaking signals were recorded while the patient was performing basic orthopaedic test 
motions such as walking, standing and sitting, and stair ascents. Therefore it is very likely that 
implant joint angles and loadings changed significantly during the squeak. Literature concerned 
with squeaking of THRs has found that squeaking frequencies tend to increase with increased 
implant loads (Hothan et al., 2011). An increase in implant loadings may affect factors such as 
the stiffness of the entire implant-bone system and consequently modify the natural vibration 
frequencies of the system. 
The results from the ST cepstrums showed that when strong harmonics were present in the AE 
signals, the peak magnitudes of the cepstrums were closely aligned with the fundamental 
frequencies seen in the spectrogram results. During these periods where strong harmonics are 
present, the cepstrum analysis performed well at collapsing the higher harmonics of the signal 
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and identifying the fundamental vibration frequency. The identification of the fundamental 
vibration frequency allows for more reliable comparisons of squeaking frequencies between 
separate AE signals. Prior comparisons of AE signals compared the peak magnitude frequency 
content which exhibited substantial variations due to the harmonics present in the signal. 
Comparisons between AE signals using the frequencies identified by the cepstrum analysis has 
the potential to more reliably categorise AE signals based on the fundamental mode and thus 
assist in identifying signals that characterise particular implant failure modes or conditions.  
One of the main limitations of the cepstrum is its inability to isolate frequencies of significance 
when strong harmonics are not present. This limitation is easily observed in the scattered peak 
magnitude markers of Figure 4.7c, Figure 4.8c, and Figure 4.9c for periods of time where the 
corresponding spectrograms show weak harmonic frequencies. It might be expected that the 
cepstrum would be able to identify the peak magnitude frequency content during time periods 
without harmonics; however, this was not the case and the associated frequencies of the peak 
cepstrum magnitudes during these periods had no obvious significance. It is therefore important 
to carefully consider the frequency content of any signal before applying a cepstrum analysis 
in order to interpret the results accordingly. 
Another limitation of the cepstrum is that while the quefrency resolution is constant, the 
equivalent frequency resolution is not constant. The equivalent frequencies of the cepstrum are 
related to the quefrencies through an inverse relationship (i.e. frequency = 1/quefrency) and 
hence the frequency resolution of the cepstrum is very high at low frequency and decreases as 
frequency increases. This trend means that the cepstrum may produce distorted result if the 
frequencies of interest have a large bandwidth. In the case of the audible squeaks of Figure 4.7, 
Figure 4.8, and Figure 4.9 a large bandwidth is not a significant issue as the frequencies of 
interest are below 4 kHz. The coarsest frequency resolution up to 4 kHz is approximately 
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150 Hz which is sufficient for useful frequency comparisons between squeaks. However, the 
equivalent frequency resolution must be considered if the frequencies of interest become higher 
than 4 kHz, or if the length of the cepstrum time window decreases, as this will also affect the 
size of the quefrency resolution. 
A further limitation of the cepstrum is its sensitivity to signal noise. The cepstrum is defined 
as the “spectrum of the log-magnitude spectrum of a signal” (Randall, 2013). The spectrum of 
a signal will inevitably contain some level of noise. When the log-magnitude spectrum is 
computed and then treated as a linear scale in decibels, any noise will be amplified along with 
the signal. When the inverse Fourier transform is applied to the log-magnitude spectrum the 
amplified noise will much more significantly affect the result. Higher sampling rates will also 
have a similar effect as they will include high frequency noise in the signal, which may have 
otherwise not been recorded. Much of the scatter observed in Figure 4.7, Figure 4.8, and Figure 
4.9 can be attributed to time windows without major AE content, resulting in primarily ambient 
noise with a low signal-to-noise ratio. 
4.3.4 In-vivo Non-squeaking Events 
Worldwide research interest in the occurrence of THR implant squeaking has meant that special 
attention has been given to the study of THR implant squeaking. The origin of squeaking is 
still debated among researchers and is repeatedly reported as multifactorial. Implant squeaking 
produces strong AE signals which are easy to record and to distinguish from other recorded 
AE signals. Therefore, the analysis of THR implant squeaking is a good starting point for 
investigation of implant AEs in general. However, it should be noted that audible squeaking is 
not considered a major problem of THR implants. As identified in Section 2.2.4, a recent meta-
analysis found the incidence of squeaking in ceramic-on-ceramic THRs to be 4.2%, of which 
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the incidence of subsequent revision for squeaking was 0.2% (Owen, D. H. et al., 2014). 
Implant failures such as loosening and repeated dislocations have a much greater prevalence in 
THR participants and squeaking is not usually associated with these failure mechanisms.  
Therefore, this study is not focussed exclusively on THR implant squeaking as is demonstrated 
in the following sections. 
The large majority (approximately 95%) of the in-vivo acoustic events observed from initial 
observations of the time domain signals had durations below 20 ms. In contrast to audible 
squeaking events, most of these short duration (<20 ms) events were not heard by the naked 
ear during the in-vivo testing. A very small number of audible ‘clicks’ or ‘pops’ did occur 
during testing but it was not practical to keep track of which specific acoustic event matched 
an audible sound during testing (in some cases, a note was taken of the specific test recording 
during which an audible sound occurred, but no particular acoustic signal event or fluctuation 
could be reliably associated with the audible noise). Nonetheless, being able to confirm the 
presence of audible short duration acoustic events in a particular acoustic recording was of less 
importance to the study than noting the presence of audible squeaking. 
Figure 4.10 shows the time and frequency domain responses of an in-vivo short duration event 
from a select participant (Participant 1). It was observed that, at 6.7 ms, the event duration was 
significantly lower than those of the squeaking events in Section 4.3.2 (Figures 4.2-4.4). The 
overall magnitude trend was observed to be similar to the behaviour that would be expected 
from an impulse excitation, i.e. peak magnitude is reached relatively quickly (short rise time) 
and then the oscillation amplitude decays gradually to background noise levels. An important 
observation to note was that the peak amplitude of this acoustic event was approximately 
0.15 V which was comparable to the amplitude of the first squeak of Section 4.3.2 in Figure 
4.2. The frequency response of the event of Figure 4.10 was observed to have a main peak at 
  93 
approximately 3 kHz and did appear to contain shallow broad harmonic frequency peaks at 
approximately 6 and 9 kHz, potentially indicating the presence of harmonics. 
 
Figure 4.10: (a) Time-domain and (b) frequency-domain response plots of an in-vivo AE event from Participant 1, 
recording 3. 
Figure 4.11 shows the time and frequency domain responses of an in-vivo short duration event 
from a different participant (Participant 112). It was observed that the behaviour of the signal 
was similar to that of Figure 4.10 in that the signal indicates an impulse excitation has occurred. 
The most notable feature of the signal is that it looks very similar to a decaying sine wave with 
only one frequency component. The frequency spectrum (Figure 4.11b) supported this feature 
as it showed the presence of a single relatively narrow bandwidth frequency magnitude peak 
at approximately 3.1 kHz dominating the frequency response of the signal. A much lower 
magnitude and broader peak was present at approximately 1.1 kHz but the effect of this was 
not obvious in the time domain response of Figure 4.11a. 
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Figure 4.11: (a) Time-domain and (b) frequency-domain response plots of an in-vivo AE event from Participant 112, 
recording 26. 
The signals of Figure 4.10 and Figure 4.11 were typical of in-vivo short duration AE events 
that occurred when long duration events did not occur in close time proximity to the short 
duration event. However, a number of short duration events did occur in close proximity to the 
long duration squeaking events. It was noted in Section 4.3.2 that some squeaking events had 
distinct pulses that occurred. This meant the signal returned to background noise levels for a 
brief time (typically only a few milliseconds) before exhibiting oscillations of significant 
magnitude again during squeaking events. Figure 4.12 shows the time and frequency domain 
response of an acoustic event that occurred within a few milliseconds after the end of the 
squeaking event shown in Figure 4.4. Note that the event detection algorithm determined the 
squeaking event of Figure 4.4 to be between 2.2-2.4 seconds of the AE recording. Furthermore, 
the two distinct pulses that occurred after 2.4 seconds in Figure 4.4 were determined to be two 
separate AE events by the event detection algorithm and it is the first of these pulses that is 
shown in Figure 4.12.  
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Figure 4.12: (a) Time-domain and (b) frequency-domain response plots of a second in-vivo AE event from Participant 27, 
recording 1, where the immediately preceding event was previously presented in Figure 4.4. 
It was observed from Figure 4.12 that the acoustic event showed similar behaviour to the short 
duration events already presented. Nevertheless, given the close proximity of the event of 
Figure 4.12 to the other pulses of the audible squeak of Figure 4.4 and the overall similarity of 
their frequency profiles, the event of Figure 4.12 was likely to have been an audible portion of 
the distinct audible squeak of Figure 4.4. To the human ear, the event of Figure 4.12 sounds 
like a “click” when listened to in isolation. However, when the event was listened to 
immediately following the squeaking event of Figure 4.4 the “click” is indistinguishable from 
the squeaking sound and demonstrates that the event likely contributed to the squeaking sound 
that was observed. 
Occasionally in-vivo short duration acoustic events occurred that had most of their frequency 
content above approximately 5 kHz. Figure 4.13 shows an example of such an event where it 
was observed from the frequency response (Figure 4.13b) the event had a main frequency of 
approximately 9.1 kHz and many other peaks of relatively large magnitudes at frequencies 
above 5 kHz. It was also observed from Figure 4.13b that the magnitude of the frequency 
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response for frequencies between approximately 1 kHz and 4 kHz (the range where the peak 
frequencies of all acoustic events presented thus far had occurred) were insignificant when 
compared to the magnitudes for frequencies above 5 kHz. This result indicates that while most 
of the short duration events were observed to behave similarly, some short duration events were 
recorded during testing that had main frequency content at much higher frequencies. Therefore, 
further investigation of the short duration events would be necessary to determine the 
significance of their differences and similarities. 
 
Figure 4.13: (a) Time-domain and (b) frequency-domain response plots of an in-vivo AE event from Participant 23, 
recording 5.  
4.3.5 Control Hip Acoustic Emissions 
Initial observations of the AE signals that were obtained from the control participants during 
in-vivo testing indicated a relative lack of AE activity above background noise levels (when 
compared to the in-vivo THR AE recordings). The mean rate of AE events occurring during all 
test recordings for the THR participants was 1.17 AE events per second, whereas the mean rate 
for the control participants was 0.65 AE events per second. Consequently, yielding an 
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approximate 45% decrease in the rate of occurrence of AE events in the control participants 
compared to the THR participants. Nevertheless, the total number of AEs recorded from the 
control participants was substantial. Figure 4.14 and Figure 4.15 show the time and frequency 
domain responses of an AE event that occurred during the AE recordings for two select control 
participants (Control 1 and Control 20 respectively). The AE events of Figure 4.14 and Figure 
4.15 were typical of most AE events observed from the control participants. It was also 
observed that these typical events were similar in nature to the THR participant in-vivo short 
duration AE events of Figure 4.10 and Figure 4.11. This result is significant in that it indicates 
the high likelihood that the THR in-vivo AE recordings contained AE events that did not 
originate from the implant components. AE events that have not originated from the implant 
components are most likely to have been induced from sources such as other joints in the body, 
muscle movements, movement or sliding of tendons, fascia, ligaments, and other inherent 
movement of biological material. However, it is also possible that some AEs could be artefacts 
from the sensing hardware such as movement of the sensor array on the skin surface.  
 
Figure 4.14: (a) Time domain and (b) frequency domain response plots of an in-vivo AE event from Control 1, recording 7. 
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Figure 4.15: (a) Time domain and (b) frequency domain response plots of an in-vivo AE event from Control 20, recording 6. 
As observed from the empirical CDFs of Figure 4.1, the control participant AE data 
demonstrated broadly similar trends to that of the THR participant data in which approximately 
90% of the AE events had main frequency content below 3.4 kHz. Accordingly, control AE 
signals occasionally showed the presence of short duration AE events with main frequency 
content above 3.4 kHz. Figure 4.16 shows the time and frequency domain responses of a second 
in-vivo AE event from one of the control participants (Control 1). It was observed from Figure 
4.16b that the main frequency content of the event was approximately 21 kHz. As with the 
THR participant AE data, further investigation of the short duration events from control 
participants would be necessary to determine the significance of the high main frequency 
content AE events. 
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Figure 4.16: (a) Time domain and (b) frequency domain response plots of an in-vivo AE event from Control 1, recording 10. 
Another observation from the control participant AE data was the presence of events with 
relatively long durations. Figure 4.17 shows the time and frequency domain responses of an 
in-vivo AE event from a third select control participant (Control 9). It was observed from Figure 
4.17 that the duration of the AE event was approximately 40 ms, which was considerably longer 
than the vast majority of control participant AE events. Approximately 90% of control 
participant AE events had durations of 12 ms or less. Conversely, a small number of the control 
participant AE events had durations considerably larger than 12 ms. The typical frequency 
response of these long duration (>12 ms) control participant events was relatively noisy and 
generally contained a broad magnitude peak in the region between approximately 1 to 5 kHz 
as was observed in Figure 4.17. The behaviour observed from the long duration AEs in the 
control participant data was in contrast to the general behaviour observed in the long duration 
THR participant AEs of Section 4.3.2 which were generally squeaking events. 
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Figure 4.17: (a) Time domain and (b) frequency domain response plots of an in-vivo AE event from Control 9, recording 22. 
The AEs that were detected from the control participants confirm that, as would be expected, 
some AEs are produced from sources unrelated to the components of a THR implant. Further 
analysis of this AE data from the control participants could lead to the ability to distinguish 
between AEs produced as a result of the presence of a THR implant and AEs produced due to 
interactions of biological matter unrelated to THR implants. The ability to distinguish between 
AEs in the aforementioned way would allow for a more focussed study on THR AEs to be 
carried out as AEs unrelated to the presence of the THR could be identified and excluded from 
analysis. Therefore, the data collected from the control participants provides useful reference 
AEs for the ongoing analysis of the in-vivo THR AEs. 
4.4 In-vitro Acoustic Emissions 
Initial in-vitro testing was focussed on ceramic-on-ceramic (CoC) implants in an attempt to 
replicate the audible squeaking that was produced in-vivo from the same implants. In-vitro 
testing of five retrieved CoC implants from the revised participants have been performed at the 
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time of writing. As indicated in Section 4.2, 11 participants with CoC implants had been 
revised. However, of these 11 participants, only five had made their retrieved implant 
components available for in-vitro testing. Four of the five available retrieved CoC implants 
produced audible squeaking during in-vivo AE monitoring confirming that the detected 
emissions were originating from the hip joint rather than any other biological activity. When 
tested in-vitro, under non-lubricated conditions, all five implants produced squeaking during 
both flexion/extension and trunnion Morse taper (TMT) rotation motions (see Section 3.5 for 
testing methodology).  
The major observation from the in-vitro AE signals was that the proportion of recorded AEs 
that had short durations (below approximately 20 ms) was substantially less relative to the 
durations observed from in-vivo testing. Approximately 47% of in-vitro AE events had 
durations less than 20 ms, significantly contrasting the 95% from the in-vivo AE data. 
Additionally, only approximately 25% of in-vitro AE events had durations less than 10 ms 
while 80% of in-vivo AEs and 85% of control AEs had durations less than 10 ms. It should be 
kept in mind that the in-vitro testing was not an exact replication of the in-vivo testing 
environment. However, the in-vitro testing observations suggest that short duration AE events 
measured in-vivo may not be a result of interactions within the THR implant components 
themselves given the observed lack of short duration AEs in-vitro. As identified in Section 3.5, 
during the in-vitro AE monitoring an acoustic sensor was attached directly to the implant 
femoral stem and vibration isolation material was used to attenuate unwanted external 
vibrations propagating through to the implant from the robotic manipulation process. 
Therefore, the nature of the in-vitro test setup suggests that the vast majority of AEs detected 
in-vitro were the result of implant vibrations induced by the interaction of the manipulated 
implant components. Conversely, it is likely that a substantial proportion of the short duration 
AE events detected in-vivo are a result of interactions between other components of the overall 
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joint system (such as muscle, soft tissue, bone, ligaments, fascia, tendons, bone to implant 
interactions, or possibly even the knee joint).  
As with the in-vivo AEs, the long duration in-vitro AEs were generally audible squeaking 
events. The time and frequency domain responses of these audible squeaking AEs exhibited 
similar trends to those of the in-vivo audible squeaking AEs of Section 4.3.2 (Figures 4.2-4.4). 
However, some differences were observed between the frequency domain responses of the in-
vitro and in-vivo AEs. Each implant tested in-vitro generally exhibited different main frequency 
content to the other implants from the flexion/extension motion. Additionally, for some 
implants, the main frequency content of the AEs was found to be different if the relative 
rotational orientation of the implant bearing surfaces, along the rotational axes (see Figure 3.8) 
of the implant components, was changed between tests. Across the different implants tested in-
vitro, the main frequency content varied between approximately 1 kHz and 8 kHz. 
A small number of short duration AE events occurred during the in-vitro testing which were 
generally similar in form to the in-vivo short duration events of Section 4.3.4 (Figures 4.10-
4.12). However, the in-vitro short duration events were observed to occur with more periodic 
consistency between their occurrences than those observed during in-vivo testing. The 
periodicity of the short duration events was primarily a result of the periodic flexion/extension 
motions performed by the robot arm during in-vitro testing, described in Section 3.5.3. The 
periodic consistency was also observed in the long duration in-vitro events and hence 
consistency was observed in the timing gaps between long and short duration events. Figure 
4.18 shows a time domain response of AEs recorded during an in-vitro test where consistent 
timing gaps were observed between subsequent long and short duration events. The consistency 
in the timing gaps indicates that the occurrence of long and short duration THR AE events may 
not be independent of each other which may be useful information for categorising both in-
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vitro and in-vivo THR AEs. While it was immediately obvious that most in-vitro events had 
this consistency in timing gaps, without further investigation, it cannot be concluded that the 
in-vivo events did not also exhibit similar consistency behaviour. 
 
Figure 4.18: Time domain in-vitro flexion/extension test result showing consistent timing gaps between long and short 
duration events. 
Further observations from the in-vitro testing were related to the AEs generated from manual 
trunnion Morse taper (TMT) rotation of the femoral head on the femoral stem, described in 
Section 3.5.4. The overall frequency responses of the in-vitro TMT rotations were noticeably 
more variable, in terms of main frequency content, and contained frequency content above 
background noise levels across the entire measured spectrum. Some of the variability observed 
in the TMT rotation AEs may be explained by inherent inconsistencies introduced by the 
manual manipulation of the femoral implant components. The nature of the manual 
manipulation meant that the force, speed, and rotation that was applied to manipulate the joint 
was not able to be controlled as accurately as with the flexion-extension manipulations using 
robotic control. Therefore, it would be desirable to conduct further TMT rotation testing to 
investigate the effect of different testing conditions on the observed AEs, preferably using 
robotic manipulation.  
Nevertheless, it was observed that most AEs generated from the TMT rotation had main 
frequency content above approximately 12 kHz. On occasion, audible squeaking was observed 
during TMT rotation testing. The observed squeaks generally had a noticeably higher pitch 
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than the squeaks of the flexion-extension motion which was consistent with their frequency 
content being above 12 kHz. Additionally, occurrences of large voltage values from the 
ultrasonic receivers were often observed during TMT rotation testing, indicating substantial 
acoustic activity had occurred, but these occurrences had not been perceived by the naked ear. 
Given that the frequency range of human hearing only extends up to approximately 20 kHz, 
the unperceived AEs necessarily had their main frequency content above 20 kHz which was 
confirmed by examining their frequency responses. Figure 4.19 shows the time and frequency 
domain responses of a typical in-vitro AE event from the TMT rotation motion where it was 
observed that the main frequency content occurred at approximately 22 kHz. Across all of the 
in-vitro tests, the main frequency content of the TMT rotations generally ranged from 
approximately 12 kHz up to 45 kHz. 
 
Figure 4.19: (a) Time domain and (b) frequency domain response plots of an in-vitro trunnion Morse taper rotation AE event 
from Participant 1 (Bench 76, recording 13). 
Another important observation from the TMT rotation testing was that grinding noises were 
often heard as a result of friction induced by the implant interactions. Frequency responses of 
multiple TMT rotation tests where audible grinding occurred, but no audible squeaking, were 
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examined and were found to contain main frequency content in the 1-5 kHz range. Figure 4.20 
shows the time and frequency domain responses of an in-vitro TMT rotation AE where audible 
grinding was observed. It was apparent from Figure 4.20 that the main frequency content of 
the grinding noise was at approximately 2.4 kHz. The observation that TMT rotation grinding 
noises have main frequency content in the range below 5 kHz is important because the audible 
AEs of the flexion-extension motions also had main frequency content within this range. It is 
also important to note that when only audible grinding noises were observed there was no 
noteworthy frequency content above approximately 12 kHz in the AEs.  
 
Figure 4.20: (a) Time domain and (b) frequency domain response plots of an in-vitro trunnion Morse taper rotation AE event 
from Participant 53 (Bench 78, recording 9). 
4.5 In-vivo & In-vitro Comparisons 
The frequency responses of the in-vivo and in-vitro flexion-extension motion were compared 
for particular participants and it was found that they exhibited similar characteristics. The 
frequency responses were computed using a Fast Fourier Transform (FFT). In order for the 
frequency domain transforms to be comparable in both frequency and magnitude, the time 
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domain signals were split into time windows with a duration of two seconds. A Hanning 
windowing function was applied to the signal data to remove any effects from non-periodicity 
or discontinuous signals. After the FFTs had been applied, the frequency magnitude spectrum 
of the windowed signals, from 0 Hz to the Nyquist frequency of 50 kHz, was plotted.  
Figure 4.21 shows all the frequency responses of the in-vivo and in-vitro flexion-extension and 
in-vitro TMT rotation motions for one of the five CoC THR participants whose implant 
underwent both in-vivo and in-vitro testing. That is, the individual frequency response for each 
two second window of time has been overlaid onto the same plot and coloured corresponding 
to its signal motion group. Consequently, the resulting plot of Figure 4.21 emphasises the 
common frequencies that dominated the AE signals for each of the three signal motion groups. 
Figures 4.22-4.25 show equivalent plots to Figure 4.21 for the other four of the five CoC THR 
participants whose implant underwent both in-vivo and in-vitro testing. It was observed from 
Figures 4.21-4.23 that the positions of the main frequency content of the in-vivo and in-vitro 
flexion-extension motion datasets for three of the participants were broadly similar. However, 
the in-vivo results generally showed a much broader peak as might be expected due to the 
higher complexity of testing and sound transmission paths which subtly affect the position of 
the main frequency content. Upon closer inspection, the presence of harmonics was observed 
in the in-vivo results of all five participants. Figures 4.24-4.25 demonstrate that while the main 
frequency content of the in-vivo and in-vitro flexion/extension motions did not align for two of 
the five participants, the main frequency content of these two participants’ in-vitro flexion-
extension responses approximately aligned with a harmonic peak of the corresponding in-vivo 
responses. 
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Figure 4.21: Overlaid frequency responses for all in-vivo and in-vitro flexion motions and in-vitro trunnion Morse taper 
rotations for Participant27. 
 
Figure 4.22: Overlaid frequency responses for all in-vivo and in-vitro flexion motions and in-vitro trunnion Morse taper 
rotations for Participant25. 
 
Figure 4.23: Overlaid frequency responses for all in-vivo and in-vitro flexion motions and in-vitro trunnion Morse taper 
rotations for a fifth select participant Participant53. 
 
Figure 4.24: Overlaid frequency responses for all in-vivo and in-vitro flexion motions and in-vitro trunnion Morse taper 
rotations for Participant1. 
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Figure 4.25: Overlaid frequency responses for all in-vivo and in-vitro flexion motions and in-vitro trunnion Morse taper 
rotations for Participant6. 
In contrast to the flexion-extension motion AEs, the in-vitro TMT rotation AEs yielded main 
frequency content above 12 kHz as identified in Section 4.4. It was clearly observed from 
Figures 4.21-4.25 that the overall frequency responses of the TMT rotation AEs had more high 
frequency content than the flexion-extension motion AEs. The occurrence of more high 
frequency content in the TMT rotation AEs indicates that the vibrations induced by the TMT 
rotations were noticeably different to those induced by both the in-vivo and in-vitro flexion-
extension motions. The frequency responses of the in-vivo AEs show more similarity to the in-
vitro flexion-extension motion AEs than they do to the in-vitro TMT rotation AEs. Hence, the 
results of Figures 4.21-4.25 suggest that the AEs observed in-vivo are more likely to be induced 
by the interaction of the main bearing surfaces of the THR implant than the rotation of the 
femoral head relative to the femoral stem (i.e. TMT rotation). However, it was also observed 
that some of the TMT rotation recordings did contain AEs with noticeable frequency content 
below approximately 12 kHz which overlapped with the main frequency content of the flexion-
extension motion AEs (see Figures 4.22 and 4.23 in particular). Further investigation 
determined that the frequency content that overlapped with that of the flexion-extension motion 
AEs was a result of a friction grinding noise at the TMT interface during the component 
manipulations, such as that shown in Figure 4.20, and was not the result of any squeaking AEs.  
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4.6 High Frequency In-vivo Acoustic Emissions 
The in-vivo and in-vitro comparisons showed that the in-vivo AEs did not have any substantial 
frequency content above approximately 10 kHz. Furthermore, research into attenuation 
characteristics of the soft tissue surrounding THRs had suggested that there is significant 
attenuation of vibrations above 10 kHz (Khan-Edmundson et al., 2012). Therefore, it could be 
argued that the soft tissues may have masked the occurrence of high frequency AEs during the 
in-vivo testing. Consequently, comparisons were performed between ambient noise and clearly 
audible in-vivo squeaking events to reinforce the ability of the current AE monitoring 
equipment to detect the presence of high frequency in-vivo AEs. An example of the time 
domain response of an in-vivo AE recording in one participant with three audible squeaks (at 
approximately 0.75, 1.25, and 2.25 seconds) is shown in Figure 4.26. A spectrogram of this 
recording was taken to show the transient frequency content throughout the recording (Figure 
4.27). It was observed from Figure 4.27 that during the three audible squeaks there was a 
noticeable increase in the frequency content across the entire 0-50 kHz spectrum relative to the 
ambient noise level during the other parts of the recording. This result is important since it 
confirms with good confidence that if high frequency AEs occurred during in-vivo testing they 
would have been detected by the AE monitoring equipment.  
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Figure 4.26: Time domain response of three in-vivo audible squeaks from Participant 1. 
 
Figure 4.27: Spectrogram of time domain response shown in Figure 4.26. 
4.7 Clinical Relevance of In-vivo & In-vitro Comparisons 
In-vitro rotation of the trunnion Morse taper connection (TMT) produced characteristic 
squeaking with frequency responses which did not overlap with the frequencies observed 
during in-vivo squeaking. The in-vitro flexion-extension (FE) results, representing AEs from 
the main bearing surface interaction, showed a notably better fit to the in-vivo data than the in-
vitro TMT rotation results. In spite of directly observed fretting of the trunnion Morse taper, 
this would strongly suggest that the AEs generated from a participant’s hip prosthesis are likely 
to be induced from the main bearing surface interaction rather than any rotation occurring at 
the TMT. 
As mentioned in Section 4.6, previous research had suggested that significant attenuation of 
vibrations above 10 kHz occurs due to the soft tissue surrounding a THR (Khan-Edmundson 
et al., 2012). It can be reasoned that AEs seen in-vivo may in fact still have contributions from 
TMT rotation as only low frequencies reach the sensors on the skin’s surface. However, it was 
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demonstrated that the AE sensors recorded an increase in the frequency content across the 
entire 50 kHz spectrum relative to ambient noise during in-vivo testing (Figure 4.27). This 
implies that high frequency (>10 kHz) AEs would in fact reach the skin and be detected by the 
sensors, albeit at reduced magnitude. From the results, it can be concluded that squeaking in-
vivo is not likely caused by TMT rotation as the presence of characteristic high frequency TMT 
rotation squeaking AEs was not detected in the in-vivo tests of the 111 participants in this study. 
While it is true that a very small number of in-vivo recordings did have main frequency content 
above 10 kHz, the durations of these high frequency AEs were too short (i.e. less than 10 ms 
in duration) to be observed as squeaking. 
These findings suggest there is no significant movement occurring at the TMT in-vivo and, by 
implication, we should not expect to see excessive wear on this interface. However, wear at 
this interface is extremely common and was shown on the retrieved implants within this study 
and on those examined by others (Goldberg et al., 2002; Hallab et al., 2004; Hannouche et al., 
2010; Jacobs et al., 2014; Kop & Swarts, 2009). Figure 4.28 shows an image of a retrieved 
femoral head from this study with obvious wear markings in the Morse taper region (see arrow) 
of the component. All five of the retrieved CoC components in this study had such surface 
markings in their Morse taper region. 
 
Figure 4.28: Retrieved thirty-six millimetre ceramic femoral head showing wear markings on the Morse taper (see arrow). 
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This TMT wear is believed to be due to micro-movement and micro-separation as synovial 
fluid penetrates the junction to initiate fretting corrosion and metallosis (Hallab et al., 2004; 
Kop & Swarts, 2009). The larger the femoral head size, the greater the extent of trunnionosis 
that can occur, with subsequent metal ion release (Smith et al., 2014). The five key participants 
in this study all had moderately sized implants (32 mm and 36 mm). Micro-separation has also 
been demonstrated to occur between the ceramic head and liner in certain movements which 
may contribute to wear (Nevelos et al., 2000). The production of debris from this wear may 
then influence function of the main bearing surface. Furthermore, fretting of a ceramic head on 
a metal neck has been shown to occur less often than with a metal-on-metal connection (Hallab 
et al., 2004). Proper application of the head onto the neck at time of surgery is the most 
important step to reducing the prevalence of such wear. 
These observations support the conclusion that squeaking originates from the bearing surface 
secondary to lubrication film breakdown and third body debris. Chevillotte et al. (2010) 
observed that there was always squeaking in non-lubricated conditions and when lubrication is 
present, noise only occurs when metal debris is present between the femoral head and 
acetabular liner. Furthermore, the disruption of lubrication appears related to the presence of 
third body wear (i.e. particles between liner and head) (Chevillotte et al., 2010). These third 
body particles can be produced by neck impingement (Ecker et al., 2008; Walter et al., 2004), 
stripe wear formation (Taylor et al., 2007), and fretting of the TMT articulation (Goldberg et 
al., 2002; Jacobs et al., 2014). Furthermore, upon physical inspection of the retrieved THR 
implant components in the present study, visible wear was apparent in particular locations on 
the components. It has been reported in literature that retrieved CoC femoral heads sometimes 
have a long, narrow area of damage known as stripe wear; after a period of time the narrow 
stripe becomes a broader wear region (Walter et al., 2006). Figure 4.29 shows obvious broad 
stripe wear on the main bearing surface of a retrieved 36 mm femoral head and its matching 
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acetabular liner. Note that the components shown in Figure 4.29 had a thin layer of carbon 
coating applied so that their surfaces could be examine under a scanning electron microscope 
(SEM) and as a result the stripe wear marking became much more visible. It has been reported 
that the presence of stripe wear alone is not related to squeaking (Walter et al., 2004) but can 
accelerate its production (Chevillotte et al., 2010). Thus, the stripe is an indicator of wear but 
is not necessarily associated with squeaking much like the fretting observed at the TMT.  
 
Figure 4.29: a) Retrieved thirty-six millimetre ceramic femoral head showing an obvious broad stripe wear region after 
carbon coating and b) matching retrieved ceramic acetabular liner also showing obvious visible wear region 
(with boundary indicated by arrows) after carbon coating. 
Femoral neck length and rim design are important risk factors when considering the production 
of squeaking (Keurentjes et al., 2008; Parvizi et al., 2011). A shorter neck length reduces the 
range of motion and increases the risk of impingement on the acetabular cup occurring during 
daily activities (walking, standing from chair) (Keurentjes et al., 2008). Another factor that 
increases impingement is an elevated rim of the acetabular cup designed to protect the ceramic 
from direct contact with the femoral neck (Parvizi et al., 2011; Walter et al., 2011). As noise is 
not typically produced at the extremes in range of motion, and an elevated rim is not the only 
design-dependant feature for squeaking (Parvizi et al., 2011), it is unlikely that neck 
impingement itself is producing noise. Instead, the contact produces metallosis with debris 
acting as third bodies to disrupt the lubrication film (Ecker et al., 2008). This contributes to the 
multifactorial nature of debris production followed by lubrication disruption and increased 
friction at the bearing surface to produce noise. 
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4.8 Summary  
This chapter has presented an initial overview of AE signal characteristics and some broad 
trends observed within the data. This initial presentation of key signal characteristics and 
overall trends was presented so that the more details results and quantitative comparisons made 
in subsequent chapters can be considered in context. 
The results presented within this chapter indicate that, approximately 95% of the clear 
individual events that were identified from the in-vivo AEs, were found to have durations below 
20 ms. The vast majority of these individual events were not identified as audible during the 
testing but a small number were associated with audible clicking sounds. Audible squeaking 
was observed from some of the in-vivo THR AE testing and these audible squeaking events 
were all found to have durations longer than 20 ms. In general, the in-vivo audible squeaking 
AEs showed much variability in terms of overall duration and the form of their time domain 
response. Nevertheless, the frequency responses typically had main frequency content in the 
range of 1-4 kHz and showed either distinct narrow-band peaks (Figure 4.3), sometimes 
indicating strong harmonics (Figure 4.2), or more broad-band noisy peaks (Figure 4.4). The in-
vivo non-squeaking THR AEs were generally found to have main frequency content in the 
same 1-4 kHz range. However, there were a small number of non-squeaking AEs observed to 
have main frequency content above 4 kHz. 
An important difference between the control AE observations and those of the in-vivo THR 
AEs was that the occurrence of clear AE events was noticeably less frequent in the former. 
That is, in terms of AEs, control hips were much less noisy than the hips of THR participants. 
However, in-vivo control AEs were commonly found to have similar behaviour to the non-
squeaking THR AEs. Therefore, it was concluded that there was a high likelihood that the THR 
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in-vivo AE recordings contained many AE events that did not originate from the implant 
components. 
In-vitro flexion-extension AEs were observed to have frequency responses with main 
frequency content similar to that of the in-vivo THR AEs. Conversely, the in-vitro TMT 
rotation AEs were observed to have frequency content which was at distinctly higher 
frequencies, typically in the range of 18-22 kHz. The in-vitro flexion-extension results, 
representing AEs from the main bearing surface interaction, showed a notably better fit to the 
in-vivo data than the in-vitro TMT rotation results. The results strongly suggest that the AEs 
generated from a participant’s hip prosthesis were likely to be induced from the main bearing 
surface interaction rather than any rotation occurring at the TMT. Based on quantitative AE 
records and frequency analysis in this study, it does not appear that audible squeaking in THR 
patients occurs due to movement at the TMT connection, albeit from a limited in-vivo data set. 
Wear occurring at the TMT junction likely contributes to the presence of debris at the bearing 
surface which may be responsible for disrupting lubrication, increasing friction and noise 
production. Therefore, it is still possible that wear at the TMT interface could be indirectly 
causing, or contributing to, squeaking at the primary bearing interface. 
A method for determining the fundamental frequency content of squeaking AEs was also 
presented in this chapter. The method, a cepstrum analysis, has the ability to isolate 
fundamental frequencies in signals that contain strong harmonics. The cepstrum analysis was 
applied to AE data of total hip replacement implants. The cepstrum analysis showed promise 
in identifying the primary vibration mode when strong harmonics were present, but resulted in 
large variation and poor identification in regions where these strong harmonics were not 
present. This method has promise, but it is important to carefully consider the frequency 
content of any signal in order to properly interpret the results of the cepstrum analysis. 
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Limitations of the initial stage of this study include the small number of retrieved implants 
available for testing, inability to obtain original acetabular shell and femoral stem, soft tissue 
attenuation during in-vivo testing and the manual rotation of the TMT. Retrieval of implants 
post-surgery for in-vitro testing has proven difficult; however, several of the in-vivo participant 
cohort are still awaiting surgery making it possible to acquire their implant components in the 
future. Acquisition of an entire THR after surgery would be the most ideal to study emissions 
from all components that contributed to the prosthesis as it was monitored in-vivo. However, 
this will be very rare and this research cannot dictate surgical decisions on what components 
are removed. As discussed earlier, another limitation is the attenuation effects of soft tissue 
during in-vivo recordings compared to those made in-vitro. Finally, removal of error borne 
from the unavoidable variance in manual rotation of the TMT could be gained if a mechanical 
system were developed that consistently rotated the components with equal pressures and 
speeds across different prostheses and is the focus of ongoing work. 
This chapter presented a summary of the demographics of the study participants and initial 
comparisons from the analysis of the recorded AE data. The primary purpose of the initial 
comparisons of THR AEs was twofold; to introduce the basic characteristics of the AE signals, 
and to compare similarities in overall frequency content to help validate the usefulness of the 
AE monitoring technique as applied to THRs, before additional analyses were undertaken. The 
preliminary results from the AE monitoring device have shown that the in-vitro technique is 
useful at providing further insight into the mechanisms of acoustic emissions and wear of total 
hip replacement implants. The testing and analysis of the same implant components both in-
vivo and in-vitro is a unique contribution of this research and provides important initial results 
for assessment of this sensing technology. Additionally, the initial results have shown promise 
in the AE monitoring technique as a diagnostic tool for the evaluation of the condition of THR 
implant components. Through the analysis of the time and frequency domain content of the 
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THR AEs, the AE monitoring technique has demonstrated that some behaviours are common, 
and others unique, to the AEs of different study participants. 
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Chapter 5 Acoustic Event Analysis 
5.1 Introduction 
This chapter presents the quantitative analysis of AE events. An event detection algorithm was 
employed to identify distinct AE events and quantify their associated signal metrics across the 
entire AE dataset. Due to the large number of AE signals that were recorded, it was more 
feasible to develop quantitative measures for comparison as opposed to qualitative visual 
inspections of the voltage-time signals which was inherently a manual and slow process. This 
chapter begins by providing an explanation and subsequent performance evaluation of the AE 
event detection algorithm as applied to the AE signals. The remainder of the chapter presents 
a quantitative analysis of the detected AE events based around comparisons of the AE event 
metrics. Overall statistics of the AE event metrics are presented and comparisons are drawn 
between the AEs from the control participants and the noise, loosening, and excessive wear 
revision reason participant groups. Subsequently, the results from a series of statistical 
hypothesis tests investigating the event metric distributions of the participant groups are 
presented. Finally, results from multidimensional metric comparisons are presented to gain 
more insight into correlations between the different AE event metrics. 
5.2 Event Detection Algorithm 
As stated in Section 2.4.3, an AE event is usually defined as an AE pulse that exceeds an 
arbitrary voltage threshold and then decays back to the noise level. Therefore, to automatically 
detect AE events from the recorded AE signals a voltage threshold needed to be chosen. 
However, due to the varied nature of the biological AE signals it was not immediately obvious 
what value for the voltage threshold should be chosen. Previous work had been performed 
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using a range of different threshold values to determine an appropriate value for the event 
detection. However, it was found that using a simple voltage threshold produced undesirable 
event detection results. It was found that larger voltage thresholds resulted in the failure to 
detect many AE events. Furthermore, AE events that visually appear to be single events would 
often be split into multiple events. It was also found that small voltage thresholds resulted in 
AE events being defined that had very large durations. Visual inspections of these large 
duration detected events would tend to suggest shorter durations would have been more 
appropriate. In an attempt to achieve an event detection method that distinguished AE events 
more reliably, previous work had suggested that applying the event detection to a variance 
signal computed from the original AE signal would yield more desirable results. Applying the 
event detection method to the variance model minimises noise and amplifies periods of 
intensive signal activity.  
The variance model event detection algorithm had three simple steps as follows: 
1) The signal was divided into short and overlapping time intervals and the signal variance 
was calculated for each interval.  
2) An event was then identified by finding a time interval where the variance value exceed 
an arbitrary threshold.  
3) An identified event was then isolated by determining its start and end points to occur 
when the statistical range of surrounding time interval variances failed to exceed a 
second and smaller threshold. 
The first step of the event detection algorithm involved dividing the discrete AE signal into 
short overlapping time intervals/windows and finding the variance of the signal across each 
window. MATLAB was used to take a signal window of 32 samples from the beginning of the 
signal and the variance was then calculated for the window using MATLAB’s inbuilt variance 
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function. The window was then shifted by 10 samples forward in time and a new variance value 
was calculated in the same way from the new signal window. This procedure was applied 
repeatedly until the entire AE signal had been processed and hence a new signal (consisting of 
variance values) was created with a length one-tenth of the original. The window overlap 
created by shifting 10 samples was used in order to create a higher time resolution variance 
signal to more effectively capture large voltage variations in the original signal and produce a 
more continuous variance signal. Figure 5.1a and Figure 5.1b show an example of a time-
domain signal and its associated variance signal respectively. It should be noted that the 
horizontal axis of the variance signal has been converted to time and hence the signals appear 
the same length but in fact the variance signal has less data points. It can be seen from Figure 
5.1b that the variance signal shows two events of significant amplitude and the remaining small 
fluctuations of the original signal do not feature. 
 
Figure 5.1: (a) An AE time-domain signal and (b) corresponding signal showing the variance. 
The second step of the event detection algorithm was to use the variance signal to identify 
events. This was done by stepping through the variance values and checking them against a 
specified magnitude threshold. If a variance value was found to exceed the specified threshold 
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an event was identified as present and this would invoke the third step of the algorithm; the 
event isolation. The magnitude threshold for event identification was chosen arbitrarily to be 
2.5 × 10−3 V as this value provided the most satisfactory event identification for a range of 
test recordings. Figure 5.2a shows a scaled version of the variance signal with the magnitude 
threshold overlaid. It was observed from Figure 5.2a that the chosen threshold allowed clear 
identification of the two perceived events of the recording whilst excluding the small duration 
and magnitude signal fluctuations.  
 
Figure 5.2: a) Variance signal scaled to show threshold and (b) variance signal scaled to show event and threshold with 
annotations identifying final threshold crossing and a more appropriate event ending. 
However, Figure 5.2b shows a further scaled version of the variance signal and overlaid 
magnitude threshold and it was observed that the signal crosses the threshold a number of times 
during what would reasonably be defined as one event (between approximately 1.3 and 1.7 
seconds) without actually returning to the background noise level. Hence, defining the 
beginning and end points of an event simply by threshold crossings would result in many 
different events being defined when in fact it may be more appropriate to define only one event. 
Further observation found that it may also be more appropriate for the beginning and the end 
of the event to be somewhat before and after the initial and final threshold crossings of an event 
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respectively, as is identified by the annotations in Figure 5.2b. To address these issues an event 
isolation algorithm was incorporated into the process. 
The event isolation process occurred in conjunction with the event identification in order to 
prevent multiple events being identified from what would reasonably be considered a single 
event and also allowed more appropriate event beginning and end points to be identified. 
Therefore, once the identification algorithm had detected a variance threshold crossing the 
isolation algorithm was applied to determine the appropriate event extremities before the 
identification algorithm then continued from the end of the isolated event.  
In order to determine the beginning of an event, the statistical range of the variance value found 
by the identification algorithm and the previous four variance values was taken. If the range 
calculated was larger than a second arbitrary threshold, known as the range threshold, a new 
statistical range was calculated from the five variance values shifted back by one value from 
the previous (i.e. add the fifth previous variance value and remove the one found by the 
identification algorithm). This process continued until the statistical range of the variance 
values became smaller than the range threshold. When the range was low enough the beginning 
of the event was taken to be the latest time associated with the five current variance values used 
for the range calculation.  
Figure 5.3 demonstrates the points used for the first, second, third, and final (eleventh) range 
calculation of a particular AE event example. It can be observed from Figure 5.3a-c that the 
five points used in the range calculation step backward in time by one sample for each 
calculation. Figure 5.3d shows the position of the five points when the range first falls below 
the specified range threshold (0.5 mV for this example) and hence the event beginning point 
has been identified as the latest time associated with the five points used in the calculation. 
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Figure 5.3: Plots demonstrating the variance value points used in the event isolation range calculation algorithm for the (a) 
first, (b) second, (c) third, and (d) final/11th calculations. Note that the range threshold value used to determine 
the event beginning point for this example signal was not the same as that which was used for the actual AE 
data; the threshold used here was chosen to demonstrate the algorithm more clearly. 
To find the end of an event the same process was used, however, the five variance values used 
shifted forward in time and the end of the event was defined as the earliest time associated with 
the five current variance values. The value of the range threshold used for the actual 
implementation of the isolation algorithm was 0.005 mV and this was chosen as it produced 
the most satisfactory results for a range of different events. 
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Figure 5.4 shows the result of the event isolation (vertical lines) for the variance signal of 
Figure 5.2a where it was observed that the first event (Figure 5.4a) has been isolated reasonably 
well. Figure 5.4b shows the second event which has in fact been separated into two events by 
the algorithm. Hence the event detection algorithm has isolated three separate portions of 
interest of the input signal of Figure 5.1a and this information was then stored for later use. 
The effectiveness of the event detection algorithm and the chosen threshold values will be 
discussed in the following section. 
 
Figure 5.4: Variance signal plots showing result of event isolation algorithm for (a) first and (b) second and third events.  
5.3 Event Detection Evaluation 
A major limitation of the initial observations of Chapter 4 was that the frequency responses 
were found by computing Fast Fourier Transforms (FFTs) for two second time windows across 
the AE recordings. As previously identified, the AE recordings generally consisted of long 
durations of background noise with sporadic occurrences of AE activity above the level of 
background noise (i.e. acoustic events). Since the frequency responses were computed using a 
fixed duration window, it was certain that for some AE recordings the frequency response 
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obtained by the FFT was an averaged frequency response of multiple acoustic events. For 
example, if both a short duration event and an audible squeak occurred during a single time 
window the corresponding FFT would yield the average frequency response of the two 
seemingly unique events. The application of the event detection algorithm provided a method 
to address this limitation. By isolating the acoustic events the behaviours that were common 
and those that were unique were able to be investigated with greater rigour. 
The AE recordings from the in-vivo data collection were typically 1-5 seconds in duration but 
were sometimes up to 25 seconds in length. The variation in recording durations was a result 
of the data collection protocol as explained in Section 3.4. Due to the relatively long durations 
of the AE recordings, and the intermittent nature of the occurrence of significant hip AEs, the 
recorded AE signals had a substantial duration of signal content that did not exceed normal 
background noise levels. Additionally, there were many cases where multiple unique AEs 
occurred during a single AE recording; a specific example of this being two separate hip 
squeaks occurring on two consecutive paces of a walking motion. Therefore, for further 
analysis it was considered necessary to separate unique AE events from single AE recordings 
to allow analysis of AE events separately whilst also excluding signal portions that only 
contained background noise. 
Figure 5.5 shows examples of an AE recording for an ambient test, a control participant test, 
and a hip replacement participant test. The ambient test was a recording taken while the sensors 
were not attached to a participant and remained stationary in the test room. The control 
participant and hip replacement participant tests were recordings taken while the sensors were 
attached to a control cohort participant and hip replacement participant respectively whilst they 
performed a prescribed motion (squatting motion in these cases). Most notably, the ambient 
noise recording of Figure 5.5a remained at very low voltage amplitude for the duration of the 
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recording while the control hip recording (Figure 5.5b) had three major voltage spikes of very 
short durations and the participant recording (Figure 5.5c) had a number of voltage spikes with 
both short and very long durations. 
 
Figure 5.5: Example of AE signal recording for (a) ambient noise, (b) control hip, and (c) hip replacement participant tests. 
It was evident from observing the time domain responses of AE recordings that large durations 
of the recordings contained very little acoustic information (i.e. regions where the voltages 
were consistently very low). Therefore, the regions of the recordings where voltage spikes 
occurred were considered to be unique AE events and separating these events from the 
remainder of the recordings would be useful for further analysis of the signals. Hence, the three 
voltage spikes of Figure 5.5b (at approximately 0.75, 1, and 2.75 seconds respectively) would 
be treated as separate AE events. Likewise, for the participant recording of Figure 5.5c the two 
short duration voltage spikes (at approximately 1.5 and 3.25 seconds respectively) would be 
treated as separate events and the long duration voltage spike (between approximately 2 and 3 
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seconds) as a third event. Additionally, the long duration voltage spike could arguably be 
separated into two different events as the signal does appear to return to background noise 
levels at approximately 2.1 seconds. 
In order to perform the event separation the event detection algorithm explained in Section 5.2 
was applied. Figure 5.6 shows the result of the event detection algorithm as applied to the 
participant recording signal of Figure 5.5c (Participant 1, recording 6). Four events were 
detected by the algorithm and are shown in Figure 5.6 as the regions highlighted in yellow and 
bordered by dotted vertical lines. As expected, the two short duration events (events one and 
four) were separated well. The long duration voltage spike was split into two separate events 
by the algorithm but the end point location of the second of these two events may not agree 
with that which would have otherwise been chosen by a visual inspection of the signal. A visual 
inspection of the signal would likely have resulted in the third event being defined between 
approximately 2.1 and 2.9 seconds as opposed to ending at 2.7 seconds as shown in Figure 5.6.  
 
Figure 5.6: Participant AE recording from Figure 5.5c with four events, as identified by the event detection algorithm, shown 
bordered by dotted vertical lines and highlighted yellow. 
However, it remains very subjective as to exactly where separate event start and end points 
should be placed. It was generally not evident whether particular AEs were from the same 
source; it was possible for AEs to occur from multiple sources at the same time and hence their 
detected signals would be superposed. Additionally, it was not clear whether two events that 
occurred in close proximity (with respect to time) of each other had any influence or 
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dependence on each other. The possibility of events influencing or depending on each other 
also raises the question as to whether the events should be considered together as one event 
anyway. For simplicity in initial analyses of this study all events were assumed to have no 
dependence or influence on each other. Regardless, the event start and end point decisions 
remain dependent on multiple factors but for the event detection process to be automated event 
bounds must be defined using an objective metric such as relative signal variance or amplitude 
threshold. Hence, the performance of any event detection algorithm will inevitably always be 
subjective. 
Figure 5.7 shows the four events (coloured blue) of Figure 5.6, with individual axis scaling for 
easier viewing of the event signals, in addition to the immediately adjacent signal portions 
(coloured red) of each event. It was observed that event one and four (Figures 5.7a and 5.7d 
respectively) were isolated very well from the surrounding signal. However, the 
appropriateness of the event start and end points of event two and three (Figures 5.7b and 5.7c 
respectively) was less clear. The surrounding signals of event two and three did not appear to 
remain consistently at the background noise levels and had some notable signal variation that 
fell outside the event window. 
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Figure 5.7: Event number (a) one, (b) two, (c) three, and (d) four from the signal of Figure 5.6. Note the event is coloured 
blue with the red signals being part of the original recording immediately surrounding each event. 
Figure 5.8 shows a signal recording from a second select participant (Participant 27, 
Recording 2) and the associated events identified by the event detection algorithm. It was 
observed that the algorithm had identified seven separate events. However, initial observation 
of Figure 5.8 would seem to show that some of those events should not be separated from each 
other. To investigate the result from the algorithm better Figure 5.9 shows the first, second, 
third, and fifth events from Figure 5.8 with individual axis scaling for easier viewing. It was 
observed from Figure 5.9a that the first event showed an overall gradual increase in amplitude 
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but had intermittent decaying behaviour which was most pronounced towards the end of the 
event. This decaying behaviour is not evident in Figure 5.8 due to the time scale on the 
horizontal axis. Figure 5.9b shows the second event and it was observed that this event occurred 
immediately before the third, to the extent that it also appears in the plot of the third event 
(Figure 5.9c). From Figure 5.9c it was observed that the signal behaviour was similar to the 
first event in that a decay between impulses was evident but the time between the impulses was 
greater than in the first event. As a result of the greater time between impulses, the event 
detection algorithm has split off the first impulse as a separate event when in fact it may be 
more appropriate for both events to be considered as a single event. Alternatively, it could be 
argued that each impulse should be considered a separate event and consequently the algorithm 
should have split event three into four separate events.  
 
Figure 5.8: An AE recording from a second select participant (Participant 27, recording 2) with seven events, as identified 
by the event detection algorithm, shown bordered by dotted vertical lines and highlighted yellow. 
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Figure 5.9: Event number (a) one, (b) two, (c) three, and (d) five from the signal of Figure 5.8. Note the event is coloured 
blue with the red signals being part of the original recording immediately surrounding each event. 
Figure 5.9d shows the fifth event where it was observed that a similar sequence of successive 
decaying cycles to that of the second and third events has occurred. It was evident from 
observations of Figure 5.9d and the plots of the sixth and seventh events (not shown) that the 
two impulses that occurred immediately after the fifth event in Figure 5.9d (labelled Event 6 
and Event 7 in the figure) were in fact identified as the sixth and seventh events by the event 
detection algorithm. Hence, the question was raised as to whether the sixth and seventh events 
should have been included into the fifth event due to their proximity and apparent likeness to 
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the pulses that occurred at the end of the fifth event (see annotation in Figure 5.9d identifying 
pulses with similar likeness). Conversely, it could be argued that the fifth event should have 
been split up further to separate more individual pulses from the end of the event as the signal 
voltage becomes very close to background noise voltages between the last few pulses of the 
fifth event. These results confirmed that when a series of successive events or pulses occur it 
will always be debatable as to where the cut-off between multiple events should lie or whether 
defining one long event would be more appropriate. 
A range of different event detection threshold values were trialled and visual inspections of the 
event separation results were performed to determine the most suitable threshold values. For 
example, the event of Figure 5.9a contained a series of pulses and, after observing these pulses 
along with the signal surrounding them, it was determined that it was most appropriate to 
consider these pulses as a single event and so the algorithm threshold values were adjusted 
accordingly. However, in order for the events of Figure 5.9b and Figure 5.9c to become one 
event, the algorithm threshold values needed to be so low that merging of other arguably 
separate events occurred. The most suitable threshold values were determined to be those that 
provided a good balance between excluding long durations of low magnitude voltage values 
and avoiding extensive separation of pulse-like signals. As stated in Section 5.2, the value used 
for the initial variance threshold was 2.5 millivolts. 
5.4 Event Metrics Summary 
5.4.1 Introduction 
A number of event signal metrics were computed in order to summarise each AE event by a 
limited number of representative metrics in place of a complete voltage-time signal. Due to the 
large bank of data and the 100 kHz recording rate, these representative metrics were needed to 
  134 
reduce the data down to a manageable size and to make conclusions. The metrics computed 
were event duration, RMS amplitude, maximum amplitude, rise time, and main frequency 
content. Two additional metrics concerning the rate of occurrence of events, duration between 
consecutive events and the number of events per AE recording duration, were also determined. 
There were approximately 21,000 AE events detected by a sensor across the entire control and 
THR participant datasets with the median number of data points per event being approximately 
650. By summarising each event by seven event metrics, there was an approximately 99% 
reduction in the amount of data representing the AE events. Consequently, while the data 
reduction does simplify subsequent analyses, it is important to keep in mind that such a 
significant data reduction has the potential to substantially limit the reliability of the subsequent 
analysis and conclusions that are drawn. Nevertheless, there still remained a large amount of 
data to analyse given the extensive number of AE events. The remainder of this section defines 
the specific definitions of the duration, peak amplitude, RMS amplitude, rise time, and main 
frequency content metrics as applied to the identified AE events. 
The duration of an AE event signal was simply defined as the time elapsed in seconds between 
the first and last samples of the signal. For the AE event signals the sample rate was 100 kHz 
and therefore the time between samples was 1 × 10−5 seconds (0.01 milliseconds). Hence, the 
duration of an AE signal was given by Equation 5.1 as follows: 
 𝑡𝑑𝑢𝑟 = (𝑁 − 1) × (1 × 10
−5) (5.1)  
Where, 𝑁 was the number of samples in the signal and 𝑡𝑑𝑢𝑟 was the duration in seconds. 
The peak amplitude of an AE event signal was defined as the maximum absolute voltage value 
of the signal. For the AE event signals each sample value was a voltage amplitude value in the 
range ±2.5 volts with a mean of zero volts. Hence, the voltage value furthest from zero in either 
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the positive or negative direction would be considered the peak amplitude. Therefore, the peak 
amplitude value was given by Equation 5.2 as follows: 
 𝐴𝑝𝑒𝑎𝑘 = max |𝑥| (5.2)  
Where, 𝑥 was the set of signal sample values and 𝐴𝑝𝑒𝑎𝑘 was the peak (maximum absolute) 
amplitude value. Additionally, the root-mean-squared (RMS) signal amplitude was defined by 
Equation 5.3 as follows: 
 𝐴𝑅𝑀𝑆 = √[∑ 𝑥𝑖
2𝑁
𝑖=1
] 𝑁⁄  (5.3)  
Where, 𝑥𝑖 was the voltage given by the i
th signal sample, 𝑁 was the total number of samples in 
the signal, and 𝐴𝑅𝑀𝑆 was the RMS voltage. 
The rise time of an AE event signal was defined to be the duration in seconds from the 
beginning of the event to the occurrence of the peak amplitude of the event. This definition 
was used for computational simplicity as opposed to an alternate definition of, for example, the 
rise time being the duration between 10% and 90% of peak amplitude. For the AE event signals 
the rise time was calculated using Equation 5.4 as follows: 
 𝑡𝑟𝑖𝑠𝑒 = (𝑁𝑝𝑒𝑎𝑘 − 1) × (1 × 10
−5) (5.4)  
Where, 𝑁𝑝𝑒𝑎𝑘 was the number of samples from the beginning of the signal to the peak 
amplitude sample, the constant 1 × 10−5 was the time between samples in seconds, and 𝑡𝑟𝑖𝑠𝑒 
was the rise time in seconds.  
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As mentioned in the previous chapter, the main frequency of a signal was defined as the 
frequency at which the magnitude of the Fourier transform of the signal was greatest. For each 
AE event, the Fourier transform was applied using the Fast Fourier Transform (FFT) algorithm 
to yield the frequency domain response of the event. The frequency value that corresponded to 
the maximum frequency domain magnitude was then taken as the main frequency content 
metric. 
5.4.2 Empirical Cumulative Distribution & Probability Densities 
In an effort to identify and investigate trends in the AE data, the computed metrics were first 
grouped by the revision reasons, then empirical cumulative distribution functions (CDFs) of 
each grouped metric were calculated, and finally the data plotted for visual comparisons. Figure 
5.10 presents the empirical CDFs of the control participants and THR participants with the 
noise, loosening, and wear revision reasons for each of the signal metrics. There were a number 
of important observations from the plots of Figure 5.10. The most noticeable feature observed 
from the empirical CDFs was that the metric values spanned several orders of magnitude, for 
all but one metric. Therefore, the metric value axes of the empirical CDFs, excluding that of 
the number of events per recording duration CDF, were presented using a log scale to more 
clearly show distinctions between the CDFs of the different groups. Conversely, while the 
metric values overall did span several orders of magnitude, it was typically observed from the 
empirical CDFs that a substantial proportion of the events for each metric had values within a 
relatively narrow range, as indicated in Figure 5.10 by a narrow region of metric values with a 
steep gradient for the first five of the seven metrics. 
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Figure 5.10: Empirical cumulative distribution functions (CDFs) of acoustic event metric a) duration, b) RMS amplitude, c) 
main frequency content, d) rise time, e) peak amplitude, f) duration between events, and g) number of events per 
recording duration. Each subfigure contains a CDF for the control group and the noise, loosening, and excessive 
wear revision reasons. 
To more thoroughly investigate the distribution of the AE metrics, probability density 
histograms were computed of the AE metrics. These histograms used the same groupings 
presented in the empirical CDFs of Figure 5.10 (i.e. control participants, noise revision, 
loosening revision, and excessive wear revision reasons) as well as an additional group 
containing all THR participant AE events. The probability density histograms allow a more 
natural interpretation of the distributions of the datasets and place an emphasis on comparisons 
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of the main representative portions of the data, whereas the empirical CDFs emphasised 
differences in the extremities of the datasets. That is to say, the histograms are dominated by 
data around the central tendency and the data at the extremities is much less prominent and 
sometimes unnoticed. 
The histograms were normalised to make the total area of each histogram equal to one (i.e. 
integration of these histograms would produce the corresponding CDFs). Additionally, for each 
metric in turn, the histograms across each different grouping could be directly compared since 
the same bin size and locations were used for the computations. The histograms for the event 
duration, RMS amplitude, main frequency content, and number of events per recording 
duration are shown in Figures 5.11-5.14 respectively. Furthermore, as a quantitative summary 
of the distributions, Tables 5.1 and 5.2 present the 1st, 25th, 50th, 75th, and 99th percentile values, 
the mean value, and the interquartile range (i.e. 75th minus 25th percentile) for the AE data of 
each group and for each of the metrics. By observing the histograms and summary percentiles, 
in addition to the empirical CDFs, the distributions of the AE event data metrics were more 
apparent and a better understanding of the general nature of the AE events for each grouping 
was gained through quantitative comparisons. Note that the histograms of the rise times, peak 
amplitudes, and duration between events have not been presented here as they did not offer any 
substantial further insight in addition to what was gained from the other four metrics.  
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Figure 5.11:  Histogram of AE event durations for a) control, 
b) all THR, c) noise revision reason, d) 
loosening revision reason, and e) excessive 
wear revision reason participants. 
 
Figure 5.12:  Histogram of AE event root-mean-squared 
amplitudes for a) control, b) all THR, c) noise 
revision reason, d) loosening revision reason, 
and e) excessive wear revision reason 
participants. 
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Figure 5.13:  Histogram of AE event main frequency 
content for a) control, b) all THR, c) noise 
revision reason, d) loosening revision reason, 
and e) excessive wear revision reason 
participants. 
 
Figure 5.14:  Histogram of number of AE events per 
recording duration for a) control, b) all THR, 
c) noise revision reason, d) loosening revision 
reason, and e) excessive wear revision reason 
participants. 
 
  141 
Table 5.1: Percentile, interquartile range, and mean values of four event metrics for the control, noise revision, loosening 














Control 2.9 5.1 6.2 7.8 24.3 2.7 7.2 
Noise 2.3 5.3 7.7 12.3 266.9 7.0 20.0 
Loosening 2.1 4.8 6.1 8.5 18.4 3.7 7.0 
Excessive Wear 2.2 5.1 6.9 9.3 40.4 4.2 8.9 




Control 19.7 29.2 40.5 64.5 478.8 35.3 61.3 
Noise 15.5 30.5 48.9 90.6 442.6 60.1 80.8 
Loosening 18.5 29.3 39.9 61.8 229.9 32.5 53.6 
Excessive Wear 17.8 30.2 44.1 73.8 341.3 43.6 65 





Control 0.75 2.66 2.77 2.92 19.98 0.26 3.14 
Noise 0.49 2.52 2.67 2.81 19.42 0.29 3.41 
Loosening 0.44 2.55 2.67 2.80 19.02 0.25 2.99 
Excessive Wear 0.35 2.61 2.73 2.80 19.20 0.19 3.15 






Control 0 0 0.45 0.94 3.33 0.94 0.65 
Noise 0 0.21 0.79 1.79 7.94 1.58 1.44 
Loosening 0 0.21 0.71 1.46 5.92 1.25 1.05 
Excessive Wear 0 0.14 0.68 1.67 6.12 1.53 1.13 
All THR Participants 0 0.21 0.77 1.67 6.57 1.46 1.17 
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Table 5.2: Percentile, interquartile range, and mean values of three event metrics for the control, noise revision, loosening 













Control 0.6 1.3 1.7 2.2 11.8 0.9 2.2 
Noise 0.5 1.4 2.1 3.7 142.1 2.3 8.4 
Loosening 0.6 1.2 1.5 1.9 8.2 0.7 1.8 
Excessive Wear 0.5 1.3 1.7 2.2 21.0 0.9 2.5 




Control 70 110 164 288 2424 178 276 
Noise 74 137 245 529 2527 392 459 
Loosening 71 107 165 284 1478 177 251 
Excessive Wear 71 118 195 388 2101 270 335 




Control 1.4 95.9 331.1 748.0 3963 652.1 585.9 
Noise 0.5 10.6 69.4 313.4 2873 302.8 306.4 
Loosening 1.7 60.1 224.4 617.2 3119 557.1 461.8 
Excessive Wear 0.8 39.0 171.3 548.7 3421 509.7 426.6 
All THR Participants 0.6 44.0 191.2 562.2 3253 518.2 433.7 
From observing the empirical CDFs, probability density histograms, and the summary statistics 
of Tables 5.1 and 5.2 a positive skew of all the data across all metrics and for all groupings was 
apparent. The positive skew in the data was obvious from observing that, for all metrics and 
all groups, the mean values were greater than the median values. Additionally, the relative 
skewness between groups (indicated by a larger difference in the mean and median values) was 
increased for the groups with increased interquartile ranges. The positive skew of the data is 
important to note as it indicates that the data is not normally distributed. For all the metrics of 
Tables 5.1 and 5.2 the data can be skewed upwards. However, the data cannot be skewed very 
far downwards since negative values make no physical sense for the metrics. The skewed 
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characteristics of the metrics initially suggest a lognormal distribution may be present. While 
the lognormal distribution did appear to fit the data well for some metrics of some of the 
participant groups, the lognormal distribution was not always a good fit for most of the data. 
Consequently, treating any metrics as lognormally distributed would not necessarily aid 
analysis and care needs to be taken when applying any statistical analysis techniques to the 
metrics.  
Nevertheless, presenting the empirical CDFs with a log scale further distinguished another 
noticeable feature of the plots. Figure 5.10 clearly shows the empirical CDF of the noise 
revision reason group, across all metrics, was noticeably different than the empirical CDFs of 
the other groups. This observation can largely be explained by considering that the noise 
revision reason group contained the participants whose implants produced audible squeaking. 
The audible squeaking events had considerably longer durations than the majority of other 
events that were detected as identified in Section 4.3. Figure 5.10a confirms the occurrence of 
longer durations by showing that the gradient of the noise group CDF began to substantially 
decrease at a lower duration than the other groups and hence indicated there was a higher 
proportion of events from the noise group that had longer durations. In the event duration 
histograms of Figure 5.11 it was observed that the noise revision group had a lower magnitude 
and more broad overall probability density peak than the other groups, especially compared to 
the control group, indicating a greater spread of event durations in the majority of the noise 
revision group data. The greater spread of the noise revision group was quantified by the results 
in Table 5.1 where the duration interquartile ranges (IQRs) were 7.0 ms, 3.7 ms, and 2.7 ms 
for the noise revision, loosening revision, and the control groups respectively. 
Additionally, given that for an event to be audible it must exceed a certain energy threshold 
and have sufficient duration for it to be perceived, the increased durations at sustained increased 
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amplitude levels of the audible squeaking events led to increased RMS voltage amplitudes. 
Figure 5.10b confirms that the noise revision reason group had more occurrences of events 
with increased RMS voltage amplitudes. The presence of increased RMS voltage amplitudes 
of the noise group was more subtle in the histograms of event RMS voltage amplitudes in 
Figure 5.12. However, the peak of the probability density histogram for the noise group in 
Figure 5.12 was noticeably lower than the other groups which indicated greater probability 
density magnitudes for larger RMS voltage amplitudes. Table 5.1 quantifies the increased RMS 
voltage amplitudes of the noise revision group by showing median values of 48.9 mV, 
40.5 mV, and 39.9 mV for the noise revision, control, and loosening revision groups 
respectively. Furthermore, Table 5.1 shows an interquartile range of the noise group that was 
approximately 70% larger than that of the control group. 
The rise time empirical CDF (Figure 5.10d) of the noise revision reason group indicated 
substantially more events with larger rise times than those of the other groups. It was observed 
from initial observations that, due to the way the rise time was defined, rise times for squeaking 
events would often equate to a considerable portion of the duration of the event. Hence, given 
there was a larger proportion of noise group events with increased durations, it follows that 
there would be a corresponding larger proportion of noise group events with longer rise times. 
Table 5.2 demonstrates the increased rise times of the noise group quantitatively by showing 
median rise times of 2.1 ms, 1.7 ms, and 1.5 ms for the noise revision, control, and loosening 
revision groups respectively. 
The main frequency content CDFs of Figure 5.10c showed broadly similar frequency behaviour 
across all groups. With respect to main frequency content, all of the groups had at least the 
middle 50% of their events within the range of approximately 2.5-3.0 kHz. However, despite 
the similar central tendency values of the different groups, the noise revision reason group was 
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observed to have a wider spread of event main frequency content away from the median value 
(the median value was 2.67 kHz) in both directions. This wider spread of main frequency 
content was not immediately obvious in the histograms of Figure 5.13 as the largest probability 
density magnitudes were observed in a very similar range of frequencies. Furthermore, the 
summary statistics of Table 5.1 did not emphasise the wider spread of the main frequency 
content of the noise revision group. It was observed from Table 5.1 that the main frequency 
content of the noise group had frequencies of 2.52 kHz, 2.67 kHz, and 2.81 kHz for the 25th, 
50th, and 75th percentiles respectively and all the other groups had values that were within 
150 Hz of the aforementioned frequencies for the same percentiles. 
The empirical CDF of the duration between events (Figure 5.10f) showed that for the noise 
revision reason group there was an obvious greater occurrence of shorter durations between 
consecutive events. It was also observed that the control group had more occurrences of longer 
durations between events which distinguished it from the remaining revision reason groups of 
loosening and excessive wear. These observations of the difference between groups in 
durations between consecutive events were quantitatively reflected in Table 5.2. The median 
duration between consecutive events of the control group was 331.1 ms which was over 4.5 
times longer than the median duration between consecutive events of the noise revision group 
(69.4 ms) and approximately 1.5 times longer than the median duration between consecutive 
events of the loosening revision group (224.4 ms). 
The main observation from the empirical CDFs of the number of events per recording duration 
(Figure 5.10g) was that the control group showed a distinct difference to the revision reason 
groups. The control group showed a greater proportion of data with a lower number of events 
per recording duration than the revision reason groups. This observation verifies the initial 
observations presented in Section 4.3, where it was observed that the amount of acoustic 
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activity was noticeably less for the control AE recordings than for the THR participant AE 
recordings. The histogram of Figure 5.14 confirms the observation of the control group having 
a greater proportion of data with a lower number of events per recording duration than the 
revision reason groups by showing the control group to have noticeably greater probability 
density magnitudes for the four lowest histogram bins than the corresponding histogram bins 
of the other groups. However, the histograms did not convey well an important observation for 
this metric that was evident in the empirical CDFs and Table 5.1; at least 20% of the AE 
recordings for all groups had zero events detected by the event detection algorithm. It is 
important to note that variation in the recording durations of the AE recordings was present 
due to the self-selected movement speeds of the motions performed by the participants during 
testing. This variation in recording durations should be kept in mind when making conclusions 
regarding the metrics presented here since the occurrence of AE events may be correlated to 
the specific movement of the participant’s lower limb irrespective of the time taken to make 
the movement. 
In general, the empirical CDF plots and probability density histograms suggest that THR 
participants that are categorised into the noise revision reason group have empirical CDFs and 
probability densities for most metrics that are noticeably different from those of the other 
groups. The empirical CDFs and probability density histograms for the main frequency content 
of events seemed to be generally similar for all groups. However, for the noise revision group 
there was a noticeable difference in the size of the tails of the main frequency content 
distribution indicating a larger spread of the data. Additionally, it was observed from the data 
of duration between events and number of events per recording duration that AE events 
occurred more frequently in the data from the THR participant groups than the control group. 
  147 
5.4.3 Kolmogorov-Smirnov Tests – Control and Revision Reasons 
In order to more thoroughly confirm any differences in the AE event data from the control and 
different revision reason groups a statistical test was employed. A two-sample Kolmogorov-
Smirnov (KS) test was applied to the data for each of the metrics presented in Figure 5.10. The 
two-sample KS test is a nonparametric statistical test which evaluates the null hypothesis that 
the empirical CDFs of two datasets come from the same distribution. The KS test does this 
comparison by first evaluating what is known as the test statistic: the maximum absolute 
difference between the CDFs of the two distributions. The KS test then calculates the 
probability (p value) of observing a test statistic that is as extreme as, or more extreme than, 
the test statistic observed in the first step. The KS test will then reject the null hypothesis if the 
calculated p value is less than the specified significance level, α, where α is commonly either 
0.05 (5%) or 0.01 (1%). 
As explained above, the two-sample KS test compares only two CDFs at one time. Therefore, 
to apply the KS test to all the data of Figure 5.10 the test needed to be applied multiple times. 
Consequently, for each metric, six different KS tests were conducted to cover the six possible 
different combinations of pairs for the four groups. Tables 5.3-5.6 present the results of the KS 
tests for each event metric and using a significance level of 1%. It was observed from the KS 
test results that in all but 6 of the 42 tests the null hypothesis (that the tested datasets belonged 
to the same distribution) was rejected. A rejected null hypothesis indicates that enough 
evidence was present to suggest the null hypothesis was false and the alternative hypothesis 
(that the datasets tested come from different distributions) can be accepted.  
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Table 5.3: Kolmogorov-Smirnov test results for event duration and RMS amplitudes of control and revision reason group 
participants. A significance level of 1% was used. 












Control-Noise: 1 <0.001 0.286 1 <0.001 0.131 
Control-Loosening: 1 <0.001 0.084 0 0.421 0.032 
Control-Wear: 1 <0.001 0.142 1 0.002 0.066 
Noise-Loosening: 1 <0.001 0.215 1 <0.001 0.144 
Noise-Wear: 1 <0.001 0.169 1 <0.001 0.077 
Loosening-Wear: 1 <0.001 0.096 1 <0.001 0.075 
 
Table 5.4: Kolmogorov-Smirnov test results for event main frequency content and rise time of control and revision reason 
group participants. A significance level of 1% was used. 












Control-Noise: 1 <0.001 0.224 1 <0.001 0.237 
Control-Loosening: 1 <0.001 0.241 1 <0.001 0.133 
Control-Wear: 1 <0.001 0.187 0 0.303 0.034 
Noise-Loosening: 1 <0.001 0.113 1 <0.001 0.313 
Noise-Wear: 1 <0.001 0.156 1 <0.001 0.223 
Loosening-Wear: 1 <0.001 0.179 1 <0.001 0.104 
 
Table 5.5: Kolmogorov-Smirnov test results for event peak amplitude and duration between events of control and revision 
reason group participants. A significance level of 1% was used. 












Control-Noise: 1 <0.001 0.196 1 <0.001 0.315 
Control-Loosening: 0 0.816 0.023 1 <0.001 0.106 
Control-Wear: 1 <0.001 0.099 1 <0.001 0.156 
Noise-Loosening: 1 <0.001 0.195 1 <0.001 0.237 
Noise-Wear: 1 <0.001 0.104 1 <0.001 0.175 
Loosening-Wear: 1 <0.001 0.100 1 <0.001 0.074 
 
Table 5.6: Kolmogorov-Smirnov test results for number of events per recording duration of control and revision reason 
group participants. A significance level of 1% was used. 







Control-Noise: 1 <0.001 0.245 
Control-Loosening: 1 <0.001 0.173 
Control-Wear: 1 <0.001 0.175 
Noise-Loosening: 0 0.019 0.111 
Noise-Wear: 0 0.175 0.079 
Loosening-Wear: 0 0.330 0.052 
 
For the KS tests of the metrics of event duration (Table 5.3), event main frequency content 
(Table 5.4), and duration between events (Table 5.5), it was observed that the null hypothesis 
was rejected for all tests. Hence, the KS test concluded with a 99% confidence that, for each 
of the three aforementioned metrics, the difference in the datasets of the control and revision 
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reason groups was statistically significant and consequently it could be concluded they all came 
from separate distributions. For the KS tests of the metrics of event RMS (Table 5.3) and peak 
(Table 5.5) amplitudes it was observed that the null hypothesis was rejected for all group 
parings except for the control and loosening group pair. For the KS tests of the event rise time 
metric (Table 5.4) it was observed that there was a failure to reject the null hypothesis for the 
control and excessive wear paring only. For the KS tests of the number of events per recording 
duration metric (Table 5.6) it was observed that there was a failure to reject the null hypothesis 
for the noise and loosening, the noise and excessive wear, and the loosening and excessive 
wear pairings. The failure to reject the null hypothesis for these six group pairing and metric 
combinations indicates there was not enough evidence available to conclude that the datasets 
concerned came from distributions that had a statistically significant difference. 
The KS tests indicated statistically significant differences in most of the distributions of the 
datasets from the control and THR revision reason groups. This finding was important as it 
made progress in answering two of the research questions posed in Section 1.5; could AEs 
from THR implants be reliably categorised using time and frequency domain characteristics, 
and would those categories corresponded to the clinical revision reasons? The results from the 
KS tests suggested that failing THR implants produced some AEs that were unique to the 
implant’s particular failure mode. Hence, the KS test results did suggest that THR AEs could 
be categorised into clinical revision reason groups using time and frequency domain 
characteristics. However, the results presented thus far do not indicate whether the 
categorisation of AEs can be performed reliably. To answer the research questions more 
rigorously, and validate the reliability of the categorisation of AEs, the distribution of the AEs 
of the individual group participants were compared to the overall distribution of the group to 
which they were categorised. That is, using the KS test, the empirical CDFs of the individual 
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participants of a group were compared against the empirical CDF of the entire group to check 
for any statistically significant differences. 
5.4.4 Kolmogorov-Smirnov Tests – Individual Control 
Tables 5.7-5.10 show the KS test results for the seven metrics using the pairings of the overall 
empirical CDF of the control group with the empirical CDF of each control participant 
individually. A significance level of 1% was used for all KS tests of Tables 5.7  -5.10. Given 
that it was assumed that the data from each of the control participants would be similar (thus 
characteristic of AEs not produced by a THR implant), it would be expected that the KS tests 
would fail to reject the null hypothesis and not find statistically significant differences. 
However, it should be kept in mind that failing to reject the null hypothesis only indicates that 
not enough evidence was present to reject the null hypothesis and does not confirm the tested 
distributions are from the same distribution. Nevertheless, to support the assumption that the 
control data was well categorised, the data of Tables 5.7 -5.10 would not be expected to show 
many, if any, statistically significant differences in the results. 
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Table 5.7: Kolmogorov-Smirnov test results for event duration and RMS amplitudes of control group participants. A 
significance level of 1% was used. 












Control-C1: 0 0.073 0.244 0 0.818 0.120 
Control-C2: 0 0.643 0.113 0 0.825 0.096 
Control-C3: 0 0.038 0.288 0 0.028 0.299 
Control-C4: 0 0.168 0.398 0 0.403 0.319 
Control-C5: 0 0.265 0.251 0 0.022 0.376 
Control-C6: 0 0.262 0.174 0 0.308 0.167 
Control-C7: 0 0.625 0.095 0 0.790 0.082 
Control-C8: 0 0.171 0.131 0 0.063 0.156 
Control-C9: 0 0.464 0.133 0 0.606 0.119 
Control-C10: 0 0.255 0.389 0 0.369 0.352 
Control-C11: 0 0.582 0.235 0 0.640 0.225 
Control-C12: 0 0.075 0.431 0 0.057 0.448 
Control-C13: 0 0.120 0.424 0 0.462 0.304 
Control-C14: 0 0.233 0.131 0 0.013 0.201 
Control-C15: 1 <0.001 0.545 1 <0.001 0.477 
Control-C16: 0 0.035 0.148 0 0.108 0.126 
Control-C17: 0 0.692 0.067 0 0.024 0.139 
Control-C18: 0 0.117 0.209 0 0.306 0.170 
Control-C19: 1 <0.001 0.181 0 0.610 0.068 
Control-C20: 0 0.298 0.164 0 0.301 0.163 
Control-C21: 0 0.245 0.086 1 0.006 0.143 
Control-C22: 1 0.005 0.308 0 0.106 0.215 
 
Table 5.8: Kolmogorov-Smirnov test results for event main frequency content and duration between events of control group 
participants. A significance level of 1% was used. 












Control-C1: 0 0.283 0.187 0 0.081 0.340 
Control-C2: 1 0.008 0.254 0 0.458 0.160 
Control-C3: 1 <0.001 0.649 0 0.126 0.316 
Control-C4: 1 0.007 0.604 0 0.205 0.663 
Control-C5: 1 <0.001 0.549 0 0.031 0.517 
Control-C6: 1 <0.001 0.493 0 0.266 0.231 
Control-C7: 1 <0.001 0.527 1 <0.001 0.359 
Control-C8: 1 <0.001 0.377 1 <0.001 0.287 
Control-C9: 1 <0.001 0.445 0 0.733 0.141 
Control-C10: 1 <0.001 0.794 0 0.539 0.499 
Control-C11: 1 0.009 0.500 0 0.395 0.558 
Control-C12: 1 <0.001 0.760 0 0.298 0.510 
Control-C13: 1 0.008 0.596 0 0.099 0.997 
Control-C14: 1 <0.001 0.256 0 0.916 0.088 
Control-C15: 1 <0.001 0.452 1 <0.001 0.295 
Control-C16: 1 <0.001 0.322 0 0.188 0.125 
Control-C17: 1 <0.001 0.433 1 0.007 0.174 
Control-C18: 1 <0.001 0.533 0 0.144 0.297 
Control-C19: 1 0.001 0.174 0 0.158 0.111 
Control-C20: 1 <0.001 0.385 1 0.008 0.419 
Control-C21: 1 <0.001 0.314 0 0.270 0.092 
Control-C22: 1 <0.001 0.387 0 0.383 0.243 
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Table 5.9: Kolmogorov-Smirnov test results for event rise time and peak amplitude of control group participants. A 
significance level of 1% was used. 












Control-C1: 0 0.701 0.134 0 0.201 0.203 
Control-C2: 0 0.166 0.170 0 0.391 0.137 
Control-C3: 0 0.362 0.189 0 0.019 0.312 
Control-C4: 0 0.900 0.204 0 0.838 0.221 
Control-C5: 0 0.030 0.362 0 0.096 0.309 
Control-C6: 0 0.158 0.194 0 0.535 0.139 
Control-C7: 1 0.002 0.234 0 0.176 0.140 
Control-C8: 1 <0.001 0.282 0 0.030 0.172 
Control-C9: 0 0.041 0.217 0 0.253 0.158 
Control-C10: 0 0.738 0.262 0 0.558 0.304 
Control-C11: 0 0.675 0.219 0 0.368 0.278 
Control-C12: 0 0.874 0.199 0 0.125 0.395 
Control-C13: 0 0.328 0.339 0 0.271 0.357 
Control-C14: 0 0.312 0.122 1 0.002 0.232 
Control-C15: 1 <0.001 0.675 1 <0.001 0.319 
Control-C16: 1 0.006 0.178 0 0.333 0.098 
Control-C17: 0 0.058 0.124 0 0.244 0.096 
Control-C18: 0 0.015 0.273 0 0.147 0.200 
Control-C19: 0 0.071 0.116 0 0.367 0.082 
Control-C20: 0 0.808 0.107 0 0.284 0.166 
Control-C21: 1 0.008 0.139 0 0.018 0.128 
Control-C22: 0 0.705 0.125 1 0.004 0.312 
 
Table 5.10: Kolmogorov-Smirnov test results for number of events per recording duration of control group participants. A 
significance level of 1% was used. 








Control-C1: 0 0.066 0.330 
Control-C2: 0 0.149 0.272 
Control-C3: 0 0.076 0.323 
Control-C4: 1 <0.001 0.539 
Control-C5: 0 0.046 0.328 
Control-C6: 0 0.736 0.163 
Control-C7: 0 0.060 0.260 
Control-C8: 1 0.002 0.390 
Control-C9: 0 0.390 0.184 
Control-C10: 1 <0.001 0.567 
Control-C11: 1 0.007 0.414 
Control-C12: 1 <0.001 0.515 
Control-C13: 1 <0.001 0.461 
Control-C14: 0 0.199 0.207 
Control-C15: 1 <0.001 0.427 
Control-C16: 0 0.037 0.321 
Control-C17: 1 <0.001 0.663 
Control-C18: 0 0.225 0.221 
Control-C19: 1 <0.001 0.622 
Control-C20: 0 0.332 0.186 
Control-C21: 1 <0.001 0.655 
Control-C22: 0 0.229 0.208 
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It was observed from Table 5.7 that for the event RMS amplitude KS tests there was a 
statistically significant difference in the data for only two of the 22 participants. For the event 
duration and peak amplitude KS tests (Tables 5.7  and 5.9  respectively), there was a 
statistically significant difference in the data for only three participants for each metric. For the 
KS tests of duration between events (Table 5.8) and those of the event rise time (Table 5.9) 
five participants had data with a statistically significant difference. The KS tests for the number 
of events per recording duration (Table 5.10) had 10 participants with a statistically significant 
difference in their data. Furthermore, the main frequency content KS tests of Table 5.8 had 21 
of the 22 datasets with a statistically significant difference. 
It would seem that, from the KS test results of the control group data, a number of the control 
participants have AE data that does not fit well with the group as a whole. However, when 
considering the recruitment criteria for the control group it would be unwise to remove 
participants’ AE data from the control group based solely on the results from the KS tests. The 
recruitment criteria for the control group required participants to have healthy natural hip joints 
with no history of hip joint trauma or injury. Hence, to get a comprehensive indication of the 
AEs from natural hips, data should only be removed from the control group if it was erroneous 
and not simply because it had AEs with differing metrics to the other control participants’ data.  
Nevertheless, performing the KS tests on the control data was not meaningless. From the data 
of Tables 5.7-5.10, control participant 15 was noted to be the only participant to have a 
statistically significant difference for all of the metrics. The empirical CDFs were then 
investigated and it was found that control participant 15 exhibited behaviour that was 
noticeably different to that of the other control participants. Upon further inspection of the time 
domain responses of control participant 15’s AEs it was found that there was an obvious 
increase in noise present. This increased noise was likely due to inadequate force holding the 
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AE sensor pad in place during testing causing AEs to be detected from the movement of the 
sensor pad. For these reasons, it was decided that the data of control participant 15 would be 
removed from all further analysis. 
A further important observation from the KS tests of the control data was the result that 21 of 
the 22 main frequency content datasets showed a statistically significant difference and 16 of 
these tests yielded p values below 0.001 (see Table 5.8). This result was initially unexpected 
as none of the other metrics showed such a trend and, as identified in the initial observations 
of Chapter 4, the frequency responses were shown to primarily cover a relatively narrow 
frequency range. Conversely, it was also identified in the observations of Chapter 4 that the 
main frequency content did vary (sometimes considerably) between participants and hence 
some variability in their distributions was expected. Therefore, the result of the KS tests in 
Table 5.8 emphasise the variability and overall data spread that was present in the main 
frequency content of the AEs was in fact significant. Thus, it was noted for future analysis that 
significant variation in the main frequency content was expected and that any comparisons of 
the frequency content should be carried out with this in mind. 
5.4.5 Kolmogorov-Smirnov Tests – Individual Noise Revisions 
Further KS tests were performed for the seven metrics using the pairings of the overall 
empirical CDF of the noise revision reason group with the empirical CDF of each noise revision 
reason participant individually. Additionally, KS tests were performed between the individual 
noise revision reason participants and the overall control group to investigate similarities of the 
individual noise revision participants to the control group. There were nine participants who 
had been categorised into the noise revision group. Hence, two sets of nine KS tests were 
carried out to compare each individual noise revision group participant to the overall noise 
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revision group and control group empirical CDFs. The results of these KS tests are shown in 
Table B.1 to Table B.4 in Appendix B and a significance level of 1% was used for all the tests. 
The results from both sets of KS tests showed that a statistically significant difference was 
present for all but one of the 18 tests of the main frequency content event metric. This result 
was consistent with the previous finding of statistically significant differences in the main 
frequency content of the individual control group participants. Across the six other metrics, for 
the set of KS tests comparing the noise revision group to its individual participants, an average 
of six out of the nine tests showed statistically significant differences. This result is important 
as it showed that, in general, for each individual metric over half of the participants categorised 
into the noise revision group showed evidence that they had AE behaviour that differed 
significantly from the overall behaviour of the group itself. Hence, the result implies that there 
was significant variation in the AEs of participants who were identified as being in the noise 
revision group. This is expected due to the range of possible sources of noise that may come 
from an implant. 
Furthermore, for the set of KS tests comparing the control group to the individual noise revision 
group participants, an average of five tests per metric (excluding main frequency content) 
showed statistically significant differences. This result implies that for each metric (excluding 
main frequency content) the AE behaviour of just under half of the noise revision group 
participants was not confirmed to be statistically different to the behaviour of control group 
AEs. Hence, more analysis would need to be carried out to investigate the possibility of noise 
group participants having AE content that was similar to that of the control group AEs. 
Interestingly, two of the noise group participants (Participants 10 and 25) were found to have 
statistically significant differences to the overall noise group in all metrics except RMS 
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amplitude. When comparing the KS tests using the control group data pairing (and excluding 
the main frequency content metric), these same two participants did not have statistically 
significant differences in any metrics except duration between events. Therefore, 
Participants 10 and 25 would be good candidates for further investigation to investigate any 
similarities of their AEs with those of the control group AEs.  
In addition, another participant (Participant 27) had statistically significant differences to the 
overall noise group for all metrics. Furthermore, Participant 53 had statistically significant 
differences to the overall noise group for all metrics except peak amplitude. However, in 
contrast to Participants 10 and 25, when comparing the KS tests using the control group data 
Participant 27 had statistically significant differences in all metrics and Participant 53 had 
statistically significant differences in all metrics except duration between events. These results 
suggest that the AEs of Participants 27 and 53 were significantly different to both those of the 
overall noise revision group (which they were a part of) and the control group. A further KS 
test between the paring of Participant 27 and Participant 53 also showed statistically significant 
differences in all metrics. This result indicates that the AEs of these two participants were also 
significantly different to each other. Therefore, given that the THR implants of both 
Participants 27 and 53 were in fact revised for noise, the results of the statistical tests confirm 
the significant variability present in the overall AEs from participants categorised into the noise 
revision group. 
5.4.6 Kolmogorov-Smirnov Tests – Individual Loosening Revisions 
KS tests were also performed for the seven metrics using the pairings of the overall empirical 
CDF of the loosening revision group with the empirical CDF of each loosening revision 
participant individually. Furthermore, KS tests were performed between the individual 
loosening revision participants and the overall control group to investigate similarities of the 
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loosening revision participants to the control group. There were 21 participants who had been 
categorised into the loosening revision group. Hence, two sets of 21 KS tests were carried out 
to compare each individual loosening revision group participant to the overall loosening 
revision and control empirical CDFs. The results of these KS tests are shown in Table B.5 to 
Table B.8 in Appendix B and a significance level of 1% was used for all the tests. 
For the duration metric, 14 of the 21 loosening revision participants had datasets with 
statistically significant differences to both the overall loosening revision group and overall 
control group empirical CDFs. This result indicates that two thirds of the loosening group 
participants had AE events with general duration characteristics that were significantly 
different to those of the control group. However, the same two thirds of participants also had 
AE event duration characteristics that were significantly different to those of the overall 
loosening group. Hence, it was indicated that a significant variation existed in the general event 
duration characteristics of loosening revision participants. One additional loosening participant 
had a dataset with a statistically significant difference to only the overall control group dataset. 
The KS tests for the remainder of the loosening participants failed to show any statistically 
significant differences in event durations to the loosening group or control group. Therefore, 
while the KS test results did not make the conclusion that these remaining loosening 
participants had similar event duration characteristics, similarity in the event duration 
behaviour of the remaining loosening participants remained a possibility. 
For the RMS amplitude metric, five loosening participants had datasets with statistically 
significant differences to the overall control group empirical CDF. Four of these five 
participants were observed to be the four loosening participants with statistically significant 
differences to the overall loosening group empirical CDF for the RMS amplitude metric. For 
the peak amplitude metric, four loosening participants had datasets with statistically significant 
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differences to the overall control group empirical CDF. Three of these four participants were 
observed to be three of the four loosening participants with statistically significant differences 
to the overall loosening group empirical CDF for the peak amplitude metric. Once again since 
failing to find a statistically significant difference does not confirm similarity in the 
distributions, it cannot be concluded that for event amplitudes the majority of the participants 
had similar behaviour. However, since the results from Section 5.4.3 could not find a 
statistically significant difference in the event amplitude behaviours of the overall loosening 
and control group empirical CDFs, the possibility still remains that the majority of the 
loosening participants have event amplitude behaviours that are similar to both the overall 
loosening group as well as the control group. 
For the duration between events metric the KS test set concerning the overall loosening group 
had 12 results with statistically significant differences while that concerning the overall control 
group had 8 results with statistically significant differences. For the rise time metric the KS test 
set concerning the overall loosening group had 9 results with statistically significant differences 
while that concerning the overall control group had 11 results with statistically significant 
differences. In addition, the number of events per recording duration KS test set using the 
overall loosening group had 7 results with statistically significant differences while that using 
the overall control group had 14 results with statistically significant differences. Furthermore, 
similar to the previous KS tests, all but two of the 42 loosening tests had a statistically 
significant difference for the main frequency content event metric. Thus, further demonstrating 
the significant variability in the main frequency content of the AEs. 
5.4.7 Conclusions from Empirical CDFs and KS Tests 
In general, a range of different observations were clear across the different metrics. From the 
empirical CDF plots and probability density histograms of Section 5.4.2 the overall noise 
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revision category was the only group that had obvious differences for most metrics which was 
likely attributed to the presence of audible squeaking AEs. The usefulness of being able to 
categorise a patient into the noise category based on data that includes audible squeaking is 
limited as it is likely that both the patient and their surgeon would already be aware that the 
implant is making audible noises and hence they would not need an AE assessment to produce 
this diagnosis. However, patients who eventually get revised for implant squeaking may 
produce non-audible, non-squeaking AEs at an earlier stage that could provide advanced 
warning of the need for implant revision. Therefore, it may be possible to categorise a patient 
into the noise revision reason category without their implant producing audible squeaks or other 
audible sounds. 
A major observation from the KS test analyses was that the main frequency content 
distributions showed statistically significant differences for almost all tests. This result 
indicates significant variability in the main frequency content of AEs across participants. 
Therefore, it is unlikely that the main frequency content metric could be used as a diagnostic 
indicator without incorporating other information about the AEs. 
The control group was observed to have an obvious difference to the THR participant 
groupings as it showed lower values for the number of events per recording duration metric 
which was consistent with prior observations of the time domain AE recordings. The individual 
control participants, in general, did not yield a large number of statistically significant 
differences in the AE metrics (excluding main frequency content) when comparing to the 
overall control group. However, as stated previously, this lack of statistically significant 
differences does not automatically confirm general similarity between the control AEs, it 
simply does not discount similarity. 
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Furthermore, the KS testing of the noise revision group found that, in general for each metric, 
over half of the participants categorised into the noise revision group showed evidence that 
they had AE behaviour that differed significantly from the overall behaviour of the group itself. 
This result indicates significant intra-participant variation in the AEs of participants who were 
identified as being in the noise revision group. Additionally, it was concluded that more 
analysis would be needed to investigate the possibility that some noise group participants had 
AE content that was more similar to that of the control group AEs than those of participants 
with known audible AEs. 
Overall, the KS tests of the individual loosening revision participants showed varied results 
between the metrics in terms of statistically significant differences. Some results seemed to 
suggest that for some metrics there were significant differences between the event 
characteristics of a considerable number of the loosening participants and the overall loosening 
group. The results of the KS tests also did not entirely reject the possibility of loosening 
revision participants having similar event characteristics to the overall control group. 
Furthermore, for the main frequency content and event duration metrics over half of the 
loosening revision participants showed statistically significant differences to both the overall 
loosening group and the control group indicating a large variability in these metrics. 
In conclusion, apart from the presence of audible squeaking, it seemed that no major 
distinctions between the THR revision reasons was present. Ideally, if obvious distinctions 
were present in the CDFs for each grouping within a metric then it would be likely that the 
corresponding metric could then be used as a diagnostic indicator for future AE detection. The 
empirical CDFs of Figure 5.10 showed that a particular event in any grouping could take on 
almost any value in the range of the particular metric but other events with a similar value of 
that metric would also have occurred in the other groupings. The implication of this result was 
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that none of the metrics could be used in isolation to classify an event into a revision reason 
category as all groupings were likely to contain events with the same metric value of that event. 
Therefore, the conclusion from the CDF and KS test analysis was that the single metrics alone 
were not an effective way to categorise participant AE data. However, by comparing or 
combining multiple metrics more distinct differences between revision reason groupings may 
be able to be determined and hence more reliable categorisation or diagnosis could be made. 
5.5 Multi-dimensional Metric Comparisons 
5.5.1 Two-dimensional Event Metric Analysis 
The analysis of Section 5.4 concluded that no AE event metric on its own was an effective way 
to categorise THR AE data. However, more insight may be gained by comparing multiple AE 
metrics simultaneously. As explained in Section 5.4, each AE event was represented by five 
signal metrics (duration, rise time, RMS amplitude, peak amplitude, and main frequency 
content). Two additional metrics concerning the rate of occurrence of events were also 
computed (duration between events and number of events per recording duration). Since the 
two additional metrics described the rate of occurrence of AE events they did not correspond 
directly to specific AE events (i.e. a specific AE event had a “duration” and “rise time” etc. but 
did not have a “duration between events” or a “number of events per recording duration”). 
Therefore, only the event duration, rise time, RMS amplitude, peak amplitude, and main 
frequency content metrics were compared in a multi-dimensional analysis.  
Two-dimensional comparisons were performed using scatter plots to provide visual 
representations of the combined distributions of the two-metric pairs of the five AE event 
metrics. That is, each AE event signal was represented on a two-dimensional plot where each 
axes was one of the five AE event metrics (e.g. an AE event which had a duration of 10 ms and 
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a RMS amplitude of 0.1 V would appear as a single data point located at the corresponding 
position on a duration and RMS amplitude scatter plot). Ten permutations of two-metric 
comparisons were possible from the five AE event metrics. Hence, ten different two-
dimensional comparisons were performed for the AE event data. Four scatter plots were 
produced for each permutation of two-metric comparisons in order to compare the AE events 
across the four different participant data groupings of control, noise revision, loosening 
revision, and excessive wear revision. Each set of four scatter plots for the ten two-metric 
comparisons are presented in Figures 5.15-5.23. Note that, like the empirical CDFs of Figure 
5.10, due to the data for each metric spanning multiple orders of magnitude, the plots of Figures 
5.15-5.23 have been presented using a log scale in order to more clearly show any distinctions. 
The scatter plots of Figures 5.15-5.23 also showed the relative density of AE events through 
the use of a colour bar. The density indicated the relative number of occurrences of AE events 
within two-dimensional regions of the scatter plot. Consequently, the relative density of the 
scatter plot expressed the two-dimensional distribution of the data and was analogous to the 
one-dimensional distributions shown by the magnitudes of the histogram bars in the probability 
density histograms of Figures 5.11-5.14. For each separate two-dimensional metric comparison 
(Figures 5.15-5.23), the relative densities were normalised across the four participant grouping 
scatter plots so that the densities were comparable. A further detail to note was that, prior to 
normalisation across groups, the densities of each individual scatter plot were divided by the 
total duration of the AE recordings that contributed to that particular scatter plot. This prior 
division operation was performed in order to account for the disparity in the total recording 
durations for the different groupings to avoid a bias in the density values (due to differing 
number of participants and individual recording durations). 
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Figure 5.15 shows the scatter plots of the event duration and RMS amplitude for the control, 
noise revision, loosening revision, and excessive wear revision groups. It was observed from 
Figure 5.15 that, in general, a slight positive correlation existed in the data. For durations below 
approximately 10 ms, the RMS amplitude increased as the duration increased (see annotation 
in Figure 5.15a). However, across all four groups, for durations greater than approximately 
10 ms the RMS amplitude values appeared to be uncorrelated to the durations. Lower RMS 
amplitudes were expected for the very short duration AE events given that RMS amplitudes 
were calculated using a summation of the squared voltage samples in the signal (i.e. shorter 
duration AE signals have less voltage samples in the summation). When comparing the scatter 
plots across the four groups, the noise revision group (Figure 5.15b) had an obvious increased 
amount of AE events in the uncorrelated region of duration values above 10 ms. Furthermore, 
a similar trend in the relative densities was observed across the four groups with the maximum 
densities for each scatter plot occurring in similar regions of the plots. Additionally, the 
loosening revision group was observed to have the largest relative density values, as indicated 
by a greater number of regions coloured brown and red (see annotation in Figure 5.15c). The 
control group had the lowest maximum relative density of the four groups at approximately 
0.6 times the maximum density of the loosening group (as indicated by the light green region 
in Figure 5.15a  which corresponded to a relative density of approximately 0.6). This result 
aligns with expected behaviour that control participants exhibited fewer AE events, leading to 
the lower density of points. 
Figure 5.16 shows the scatter plots of the event duration and main frequency content for the 
four participant groupings. It was observed from Figure 5.16 that the event durations and main 
frequency content was largely uncorrelated. However, it was observed that, across all four 
groupings, the AE events with main frequency content above approximately 5 kHz had 
durations less than 20 ms. Furthermore, it was evident that AE events with durations above 
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20 ms generally had main frequency content between 2.5-3.0 kHz. In addition, from Figure 
5.16 it was observed that the loosening and excessive wear revision groups had a cluster of 
events with main frequency content just below 2 kHz which was not evident in the scatter plots 
of the other groups. The clusters below 2 kHz had low relative density values indicating other 
regions of the scatter plots had many more occurrences of events. Nevertheless, these clusters 
below 2 kHz were a unique feature of the AEs of two of the participant groups (loosening and 
excessive wear) and further analysis of the AE event signals within these clusters may 
contribute to the diagnostic capability of THR AEs. 
 
Figure 5.15: Scatter plots of event duration and RMS amplitude for a) the control group, and b) noise, c) loosening, and d) 
excessive wear revision groups. Note the relative densities were normalised across the four participant grouping 
scatter plots so that the densities were comparable. 
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Figure 5.16: Scatter plots of event duration and main frequency content for a) the control group, and b) noise, c) loosening, 
and d) excessive wear revision groups. Note the relative densities were normalised across the four participant 
groupings. 
Figure 5.17 presents the scatter plots of the RMS amplitude and main frequency content for the 
four participant groupings. It was observed from Figure 5.17 that the RMS amplitude and main 
frequency content of the AE events was uncorrelated for all four participant groups. Figure 
5.18 shows the scatter plots for the event durations and rise times for the four participant 
groupings. In contrast to Figure 5.17, it was observed from Figure 5.18 that a moderate positive 
correlation exists between the event durations and rise times. This correlation is a somewhat 
expected result given that the maximum rise times could not exceed the duration of an AE 
event. However, it was possible for long duration AE events to have very short rise times. 
Despite the possibility of short rise times in long duration AE events, the scatter plots of Figure 
5.18 showed that longer duration AE events generally had longer rise times.  
Long durations 
below 5 kHz 
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Figure 5.17: Scatter plots of event RMS amplitude and main frequency content for a) the control group, and b) noise, c) 
loosening, and d) excessive wear revision groups. Note the relative densities were normalised across the four 
participant groupings. 
 
Figure 5.18: Scatter plots of event duration and rise time for a) the control group, and b) noise, c) loosening, and d) excessive 
wear revision groups. Note the relative densities were normalised across the four participant groupings. 
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Figure 5.19 shows the scatter plots for the event durations and peak amplitude for the four 
participant groups. It was observed from Figure 5.19 that the trends for all four groupings were 
the same as the trends observed for the event duration and RMS amplitude metric combination 
of Figure 5.15. Figure 5.20 shows the scatter plots for the peak amplitude and main frequency 
content metric combination for the four participant groupings. It was observed from Figure 
5.20 that, much like the metric combination of RMS amplitude and main frequency content in 
Figure 5.17, the peak amplitudes and main frequency content were uncorrelated for all 
participant groupings.  
Figure 5.21 presents the scatter plots for the event peak amplitudes and RMS amplitudes for 
the four participant groupings. A relatively strong correlation was observed visually across all 
four participant groupings for the peak and RMS amplitudes of Figure 5.21. The observed 
correlation in Figure 5.21 was a generally expected result. It was reasonable to assume that 
larger peak amplitudes would indicate larger RMS amplitudes given that the peak amplitude 
contributes to the RMS amplitude calculation and large peak amplitude voltages generally had 
increased voltage amplitudes surrounding them. However, it was still possible for an AE event 
signal to have a large peak amplitude voltage with the remainder of the signal having relatively 
low voltage amplitudes resulting in a low RMS amplitude. Upon closer inspection of the noise 
revision grouping, a small number of AE events were observed to have relatively low RMS 
amplitude values and higher peak amplitudes which distinguished them from the main cluster 
of AE events (see ellipse in Figure 5.21b). These distinguished AE events of Figure 5.21b are 
likely to be short ‘impulse’ type AE events which can have high peak voltage amplitudes but 
relatively low RMS amplitudes. However, the general trends of Figure 5.21 indicated that AE 
events with larger peak amplitudes also had corresponding larger RMS amplitudes. 
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Figure 5.19: Scatter plots of event duration and peak amplitude for a) the control group, and b) noise, c) loosening, and d) 
excessive wear revision groups. Note the relative densities were normalised across the four participant 
groupings. 
 
Figure 5.20: Scatter plots of event peak amplitude and main frequency content for a) the control group, and b) noise, c) 
loosening, and d) excessive wear revision groups. Note the relative densities were normalised across the four 
participant groupings. 
 
Figure 5.21: Scatter plots of event peak amplitude and RMS amplitude for a) the control group, and b) noise, c) loosening, 
and d) excessive wear revision groups. Note the relative densities were normalised across the four participant 
groupings. 
Figure 5.22 presents the scatter plots of the event peak amplitudes and rise times for the four 
participant groupings. It was observed from Figure 5.22 that, for rise times shorter than 
approximately 1.5 ms, peak amplitude increased as rise time increased. However, for rise times 
longer than approximately 1.5 ms the metrics were uncorrelated. Figure 5.23 shows the scatter 
plots of the event RMS amplitudes and rise times for the four participant groupings. From 
Figure 5.23 trends very similar to those observed in the scatter plots of the peak amplitude and 
rise time metric combination (Figure 5.22) were observed. The similar trends observed between 
Figures 5.22 and 5.23 were expected given the correlation that was observed previously 
between the RMS and peak amplitudes in Figure 5.21. 
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The final two-metric combination of rise time and main frequency content is presented in 
Figure 5.24 with one scatter plot for each of the four participant groupings. From Figure 5.24 
it was observed that the trends across all the four participant groupings were very similar to 
those observed in the scatter plots of event duration and main frequency content (Figure 5.16). 
Comparable to the similarities between Figures 5.22 and 5.23 involving the peak and RMS 
amplitudes, the similarities observed between the scatter plots of Figure 5.24 and Figure 5.16 
were expected given the moderate correlation that was observed between the event durations 
and rise times of Figure 5.18. 
 
Figure 5.22: Scatter plots of event peak amplitude and rise time for a) the control group, and b) noise, c) loosening, and d) 
excessive wear revision groups. Note the relative densities were normalised across the four participant 
groupings. 
 
Figure 5.23: Scatter plots of event RMS amplitude and rise time for a) the control group, and b) noise, c) loosening, and d) 
excessive wear revision groups. Note the relative densities were normalised across the four participant 
groupings. 
 
Figure 5.24: Scatter plots of event rise time and main frequency content for a) the control group, and b) noise, c) loosening, 
and d) excessive wear revision groups. Note the relative densities were normalised across the four participant 
groupings. 
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From the two-dimensional scatter plot comparisons of Figures 5.15-5.23 it was found that, in 
general, one main cluster of AE events was present which had a relatively wide spread much 
like what was observed in the single metric distributions of Section 5.4.2. Across all the two-
metric comparisons, the main data clusters were similar in shape when comparing between the 
four participant groupings of control, noise revision, loosening revision, and excessive wear 
revision. However, for all two-metric comparisons the noise revision grouping had additional 
low relative density AE events that spread away from the main data cluster. With the exception 
of the additional data spread in the noise revision grouping, the two-dimensional analysis 
showed that a randomly chosen AE event was likely to have event metrics that were common 
to all participant categories. Therefore, the main conclusion from the two-dimensional event 
metric analysis was that it may be possible to categorise a THR AE event into the noise revision 
group but it was more likely that a random AE event would have event metrics that are common 
to all participant groupings. However, the two-dimensional analysis was useful in that a number 
of interesting observations were made that were either not apparent or unable to be noticed 
from the previous single metric distribution analysis of Section 5.4. Table 5.11 provides a brief 
summary of the main observations from the scatter plots of each of the two-metric 
permutations. 
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Table 5.11: Summary of main observations from 2D scatter plot event metric comparisons. 
Metric Pairing Scatter Plot Visual Observations Summary 
Duration – RMS Amplitude 
 High RMS amplitudes have longer durations for 
durations below 10 milliseconds 
 Uncorrelated for durations greater than 
approximately 10 milliseconds 
Duration – Main Frequency 
 Main frequencies above 5 kHz have durations 
less than 20 milliseconds 
 Durations above 20 milliseconds mostly have 
main frequencies between 2.5-3.0 kHz 
 Loosening and excessive wear revision groups 
show a unique grouping of events with main 
frequencies just below 2 kHz 
Duration – Peak Amplitude  Same as Duration – RMS Amplitude 
Duration – Rise Time 
 An expected and relatively strong correlation 
observed 
RMS Amplitude – Main Frequency  Uncorrelated 
RMS Amplitude – Peak Amplitude 
 An expected and relatively strong correlation 
observed 
 A very small number of events had low RMS 
amplitudes but high peak amplitudes which 
made them appear as outliers to the main data 
cloud 
RMS Amplitude – Rise Time 
 Uncorrelated for rise times above approximately 
3 milliseconds 
 High RMS amplitudes have longer rise times for 
rise times below approximately 3 milliseconds 
Peak Amplitude – Main Frequency  Uncorrelated 
Peak Amplitude – Rise Time 
 Larger peak amplitudes have longer rise times 
for rise times below approximately 
1.5 milliseconds 
 Uncorrelated for rise times longer than 
1.5 milliseconds 
Rise Time – Main Frequency  Similar to Duration – Main Frequency  
 
5.5.2 Principal Component Analysis 
As an extension to the two-dimensional analysis, a five-dimensional analysis that compared all 
five of the AE event metrics simultaneously was performed on the event data. The implication 
of performing a five-dimensional analysis was that visual comparisons can only be carried out 
in up to three dimensions (i.e. 3-D scatter plots). Hence, comparing four or more metrics is 
  172 
impossible visually without combining the metrics in some way. Therefore, the five-
dimensional analysis was performed using a principal component analysis (PCA).  
PCA is a multivariate technique that extracts the important information from data that contains 
multiple dependent variables. The goal of PCA is to express the important information of a 
dataset as a new set of orthogonal variables, known as principal components (PCs), which are 
a linear combination of the original variables (Abdi & Williams, 2010). The PCs are computed 
to express the data in such a way that the first PC is aligned with the direction of largest possible 
variance in the dataset. Consequently, the first PC is said to ‘extract’ or ‘explain’ the largest 
proportion of the inertia of the dataset (Abdi & Williams, 2010). The inertia of a dataset is 
analogous to the total variance and is defined as the sum of all the squared elements of each 
variable (i.e. the sum of the squared distance of each data point from the origin). The second 
PC is constrained to be orthogonal to the first PC and is orientated such that it extracts the 
largest proportion of the remaining inertia of the dataset. Subsequent PCs are computed in the 
same manner until all the inertia of the dataset has been extracted or accounted for. Therefore, 
the total number of PCs does not exceed the total number of original variables. 
Since a PCA has the goal of expressing the important information of a dataset, the PCA will 
generally be able to express a significant proportion of the total inertia of a dataset with less 
dimensions than the original variables. That is to say, a PCA performed on a dataset with five 
dimensions may be able to express in excess of 90% of the total inertia using three PCs instead 
of five. Consequently, a PCA has the ability to reduce the dimensionality of a dataset and still 
maintain a good overall representation of the data. Furthermore, the reduction of a five-
dimensional dataset down to three dimensions allows a visual representation of the data to be 
produced using either a two- or three-dimensional plot with the first two or three PCs as the 
plot axes respectively. In the case of the five-dimensional dataset of THR AE events (using the 
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same metrics as in Section 5.5.1), PCAs applied to the four participant groupings of AE events 
did in fact result in dimensionality reductions down to three PCs. These three PCs accounted 
for approximately 95% of the variation in the datasets. Therefore, visual comparisons were 
made possible of the five-dimensional AE event data through the use of PCA.  
To apply a PCA to a participant AE event dataset, the dataset was first centred on its mean 
(zero-meaned) and then standardised. The standardisation was performed by dividing the event 
metric value for each event by the Euclidean norm of the same event metric across all AE 
events of the dataset (e.g. each duration value of a dataset was divided by the Euclidean norm 
of all event durations for the entire dataset). The standardisation of the event metrics was an 
important step in order to ensure that the PCA did not produce biased results. Since a PCA 
finds PCs that maximise variance in a dataset, variables (AE event metrics) that had generally 
large numerical values would dominate the PCs (e.g. frequency values varying in the range 1-
10 kHz would dominate duration values that vary in the range of 0.005-0.050 seconds). 
Therefore, standardisation allows an unbiased PCA to be performed without affecting the 
relative variance of the individual variables.  
After the dataset was centred and standardised, the correlation matrix, 𝑿, was computed. If the 
dataset contains 𝐼 AE events and is represented by 𝐽 variables, then the zero-meaned and 
normalised dataset is defined as a 𝐼 × 𝐽 matrix 𝑨, where the rows of 𝑨 represent each AE event 
and the columns of 𝑨 represent the AE event metrics. Therefore, the correlation matrix is 
defined as: 
𝑿 = 𝑨𝑻𝑨      (5.1) 
Where the superscript 𝑻 indicates the transpose operation. The correlation matrix by definition 
contains the correlations between the variables of the standardised data. The correlation matrix 
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has an important useful property in that the eigenvectors of the matrix are orthogonal and they 
also correspond to the directions of largest variance of the dataset 𝑨. Hence, the eigenvectors 
of the correlation matrix are the PCs of the dataset 𝑨. Additionally, the eigenvalues represent 
the inertia associated with the eigenvector or PC; the proportion of inertia for a PC is the 
associated eigenvalue divided by the sum of all the eigenvalues. Thus, to find the eigenvalues 
and eigenvectors of the dataset, an eigen-decomposition was performed on the correlation 
matrix using MATLAB. The eigen-decomposition of the correlation matrix is given as: 
𝑿 = 𝑽𝑺𝑽𝑻      (5.2) 
Where 𝑽 is a 𝐽 × 𝐽 matrix of which the columns contain the eigenvectors of 𝑿 and 𝑺 is a 𝐽 × 𝐽 
diagonal matrix containing the eigenvalues of 𝑿. The eigenvalues in 𝑺 are ordered from largest 
in the first column to smallest in the last column. Consequently, the PCs are ordered from first 
PC in the first column of 𝑽 to the last PC in the last column of 𝑽.  
A separate PCA was performed on each of the AE event metric datasets for the four participant 
groupings of control, noise revision, loosening revision, and excessive wear revision AEs. 
Table 5.12 shows the percentage of inertia explained by each of the five resulting PCs for each 
of the four datasets. It was observed from Table 5.12 that the percentage of inertia was similar 
for each PC across the four groups with the average percentages being 46.3%, 30.0%, and 
19.4% for the first, second, and third principal components respectively. Furthermore, on 
average, the first three PCs combined contained over 95% of the total inertia and over 75% of 
the total was within the first two PCs. Consequently, a large proportion of the variation in the 
four AE event datasets could be shown using two-dimensional plots of the AE events projected 
onto the first two PCs. 
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Table 5.12: Percentage of inertia explained by each principal component. 
Principal Component 1 2 3 4 5 
Control (%) 42.2 35.9 19.6 1.3 0.9 
Noise (%) 48.9 27.0 19.7 2.6 1.9 
Loosening (%) 47.9 27.5 18.4 5.2 1.1 
Excessive Wear (%) 46.0 29.4 19.8 3.5 1.3 
Average (%) 46.3 30.0 19.4 - - 
In order to transform the individual AE events of each group into the PC coordinate space, 
factor scores, 𝑭, were computed. The factor scores are the coordinates of the original dataset 
projected onto the PCs. Therefore, the matrix 𝑭 has the same size as 𝑨 and is defined as: 
𝑭 = 𝑿𝑽      (5.3) 
Where each row of 𝑭 contains the projected coordinates of one AE event and the columns 
ordered from first to last represent the PCs ordered from the first to last respectively. It is useful 
to note here that Equation 5.3 can be used to compute factor scores for additional observations 
(known as supplementary observations) that did not undergo the PCA. That is, the correlation 
matrix of supplementary observations can be multiplied by the eigenvector matrix, 𝐕, to yield 
corresponding factor scores for the supplementary observations. Supplementary observations 
must undergo the same centering and standardisation operations that were applied to the 
original dataset. Figure 5.25 shows the PCA factor scores of the AE events projected onto the 
first two PCs for the four participant groups. It was observed from Figure 5.25 that the general 
distribution of the data for all groups was broadly similar since all the groups showed one main 
cluster of data and two noticeable tails. However, the noise and loosening revision groups both 
exhibited some obvious differences. The noise revision group showed an increased occurrence 
of highly scattered AE events between the two data tails and in the direction of the first PC (see 
annotation in Figure 5.25b). The loosening revision group showed a more concentrated group 
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of AE events situated between -0.1 and 0 on PC2 and close to the PC1 axis (see annotation in 
Figure 5.25c). Furthermore, given that the two tails that were observed in the data of Figure 
5.25 extend away from the origin approximately symmetrically about PC1, it is likely that at 
least two different variables contribute to the largest variation in the data. However, the factor 
score representations are limited in their ability to express what physical quantity/original input 
event metric each PC actually represents, and so the statement that at least two variables 
contribute to the largest variation of the data cannot be verified from Figure 5.25 alone. 
 
Figure 5.25: PCA factor scores of AE events plotted against the first and second principal components for the a) control, b) 
noise revision, c) loosening revision, and d) excessive noise revision groups.  
An arguably more informative and useful result that comes from a PCA is the correlation 
between the individual PCs and event metric variables. These correlations provide an estimate 
for how much information each PC and each event metric variable share. Consequently, the 
correlations between the PCs and the variables provide a better indication as to the actual 
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the standardised correlation matrix, the correlation coefficients between the PCs and the 
variables is defined as: 
𝑳 = 𝑽√𝑺      (5.4) 
Where each row of 𝑳 represents one of the variables and each column (from first to last) 
represents a PC from first to last respectively. The correlation coefficients take on values in the 
range 0-1 and the sum of the squared correlations of each variable add to one (i.e. the rows 
of 𝑳𝟐 sum to one). Therefore, the squared coefficients of the correlations indicate what 
proportion of each variable is represented by a particular PC. Table 5.13 presents the squared 
correlation coefficients between each variable and each of the first three PCs for the four 
participant groupings. Note that the values in Table 5.13 have been multiplied by 100 to display 
as percentages. Furthermore, the summation of the columns of each of the four separate groups 
in Table 5.13 will be close to 100% (but not exactly since the values for the fourth and fifth 
PCs are not shown). 


















1 56.5 55.7 52.0 46.8 0.0 
2 40.5 41.2 44.3 49.5 4.2 
3 0.3 0.3 0.9 0.9 95.8 
Noise 
1 59.7 64.3 60.0 59.0 1.4 
2 32.0 30.9 35.2 33.1 2.7 
3 1.0 0.0 0.2 1.4 95.9 
Loosening 
1 62.2 79.4 70.1 26.5 0.4 
2 22.6 16.6 22.3 47.0 28.9 
3 0.9 1.1 2.8 17.2 70.0 
Excessive 
Wear 
1 54.4 70.2 55.4 49.8 0.3 
2 36.4 26.2 40.7 40.4 3.4 
3 0.7 0.1 0.6 1.1 96.3 
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The major important observation from Table 5.13 was that the duration, peak amplitude, RMS 
amplitude, and rise time variables dominated the contributions to the first and second PCs 
across all groups. Conversely, it was evident that the third PC was dominated by the main 
frequency content for all groups. Therefore, in general, the squared correlation coefficients 
indicated that the first and second PCs were both primarily linear combinations of the duration, 
peak amplitude, RMS amplitude, and rise time metrics. Whereas, the third PC primarily 
represented the main frequency content metric. However, there were some noticeable 
differences in the percentage values when comparing variables between the four groups despite 
the general trends being similar. 
A visual representation was produced to further interpret the correlations between the variables 
and the PCs. The correlation coefficients were used as coordinates to plot each variable as a 
point in the PC coordinate space. Figure 5.26 presents a plot for each of the four participant 
groupings where the variables have been plotted using the correlation coefficients associated 
with the first and second PCs (PC1 and PC2). Figure 5.27 presents the equivalent plots for the 
correlation coefficients associated with the first and third PCs (PC1 and PC3). To aid the 
interpretation of the variable correlation plots, a unit circle (known as a circle of correlations) 
was also plotted in the PC coordinate space. As stated previously, the sum of the squared 
correlation coefficients (coordinates) for a single variable across all PCs is equal to one. 
Furthermore, recall that the equation defining a unit circle is the sum of the squared coordinates. 
Consequently, for a two-dimensional representation of the variables in the PC coordinate space, 
each variable must fall either on or inside the circle of correlations. If the two PCs of the 
correlation plot can almost completely represent a variable (i.e. if the sum of the variable’s 
squared correlation coefficient percentages for the two PCs is close to 100%) it will be located 
very close to the circle of correlations. 
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Figure 5.26: Circle of correlations and correlation of variables with the first and second principal components for the a) 
control, b) noise revision, c) loosening revision, and d) excessive noise revision groups. 
 
Figure 5.27: Circle of correlations and correlation of variables with the first and third principal components for the a) 
control, b) noise revision, c) loosening revision, and d) excessive noise revision groups. 
It was evident from the squared correlation coefficient results in Table 5.13 that PC1 and PC2 
were primarily a linear combination of the duration, rise time, peak amplitude, and RMS 
amplitude variables. Figure 5.26 confirms the aforementioned observation since the duration, 
rise time, peak amplitude, and RMS amplitude variables were located close to the circle of 
correlations. However, the plots of Figure 5.26 offer additional information that was not 
evident in Table 5.13. The variable correlation plots provide a distinction between positive and 
negative correlations which the squared correlation coefficients do not. Consequently, a better 
interpretation of the PCs can be made by considering the plots of Figure 5.26 and Figure 5.27.  
It was observed from Figure 5.26 that the duration, rise time, peak amplitude, and RMS 
amplitude all exhibited very similar negative values with respect to PC1. In this case, the 
previous interpretation of PC1 remains such that the largest variation in the datasets is a result 
of similar contributions from the duration, rise time, peak amplitude, and RMS amplitude 
variables. However, it was also observed from Figure 5.26 that PC2 contrasted the duration 
and rise time variables with the peak and RMS amplitude variables. The duration and rise time 
variables took on large positive values while the peak and RMS variables took on large negative 
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values for PC2. The contrasting of the duration and rise time variables with the peak and RMS 
amplitude variables explains the presence of the two tails of data observed in the PCA factor 
scores plots of Figure 5.25. It was observed from Figure 5.27 that the PC3 was almost 
exclusively defined by the main frequency content variable. 
However, a further observation from both Figure 5.26 and Figure 5.27 was that the loosening 
group had noticeably large differences in the location of the rise time and the main frequency 
content variables compared to the other groups. The rise time variable for the loosening group 
was observed to have a greater contribution to PC2 and PC3. Consequently, the rise time 
variable contributed less to PC1. The main frequency content variable for the loosening group 
was observed to have a contribution to PC2 that was very similar to the contributions of the 
peak and RMS amplitudes. Therefore, for the loosening group PC2 was actually a linear 
combination of all five variables and contrasted the peak amplitude, RMS amplitude, and main 
frequency content with the duration and rise time variables. Furthermore, PC3 for the loosening 
group was a linear combination of the main frequency content and the rise time variables. 
The variable correlation plots also indicate the correlation between variables. The closer two 
variables are located to each other on the correlation plot the more correlated the two variables 
are to each other. It was observed from Figure 5.26 that the peak and RMS amplitude variables 
were highly correlated to each other with respect to PC1 and PC2. Furthermore, Figure 5.26 
shows a high correlation between the duration and rise time variables, with respect to PC1 and 
PC2, for the control, noise revision, and the excessive wear revision groups. These observations 
of high correlation between the variables is consistent with the results from the two-
dimensional analysis presented in Section 5.5.1. However, it was observed from Figure 5.26 
that the duration and rise time variables were less correlated to each other for the loosening 
group relative to the other groups.  
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In conclusion, the PCA for the control, noise revision, loosening revision, and excessive wear 
revision groups showed that the main variation in the datasets was from a combination of the 
duration, rise time, peak amplitude, and RMS amplitude. Generally, the contribution from the 
four variables to the main variation (i.e. the first PC) was similar and accounted for an average 
of 46.3% of the total variation of the datasets. The second PC accounted for an average of 30% 
of the total variation of the datasets and primarily contrasted the duration and rise time variables 
with the peak and RMS amplitude variables. The third PC was generally represented by the 
main frequency content and accounted for an average of 19.4% of the total variation of the 
datasets. In addition, the results of the PCA demonstrated that the loosening group had some 
noticeably different characteristics to the other groups.  
The PCA has indicated that, while many AEs may be common across the different groups, a 
definite difference in the distributions of different groups of AEs has occurred, particularly in 
the loosening group of THR participants. Therefore, the PCA suggests it is likely that particular 
AEs may be more (or less) prevalent in THR patients with particular implant complications 
such as loosening. The PCA results add further support for the potential diagnostic capability 
of the AE monitoring technique. Therefore, further research is needed to identify and examine 
AEs which may be characteristic to particular implant failure modes. 
5.6 Summary 
This chapter presented a quantitative analysis of AE events that were detected from the AE 
signals. The event detection algorithm was shown to provide a good balance between 
identifying AE events had occurred and adequate distinctions between events that occurred 
close in time to each other. The subsequent analysis of the metrics computed from the detected 
events provided an effective way to compare the large amount of detected events across 
different revision reason participant groups. One of the main conclusions from the AE analysis 
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of this chapter was that a randomly selected AE event from any study participant would likely 
have signal metrics that were common to any participant grouping. It was evident in the results 
of this chapter that the general distributions of the AE event metrics of the control participants 
were similar to those of the different revision reason groups. Consequently, it was concluded 
that there was a high likelihood that many of the in-vivo THR participant AE recordings 
contained AE events that might have originated from sources such as other joints in the body, 
muscle movements, movement or sliding of tendons, fascia, ligaments, and other inherent 
movement of biological material. The analyses presented within this chapter, in isolation, do 
not appear sufficient to enable the use of AE sensing as a diagnostic method. 
However, the results of this chapter did indicate that some definite differences in the AE event 
metric distributions of different groups were also present. It was very likely that the in-vivo 
THR AE recordings also contained AE events that occurred only as a result of the presence of 
the implant. Therefore, it is likely that more insight into failing implants would be gained from 
identifying the specific types of AE events that caused the differences in the event metric 
distributions of the THR participant groups. The use of AE as the only sensing method means 
that only broad conclusions can be made to broadly link AEs to the type of motion the study 
participant was undertaking at the time, such as walking. The addition of new sensing methods, 
such as gait tracking of limb angles and implant loads, would provide significant additional 
insight into the implant mechanics at the time when specific AE signal characteristics are 
observed. Such additional sensing would enable temporal analyses of recorded AEs, linking 
signal characteristics to known parameters such as hip articulation angles and approximations 
of dynamic implant loads. This additional information has the potential to provide significant 
additional insight and developing a modified sensing system with this potential being the focus 
of the next chapter.  
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Chapter 6 Combined Acoustic & Gait Analysis 
6.1 Introduction 
In this chapter the AE monitoring technique has been combined with gait analysis of the 
walking motion to provide significantly more insight into the underlying biomechanics of a 
study participant undergoing AE monitoring. The specific motivation and the basic premise of 
gait analysis is introduced, followed by an explanation of the basic methodology of the 
combined test protocol and associated data processing that has been developed. The results 
from the initial testing of the combined technique performed on three THR participants is 
presented and discussed.  
6.2 Motivation 
A limitation of the AE monitoring data presented in Chapter 5 was that no information was 
available to indicate what stage of the implant motion an AE event occurred. For example, if a 
squeak occurred during a walking test, there was no data recorded to indicate exactly what 
stage of the gait cycle the squeak occurred. Additionally, some comparisons of AE event 
metrics across different participant groups had to be normalised by the total duration of the AE 
recordings for the group. This normalisation was required to minimise the effect of potential 
biases introduced by differences in the AE recording times of participants. As stated in 
Section 3.4.2, the participants performed all test motions in their own time and at self-selected 
speeds.  
The implication of this limitation was that it was impossible to properly investigate the 
likelihood that some AEs were occurring as a consequence of specific participant (and implant) 
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motions. A solution to these limitations was to introduce a combined approach of AE 
monitoring and concurrent gait analysis. Gait analysis is generally considered the quantitative 
description of all mechanical aspects of walking (Cappozzo, 1984). Through the use of gait 
analysis, AE events could be associated with specific motions of the hip joint by simultaneously 
collecting limb motion data of the participant during the AE monitoring. Furthermore, the AE 
data could ultimately be compared with information such as hip angles and joint loadings 
through the use of computer modelling. Therefore, gait analysis may provide additional insight 
into the underlying implant mechanics and help identify cohort-specific AEs. Additionally, the 
gait analysis will be able to be used select a subset of the AE events that occur during specific 
stages of the gait cycle. The ability to be able to analyse AE signals in relation to stages of the 
gait cycle may improve the diagnostic capability of the AE technique. 
6.3 Gait Analysis 
The typical data that is collected during a gait analysis includes relative orientations and 
positions of body segments, ground reaction forces, and leg muscle activity (Abernethy et al., 
2005; Kadaba et al., 1990). The orientations and positions of the body segments are usually 
determined using video cameras that track reflective markers attached to the body segments. 
Ground reaction forces can be measured by walking over a force plate that captures force data 
in the vertical direction and two orthogonal horizontal directions. Leg muscle activity is usually 
measured using non-invasive electromyography (EMG) electrodes on the surface of the skin. 
The initial primary objective of the combined AE monitoring and gait analysis of the THR 
participants is to associate AEs with the stages of the walking motion and ultimately hip angle 
data. Therefore, EMG data was not necessary in the gait analysis performed on the THR 
participants. 
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As mentioned previously, video cameras are normally used to collect the relative orientations 
and positions of the body segments during gait analysis which is often referred to as three-
dimensional (3D) motion capture (MoCap). 3D MoCap uses multiple video cameras to track 
the location of reflective markers within a specific volume of space. MoCap can be used to 
reconstruct the 3D motion of a person if the reflective markers are placed in known locations 
on the person. The reconstructed motion can be applied to a computer musculoskeletal model 
to estimate the motion of the limbs and joints using inverse kinematics. Additionally, the 
computer model can be used to estimate joint loads and muscle forces if a force plate is used 
in conjunction with the MoCap system to capture ground reaction forces.  
Concurrent ongoing research is also being conducted by collaborators to enable the computer 
modelling to be performed from motion data recorded by multiple inertial measurement units 
(IMUs) in place of the MoCap system. The ability to perform a gait analysis from IMU data 
alone will result in a more streamlined data collection process. MoCap systems are relatively 
expensive and require using specialised equipment in a dedicated space with a limited field of 
view. Conversely, IMUs can be used as non-invasive wearable sensors that allow for extensive 
data collection in almost any situation. Nevertheless, the current study presented in this thesis 
utilises a MoCap system with an incorporated force plate, in conjunction with computer 
musculoskeletal modelling, to conduct gait analyses on THR participants. The results of the 
gait analyses presented will be limited to normal walking motions that were performed by the 
THR participants. The initial focus on walking is an important stepping stone before other more 
complex motions are considered. 
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6.4 The Gait Cycle 
The gait cycle of normal human walking is generally defined as the time between subsequent 
heel strikes of one leg. There are a number of key events and phases that characterise the gait 
cycle. Figure 6.1 presents a schematic of the gait cycle and identifies the key events and phases 
of the gait cycle. As mentioned, the gait cycle begins with the heel strike of one leg. At 
approximately 12% of a normal gait cycle the opposite toe is lifted off the ground. The halfway 
point of a gait cycle (50%) is indicated by the heel strike of the opposite leg. At approximately 
62% of the gait cycle the toe is lifted off the ground. And finally, the gait cycle ends (100%) 
when the subsequent heel strike of the same foot occurs. 
 
Figure 6.1: The human gait cycle showing key stages of gait. This is a derivative of “The gait cycle” by Iosa et al. (2013) 
used under CC BY 3.0 licensed by A. J. FitzPatrick under CC BY 3.0. 
The gait cycle is also characterised by two main phases: stance phase, and swing phase. The 
time during which a leg is in contact with the ground is defined as the stance phase of that leg. 
Therefore, the stance phase commences at 0% of the gait cycle and lasts until toe-off at 62% 
of the gait cycle. Consequently, the swing phase commences at toe-off and lasts until the heel 
of that leg strikes the ground again at 100% of the gait cycle. Furthermore, the stance phase 
  188 
contains three separate stages: the first double support, single support, and second double 
support stage. The first and second double supports indicate the times when both feet are in 
contact with the ground (i.e. 0%-12% and 50%-62% of the gait cycle respectively). The single 
support stage occurs when only one foot is in contact with the ground (i.e. 12%-50% of the gait 
cycle). 
6.5 Methodology 
6.5.1 Participants and Equipment 
Participants were recruited for the combined AE and gait analysis by the same recruitment 
process explained in Chapter 3 that was used for the general AE monitoring. A variation to the 
existing ethical approval (approval number URA/10/11/075, New Zealand Upper South A 
regional ethics committee) was granted to allow for combined AE and gait monitoring to be 
carried out. Therefore, prior to commencement of the combined AE monitoring and gait 
analysis of a participant, an informed consent process was carried out to ensure each participant 
understood the purpose of the study and what the AE monitoring and gait tracking procedure 
involved. 
The combined AE and gait analysis testing was performed in the biomechanics laboratory at 
the University of Canterbury where a MoCap system was available. The MoCap system used 
was a BTS Bioengineering SMART-D Motion Analysis System with six infrared tracking 
cameras sampling at a rate of 100Hz. A single Kistler 9286BA force plate was used in 
conjunction with the MoCap system to simultaneously record the ground reaction force of the 
participant during testing. The sample rate of data from the force plate was also 100 Hz. The 
AE data collection for the combined testing utilised the same AE equipment and AE testing 
protocols outlined in Sections 3.2 and 3.4.  
  189 
In addition to the AE monitoring equipment, three SparkFun 9DoF Razor IMU M0 inertial 
measurement units (IMUs) were attached to the participant to record motions of the pelvis, 
femur, and tibia respectively. Each IMU recorded 3D acceleration, angular velocity, and 
magnetic field strength data at 100 Hz. As mentioned previously, ongoing research is focussed 
on using the information from the IMUs to perform the gait analysis without the need for the 
MoCap system. Therefore, in the current study IMU data has been collected but has not directly 
been used in the estimation of hip joint angles. However, some IMU data was used to 
synchronise the AE data with the MoCap data, using a fourth IMU sensor synchronised to force 
plate data through impulse/drop tests at the beginning of the tests. 
The specific computer musculoskeletal modelling software that was used for the gait analysis 
was OpenSim. OpenSim is an open source software program that enables modelling and 
analysis of the neuromusculoskeletal system (Delp et al., 2007). OpenSim can utilise 
experimental MoCap and force plate data to analyse the dynamic motions of study participants. 
The software allows for a generic human skeletal model to be scaled appropriately to match 
the anthropometric measurements of the test participant. Furthermore, OpenSim employs 
inverse kinematics to resolve the joint angles associated with the observed motions.  
6.5.2 Motion Capture Data Collection 
The MoCap data collection procedure involved four key steps: the recording of anthropometric 
measurements of the participant, the placement of the reflective markers on the participant, the 
recording of a static trial, and the recording of dynamic trials. This section briefly outlines the 
four key steps. More detailed and specific instructions for the MoCap data collection can be 
found in Appendix C and Appendix D. The anthropometrics that needed to be measured and 
recorded are outlined in Table 6.1. The purpose of the basic anthropometric measurements was 
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to assist subsequent scaling of the bones of the OpenSim musculoskeletal model which 
increased the accuracy of three-dimensional motion reconstruction. 
Table 6.1: Required anthropometric measurements. 
Name Description 
Body Mass Participant mass 
Height Participant height 
Inter-ASIS 
Distance 
Distance between the left anterior superior iliac spine (ASIS) and right 
ASIS. Note, this only needs to be measured if markers cannot be placed 
directly on the ASIS (e.g. in obese patients). 
Leg Length 
(Left & Right) 
Full leg length, measured between the ASIS marker and the medial 
malleolus, via the knee joint. Measure with patient standing, if possible. 
Knee Width 
(Left & Right) 
The medio-lateral width of the knee across the line of the knee axis. 
Measure with patient standing, if possible. 
Ankle Width 
(Left & Right) 
The medio-lateral distance across the malleoli. Measure with patient 
standing, if possible. 
Reflective markers were placed on the participant in predetermined anatomical positions to 
allow the MoCap system to track body positions. The marker set used was a modified version 
of that which is included with the OpenSim Gait 2392 model. The Gait 2392 marker set has 
been developed and refined primarily from previous biomechanical studies which used three-
dimensional motion capture (Cappozzo et al., 1995; Davis et al., 1991; Hamner et al., 2010; 
Kadaba et al., 1990). Collectively, the model utilised 39 markers across the lower limbs, pelvis, 
torso, and head. For the testing performed in the current study, only 29 of the model markers 
were used, with two of these 29 markers being optional. Table 6.2 outlines the markers that 
were placed on anatomical landmarks. It was important to place the markers as accurately as 
possible on the appropriate anatomical landmarks as disparities in positioning adversely 
effected the results of the OpenSim modelling process. For the initial testing, a trained 
physiotherapist assisted with the marker placement to ensure accurate placement. 
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Table 6.2: Anatomical landmark marker positions. 
Definition Marker Position (* indicates required for static test only) 
Left ASIS Left anterior superior iliac spine. 
Right ASIS Right anterior superior iliac spine. 
Sacral 
On the skin mid-way between the posterior superior iliac spines 
(PSIS) and positioned to lie in the plane formed by the ASIS and 
PSIS points. 
Left Knee Lateral 
* On the lateral epicondyle of the left femur and positioned to lie 
along the estimated axis of rotation of the knee joint. 
Left Knee Medial 
* On the medial epicondyle of the left femur and positioned to lie 
along the estimated axis of rotation of the knee joint. 
Left Ankle Lateral 
* On the lateral malleolus of the left shank along the line that would 
pass through the transmalleolar axis. 
Left Ankle Medial 
* On the medial malleolus of the left shank along the line that 
would pass through the transmalleolar axis. 
Left Toe Tip 
If wearing shoes, on top of the shoe at the distal end and halfway 
between the first and second phalanges. If not wearing shoes, over 
the distal end of the second metatarsal. 
Left Heel 
On the posterior-most point of the calcaneus (or the shoe) and at 
the same height above the plantar surface of the foot as the Left Toe 
Tip marker. 
Right Knee Lateral * Same as Left Knee Lateral but on the right femur. 
Right Knee Medial * Same as Left Knee Medial but on the right femur. 
Right Ankle Lateral * Same as Left Ankle Lateral but on the right shank. 
Right Ankle Medial * Same as Left Ankle Medial but on the right shank. 
Right Toe Tip Same as Left Toe Tip but on the right foot. 
Right Heel Same as Left Heel but on the right foot. 
Left Acromium On the left acromio-clavicular joint. 
Right Acromium On the right acromio-clavicular joint. 
Table 6.3 outlines the markers that were placed as part of a three marker cluster on either the 
thigh or shank of the participant. The purpose of the marker clusters was to allow the upper 
and lower legs to be tracked in three-dimensions without the need for other markers on the 
same segments. The exact positioning of the marker clusters was not critical provided that data 
from a static test was collected first that contained the knee and ankle markers for reference. 
The model scaling process of OpenSim used the relative positions of the anatomical markers 
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to accurately position the marker clusters on the model. Therefore, after model scaling, the 
marker clusters were able to be used to accurately track the position of the corresponding limb. 
Figure 6.2 shows a study participant ready for testing in the biomechanics laboratory with the 
markers, AE sensors, and IMUs attached. 
Table 6.3: Limb cluster marker positions. 
 Definition Marker Position 
Left Thigh Upper 
The cluster should be placed so that this marker lies on the lateral 
thigh and approximately in the coronal plane of the femur. Note that 
the cluster can be positioned at any distance distally along the femur 
that is practicable. 
Left Thigh Front 
The cluster should be placed so that this marker lies anterior and 
distal to the Left Thigh Upper marker. 
Left Thigh Rear 
The cluster should be placed so that this marker lies posterior and 
distal to the Left Thigh Upper marker. 
Left Shank Upper 
The cluster should be placed so that this marker lies on the lateral 
shank and approximately in the coronal plane of the tibia. Note that 
the cluster can be positioned at any distance distally along the shank 
that is practicable. 
Left Shank Front 
The cluster should be placed so that this marker lies anterior and 
distal to the Left Shank Upper marker. 
Left Shank Rear 
The cluster should be placed so that this marker lies posterior and 
distal to the Left Shank Upper marker. 
Right Thigh Upper Same as the Left Thigh Upper but on the right thigh. 
Right Thigh Front Same as the Left Thigh Front but on the right thigh. 
Right Thigh Rear Same as the Left Thigh Rear but on the right thigh. 
Right Shank Upper Same as the Left Shank Upper but on the right shank. 
Right Shank Front Same as the Left Shank Front but on the right shank. 
Right Shank Rear Same as the Left Shank rear but on the right shank. 
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Figure 6.2: Images of participant with reflective markers, AE sensors, and IMUs attached ready for testing. 
A static test was carried out once all markers had been placed on the participant. The static test 
involved recording marker position data of the participant standing stationary in an upright 
position on the force plate, near the centre of the calibrated volume. The knee and ankle markers 
were then removed from the participant once a static test had been performed (See the entries 
of Table 6.2 marked by a * for markers that were removed following the static trial). Removing 
the knee and ankle markers simplified the post-processing of the dynamic MoCap data. At least 
five walking tests of dynamic data were then carried out with each participant.  
The walking tests involved recording marker position data at 100 frames per second 
concurrently with the AE and IMU data as the participant walked across the room. The 
participant was asked to walk in a straight line and at a self-selected speed. The limited size of 
the testing laboratory meant that only three consecutive walking gait cycles could be recorded 
by the motion capture during each test. Furthermore, the participants walked in such a way that 
the foot of the leg being acoustically monitored contacted the force plate during the second of 
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the three gait cycles. Therefore, ground reaction force data was captured at 100 Hz for the 
stance phase of the second recorded gait cycle. 
6.5.3 Motion Capture Data Processing and Joint Angle Estimation 
For each recorded data frame, the MoCap data from each walking test contained 3D coordinates 
of each of the 29 markers. The origin of the coordinate system was located at one corner of the 
top surface of the force plate and the coordinate values had units of metres. During testing, 
each marker must be in view of at least two cameras in order for its coordinates to be recorded. 
While it was generally uncommon, sometimes data frames had missing coordinates for 
particular markers if the marker was obscured at some point during testing. Markers can be 
sometimes momentarily obscured by things such as loose clothing or the cables from the AE 
sensors. In any cases of missing marker data, 3D spline interpolation using the marker 
coordinates from multiple surrounding frames was employed with the BTS MoCap software 
to estimate values of any missing coordinates. Once any missing markers data had been 
interpolated, the OpenSim data processing could be performed. 
The musculoskeletal model used was the OpenSim Gait 2392 model. The Gait 2392 model is 
a 23 degree of freedom 3D musculoskeletal model of the human torso and lower limbs which 
also includes a representation of 76 muscles. Figure 6.3a shows an anterior view of the 
OpenSim Gait 2392 model with the standard marker set of the model. The first step of the 
OpenSim processing was to scale the musculoskeletal model to match the specific participant. 
The scaling process involved using the static trial experimental data to resize each bone and 
then to shift the model into the pose the participant had during the static trial. To perform the 
scaling, OpenSim first used the distances between the experimental anatomical markers to 
rescale the size of each bone individually. After rescaling the bones, the model was fit to the 
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experimental data in such a way to minimise the distance between each experimental marker 
and its corresponding marker on the model. Figure 6.3b shows a scaled model fitted to the 
experimental markers of a static trial. The markers of the model are shown coloured pink in 
Figure 6.3b and the experimental markers are coloured blue. The cluster markers were not used 
at all during the scaling process (but still appear as experimental markers in Figure 6.3b) since 
their absolute positions relative to the musculoskeletal system were unknown at that point of 
the analysis. 
 
Figure 6.3: OpenSim Gait2392 model showing a) the original model with marker set, b) scaled model with marker set (pink 
markers) and static trial experimental markers (blue markers), and c) scaled model during walking test. 
The OpenSim documentation specified that a satisfactory scaling result was reached when the 
root-mean-squared (RMS) error in the distances was less than one centimetre and the maximum 
error was less than two centimetres. Sometimes the positions of particular markers on the model 
may not represent the position of the experimental marker on the test participant very well. 
a) b) c) 
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Consequently, the resultant error from the scaling process would exceed the specified limits. 
To reduce the error in the scaling process, the position of the markers on the model can be 
adjusted, if necessary, to more accurately represent the position of the corresponding marker 
that was attached to the test participant. The scaling was performed again once any model 
markers had been adjusted and the new error values were checked. This scaling process was 
iterated until the error values no longer exceed the specified limits.  
Once the errors from scaling were below the specified limits, and with the model in the static 
position, the model markers were then shifted to the locations indicated by the corresponding 
experimental markers. This step occurs under the assumption that, after scaling, the scaled and 
shifted model exactly represents the position of the participant during the static trial. Therefore, 
the positions of all the experimental markers from the static trial should be the locations of their 
corresponding model markers. Consequently, any model markers that were not in exactly the 
same position as their corresponding experimental marker are shifted, relative to the model, to 
the exact location of the experimental marker. Additionally, the locations of the cluster markers 
relative to the model are known at this point since the corresponding model markers are shifted 
to the locations of the experimental markers. Note that since it was unlikely that the model was 
scaled and shifted to exactly match the static trial exactly (i.e. maximum error value was 
unlikely to be zero centimetres) the locations of the shifted model markers are in fact 
approximations to within the associated error values. 
Finally, to perform the inverse kinematics on the walking tests, OpenSim takes the 
experimental data from the walking tests and fits the markers of the scaled model to each data 
frame of coordinates. The OpenSim documentation specified a good inverse kinematics result 
will have maximum errors less than 2-4 centimetres and an RMS error below two centimetres. 
Figure 6.3b shows the position of the scaled model for a single frame of a walking test after 
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the inverse kinematics was applied. Once the inverse kinematics had been performed, the 
estimated joint angles were output from the resultant model positions. The inverse kinematics 
result yields the estimated joint angles for each joint of the model. For the hip joint, three sets 
of angles result from applying the inverse kinematics: flexion, adduction, and rotation. 
Consequently, since each data frame had an associated timestamp that was also synchronised 
with the AE and force plate data, the joint angles were able to be plotted against the 
corresponding AE signal and ground reaction force. 
6.6 Results & Discussion 
6.6.1 Participant Data 
Combined AE and gait data has been collected for three THR participants. Table 6.4 presents 
the body weight, height, sex, leg acoustically monitored during testing, and implant bearing 
type for the three participants. All three participants were recruited for this testing because they 
had indicated that their THR implant often made audible noises. All three participants had an 
implant with a ceramic-on-ceramic (CoC) main bearing interface. 
Table 6.4: Participant sex, body weight, height, leg monitored, and implant type. 







Implant Bearing Type 
Participant118 F 736 173 Left Ceramic-on-ceramic 
Participant119 M 873 178 Right Ceramic-on-ceramic 
Participant120 M 863 170 Left Ceramic-on-ceramic 
 
6.6.2 Observations from Participant120 – Implant Squeaking 
Of the three THR participants that underwent combined AE monitoring and gait analysis, one 
participant, Participant120, produced regular audible squeaking during testing. Participant120 
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performed ten separate normal walking tests that each contained three consecutive gait cycles. 
Figures 6.4 and 6.5 show the synchronised AE, ground reaction force, and hip angle data for 
two separate walking tests of Participant120. The horizontal axes of Figures 6.4 and 6.5 show 
the percentage of gait cycle corresponding to the leg that was acoustically monitored. Since 
each walking test contained three consecutive gait cycles, the gait cycle percentages of 0%, 
100%, and 200% correspond to the start (heel strike) of the first, second, and third walking gait 
cycles respectively. The second gait cycle (100%-200%) corresponded to the participant 
stepping on the force plate with the acoustically monitored leg (left leg for Participant 120). A 
further point to note was that the average velocity of the centre of mass of the participant 
(estimated through the OpenSim inverse kinematics) was 1.15 ms-1 and 1.24 ms-1 for the tests 
of Figures 6.4 and 6.5 respectively. 
 
Figure 6.4: a) AE signal from three consecutive gait cycles of a walking test of THR Participant120 with b) synchronised 
hip angle and ground reaction force data. Note that ground reaction force data was only available for the second 
consecutive gait cycle. 
Squeaks 
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Figure 6.5: a) AE signal from three consecutive gait cycles of a second walking test of THR Participant120 with b) 
synchronised hip angle and ground reaction force data. Note that ground reaction force data was only available 
for the second consecutive gait cycle. 
It was observed from Figures 6.4a and 6.5a that six squeaks in total occurred between 
approximately 30%-50%, 130%-140%, and 225%-255% points in the gait cycle across the two 
tests. The squeaks were indicated by regions of AE signal with sustained increases in signal 
magnitude (see annotations in Figures 6.4a and 6.5a) as was demonstrated in Section 4.3.2. All 
six observed squeaks from Figures 6.4 and 6.5 had a different time domain appearance. 
Nevertheless, it was apparent that all the squeaks occurred during a similar stage of the gait 
cycle. Figure 6.1 showed that the single support stage of the gait cycle is in the range of 12%-
50%. Therefore, the squeaks of Figures 6.4 and 6.5 all occurred during the second half of the 
single support stage of the gait cycle, also known as terminal stance.  
The observation that the squeaks occurred during terminal stance was also observed in all other 
squeaks that occurred during the walking tests of Participant120. Table 6.5 presents the 
approximate gait cycle percentage that each observed squeak commenced for all ten walking 
tests. The percentages of Table 6.5 were approximated to the nearest 5%. A missing entry in 
Table 6.5 indicates that a squeak did not occur during that particular gait cycle of a test. It can 
Squeaks 
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be seen from Table 6.5 that a squeak occurred during 21 of the 30 gait cycles that were recorded 
across the ten walking tests. Sixteen of the 21 squeaks occurred during either the first or second 
gait cycle of their corresponding test. These sixteen squeaks all commenced within the range 
of 30%-40% of their respective gait cycle with an average of 36%. The remaining five of the 
21 squeaks occurred during the third gait cycle of their corresponding test. The squeaks of the 
third gait cycles commenced within the range of 25%-50% of their respective gait cycle with 
an average of 41%.  
Table 6.5: Approximate percentage of gait cycle that squeak commenced for all walking tests of THR Participant120. The 
percentages were approximated to the nearest 5% and if no squeak occurred for a particular gait cycle then no 
percentage is shown. 
Test 
Number 
Approximate Percentage of Gait Cycle when Squeak Commenced (%) 
Squeak 1 Squeak 2 Squeak 3 
1 35 135 225 
2 30 135 - 
3 40 135 - 
4 35 140 245 
5 35 130 245 
6 40 135 240 
7 40 - 250 
8 30 135 - 
9 - 135 - 
10 - - - 
Average 36 136 241 
Range 10 10 25 
 
The variability that was observed in the occurrence of squeaks during the third gait cycles of 
the tests was attributed to the testing methodology. The limited size of the testing laboratory 
meant that only three full gait cycles could be captured by the MoCap equipment. The 
participants were required to stop walking almost immediately after they had completed the 
third walking gait cycle. Consequently, during most walking tests, the participants’ third gait 
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cycle did not resemble a typical walking gait since they had started to decelerate before 
completing the cycle. Furthermore, in some cases the participants did not complete the final 
swing phase but instead brought their feet together and stopped walking. As a result, the gait 
cycle percentages from at least 250% onwards may not be accurately aligned with the AE data. 
Nevertheless, overall, the squeaks that occurred during the walking tests, especially those of 
the first and second gait cycles, showed good repeatability with respect to the stage of the gait 
cycle during which they occurred. This result is an important finding since it implies that the 
occurrence of squeaking in THR implants is likely related to specific motions of the implant.  
The hip angle data of Figures 6.4b and 6.5b was observed to exhibit behaviour in agreement 
with that of a typical walking gait. The maximum extension of the hip joint during a typical 
walking gait generally occurs at 50% of the gait cycle (Whittle, 2014), coinciding with the heel 
strike of the opposite leg. The maximum flexion of the hip joint during a typical walking gait 
is reached towards the end of the swing phase at approximately 80-90% of the gait cycle 
(Whittle, 2014). Figures 6.4b and 6.5b show the hip flexion angle to range between 
approximately -25° (25° extension) at opposite heel strike and approximately 34° (flexion) at 
90% of the gait cycle. It was also observed from Figures 6.4b and 6.5b that the hip transitioned 
from flexion to extension (i.e. positive to negative flexion angles) at approximately 25% of the 
second gait cycle.  
Hip angles during the gait cycle are generally considered to be subject-specific and dependent 
on multiple factors. However, hip angles during normal walking reported in literature were 
between maximum flexion angles of approximately 30°-40° and maximum extension angles of 
approximately 5°-20° (Abernethy et al., 2005; Beaulieu et al., 2010; Bennett et al., 2008; Chung 
& Wang, 2010; Harris & Wertsch, 1994; Whittington et al., 2008). Therefore, the observed 
maximum hip flexion angles from Participant 120 of approximately 34° flexion were within 
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the range of maximum flexion angles reported in literature. However, the observed maximum 
extension angles from Participant 120 of approximately 25° extension were 5° greater than the 
maximum values reported in the literature. The large hip extension values that were observed 
from Participant 120 were possibly the result of the participant subconsciously modifying their 
gait to ensure they contacted the force plate during testing. Additionally, the hip angle estimates 
presented in Figures 6.4b and 6.5b were computed through the inverse kinematics analysis in 
OpenSim. Therefore, it is possible that further refinement of the musculoskeletal model may 
result maximum hip extension angles that fall within the ranges reported in the literature. 
Nevertheless, the overall hip angle profiles observed during the entire gait cycle from 
Participant 120 broadly agreed with overall hip angle profiles found in literature (Abernethy et 
al., 2005; Beaulieu et al., 2010; Bennett et al., 2008; Harris & Wertsch, 1994; Whittington et 
al., 2008). 
The ground reaction forces of Figures 6.4b and 6.5b were observed to exhibit the same general 
behaviour to each other. The ground reaction forces began to increase rapidly after second heel 
strike (0% of the second gait cycle) to a maximum force peak at approximately 15% of the 
second gait cycle. A momentary minor decrease in the ground reaction forces occurred at 
approximately 5% of the second gait cycle. After the ground reaction forces had reached their 
maximum, a decrease occurred to a local minimum at approximately 30% of the second gait 
cycle. Finally, the ground reaction forces increased to another peak at approximately 45% of 
the second gait cycle before returning to zero at toe-off (62% of the second gait cycle). Table 
6.6 presents a summary of the ground reaction force magnitudes for the walking tests of Figures 
6.4 and 6.5. The magnitudes of the ground reaction forces in Table 6.6 have been normalised 
and are shown as percentage body weight of the participant obtained during the static MoCap 
trial. The ground reaction forces from the eight other walking tests of Participant120 were 
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observed to be consistent with those of Figures 6.4b and 6.5b with respect to their overall 
magnitude trends. 






Approximate Ground Reaction Force (% Body Weight) 
Walking Test 1 
(Figure 6.4) 
Average Speed = 1.15 ms-1 
Walking Test 5 
 (Figure 6.5) 
Average Speed = 1.24 ms-1 
Heel strike 0% 0 0 
Max/Peak 1 15% 112 122 
Min after Peak 1 30% 83 71 
Peak 2 45% 105 107 
Toe-off 62% 0 0 
The behaviour of the ground reaction forces observed from the participant testing was 
consistent with the behaviour of ground reaction forces of normal walking gait found in 
literature (Watkins & Mathieson, 2009; Whittle, 2014). The first characteristic peak observed 
from the ground reaction force was a result of the upward acceleration of the body as the leg 
took the full load of the body during the beginning of the stance phase. During mid-stance the 
upward acceleration was reduced as the centre of mass of the body travelled over the leg and 
the heel began to lift from the ground. During terminal stance, the force increased again as the 
body was accelerated upward prior to the opposite heel strike. Finally, the ground reaction 
force reduced to zero as the opposite heel contacted the ground and the toe lifted off.  
The momentary decrease in ground reaction force that was observed at approximately 105% 
of the gait cycle was a result of the heel strike impact (Paul, 1976; Watkins & Mathieson, 
2009). Slower walking speeds or the use of shoes result in a less pronounced, or non-existent, 
momentary decrease in the ground reaction force (Watkins & Mathieson, 2009). Participant120 
performed all testing barefoot whereas participants 118 and 119 both performed the testing 
wearing shoes. It was observed from the ground reaction forces of participants 118 and 119 
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(shown in Sections 6.6.4 and 6.6.5) that their momentary decreases were generally non-existent 
or very small. 
6.6.3 Implant Squeaking and Hip Motion 
The observations of the AE and gait analysis of Participant120 showed that squeaking AEs 
only occurred during the terminal stance stage of the gait cycle. During terminal stance the 
ground reaction force was increasing from the local minimum to the second of the two peaks 
(see Figures 6.4b and 6.5b). Figure 6.6 shows the averaged variation of the hip joint forces 
during slow, normal, and fast walking gaits from a study conducted by Paul (1976). The slow, 
normal, and fast walking speeds corresponded to participant average linear speeds of 1.10, 
1.48, and 2.01 metres per second respectively. The average linear speed of Participant120 
during the ten walking tests was 1.19 metres per second. Figure 6.6 shows that, for the study 
conducted by Paul (1976), the local hip joint force (as opposed to ground reaction force) during 
terminal stance (30%-50% of the gait cycle)  was increasing in the range of approximately 3-4 
times body weight. Therefore, during the AEs recorded from the walking tests of 
Participant120, the implant components were almost certainly subject to high loadings when 
the squeaking occurred. Furthermore, the results from the testing also showed that the 
squeaking occurred while the hip joint was in extension. The hip angle was observed to be 
moving through the range from approximately 5° extension to approximately 15° extension as 
the squeaking occurred in all tests. Consequently, the squeaking that was observed coincided 
with a high rate of change of the implant angle. A high rate of change of implant angle indicated 
a high relative angular velocity between the femoral head and acetabular liner (i.e. the two 
surfaces of the implant main bearing surface).  
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Figure 6.6:  Averaged variation during the walking cycle of the resultant hip-joint force at slow, normal, and fast speeds. 
Reproduced with permission of Royal Society of London, from Paul (1976); permission conveyed through 
Copyright Clearance Center, Inc. 
In addition, it is interesting to note that the squeaking occurred during stages of the gait cycle 
when the wear rate of the implant surfaces was likely to be increasing to its largest. One of the 
most commonly used models to quantify the rate of abrasive wear between surfaces is 




     (6.1) 
Where 𝑊 the volume of material removed by wear is, 𝑘 is a dimensionless wear coefficient, 
𝑝𝑛 is the pressure normal to the contacting surfaces, 𝑠 is the sliding distance, and 𝐻 is the 
hardness of the surface being worn. Therefore, by Equation (6.1), during the gait cycle the main 
bearing surfaces of the THR undergo the largest amount of wear during the largest normal 
pressures and largest relative motions between bearing components. The normal pressure of 
the implant bearing surfaces is correlated with the force through the hip joint. By the plot of 
Figure 6.6, the joint force during the squeaking of the THR participant would have been 
increasing rapidly to its maximum force which occurred at approximately 50% of the gait cycle. 
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Furthermore, from observing the hip angles of the THR participant, the implant bearing 
surfaces were undergoing large relative rotational displacements during the occurrence of 
squeaking. Therefore, the squeaking that was observed from Participant120 was likely to be 
occurring when the THR implant was experiencing large loads, large relative motion, and its 
largest amount of wear. 
6.6.4 Observations from Participant118 – Increased AE Activity 
Unlike Participant120, Participant118 did not produce regular squeaking during the combined 
AE and gait testing. However, there were still some interesting observations from the AE 
signals of Particpant118. Participant118 produced data for five separate normal walking tests 
that each contained three consecutive gait cycles. Figures 6.7 and 6.8 show the synchronised 
AE, ground reaction force, and hip angle data for two separate walking tests of Participant118. 
It was observed from Figures 6.7 and 6.8 that increased AE activity was consistently present 
during the stance phase of the gait cycle. Furthermore, the AE signal behaviour that was seen 
in Figures 6.7 and 6.8 was also observed in the equivalent plots for the three additional walking 
tests which have not been shown here. 
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Figure 6.7: a) AE signal from three consecutive gait cycles of a walking test of THR Participant118 with b) synchronised 
hip angle and ground reaction force data. Note that ground reaction force data was only available for the second 
consecutive gait cycle. 
 
Figure 6.8: a) AE signal from three consecutive gait cycles of a second walking test of THR Participant118 with b) 
synchronised hip angle and ground reaction force data. Note that ground reaction force data was only available 
for the second consecutive gait cycle. 
The vertical axes of Figures 6.7a and 6.8a indicate that the voltage amplitude of the observed 
AE activity is considerably lower than what was observed from the squeaks of Figures 6.4a 
and 6.5a. However, the AE activity that was observed from the walking tests of Participant118 
still had voltage amplitudes well above the voltage amplitude of the background noise. 
Similar AE activity 
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Therefore, the AE activity was almost certainly a result of the motion of the participant. It is 
possible that some of the low amplitude AE activity could have been the result of external 
factors such as clothing rubbing over the AE sensor pad or movement of the sensors on the 
skin surface. However, given that these external factors would almost certainly still be present 
during the swing phase of the gait cycle, it would be expected that the increased AE activity 
would also be present during the swing phase. While some AE activity was observed during 
the swing phases of Figures 6.7a and 6.8a, there were still considerable periods of the swing 
phases that had no noticeable AE activity. 
Another observation from the plots of Figures 6.7 and 6.8 was that there was some AE activity 
that appeared to be very similar even between the two separate tests on this study participant. 
For example, see the AE activity indicated by the ellipses in Figures 6.7a and 6.8a. The apparent 
similarities in the appearance of the AE activity that occurs at the same stage of the gait cycles 
supports the suggestion that some AEs are likely characteristic of particular implant motions. 
However, it should be kept in mind that it is also possible the AEs identified by the ellipses in 
Figures 6.7a and 6.8a are not necessarily caused by the implant components and could be the 
result of other AE sources (such as other joints in the body, muscle movements, movement or 
sliding of tendons, fascia, ligaments, and other inherent movement of biological material). 
Nevertheless, the consistency that has been observed between the AE activity and the walking 
gait as a result of the combined AE and gait analyses was not previously possible to identify 
with any certainty. 
6.6.5 Observations from Participant119 – Short Duration Impulses 
The observations from Participant119 provided further evidence that some AEs from THR 
patients were likely related to specific motions. Participant119 produced data for five separate 
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normal walking tests that each contained three consecutive gait cycles. Figure 6.9 and Figure 
6.10 show the synchronised AE, ground reaction force, and hip angle data for two separate 
walking tests of Participant119. It was observed from Figure 6.9 and Figure 6.10 that a lack of 
AE activity occurred relative to the walking tests of Participant120 and Participant118. 
However, a number of short duration AE events did occur in Figure 6.9a and Figure 6.10a that 
had amplitudes comparable to some of the AE events observed from the other participants. 
Furthermore, some of the AE events that were present in Figure 6.9a and Figure 6.10a showed 
similarities in appearance and occurred at the same stage of their respective gait cycle. For 
example, four AE events that appeared to be very similar, in Figure 6.9a and Figure 6.10a, 
occurred at percentages of the gait cycle that corresponded to heel strike (see annotations in 
Figure 6.9a and Figure 6.10a). In addition to the AE events that corresponded to heel strike, it 
was observed that AE events also occurred approximately at the stage of the gait cycle that 
corresponded to the opposite heel strike. Therefore, the AE activity that was detected from 
Participant119 showed that some short duration AE events were likely to have been induced 
by specific motions or gait cycle events such as the impact from heel strikes. 
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Figure 6.9: a) AE signal from three consecutive gait cycles of a walking test of THR Participant119 with b) synchronised 
hip angle and ground reaction force data. Note that ground reaction force data was only available for the second 
consecutive gait cycle. 
 
Figure 6.10: a) AE signal from three consecutive gait cycles of a second walking test of THR Participant119 with b) 
synchronised hip angle and ground reaction force data. Note that ground reaction force data was only available 
for the second consecutive gait cycle. 
6.6.6 Squeak Event Metric Comparison 
As noted in Section 6.6.2, all six observed squeaks from Figures 6.4a and 6.5a had a different 
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observation that all the squeaks of the walking tests of Participant120 occurred during similar 
points within terminal stance. To further investigate the differences in the squeak signals the 
event detection algorithm was applied to the AE signals of Figures 6.4a and 6.5a. Table 6.7 
presents the AE event duration, RMS amplitude, peak amplitude, rise time, and main frequency 
content for each of the six squeaks of Figures 6.4a and 6.5a. The mean and standard deviation 
across the six squeaks, for each of the five metrics, is also shown in Table 6.7. It was observed 
from Table 6.7 that the standard deviation values for all the metrics were seemingly large for 
all five metrics. Therefore, it was indicated that a large variation was present in the event 
metrics across the six squeak signals, showing that each individual squeak had unique 
characteristics.  


















Squeak 1 202 0.37 1.10 126 1.75 
Squeak 2 147 0.20 1.01 117 1.70 
Squeak 3 83 0.08 0.32 50 1.58 
Walk 5 
(Figure 6.5) 
Squeak 1 147 0.33 2.54 28 2.37 
Squeak 2 145 0.08 0.40 12 2.44 
Squeak 3 101 0.09 0.33 46 1.46 
Mean 138 0.19 0.95 63 1.88 
Standard Deviation 42 0.13 0.85 47 0.42 
The metric values of Table 6.7 were compared to the principal component analysis (PCA) that 
was performed in Section 5.5.2 to further investigate the variation between the six squeaks. 
The PCA factor score plot of Figure 5.25b presented the AE events from all study participants 
that had been revised for a noisy implant against the corresponding first and second principal 
components (PCs). From Section 5.5.2 it was found that the first principal component (PC1) 
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represented a linear combination of the event duration, rise time, peak amplitude, and RMS 
amplitude with each metric having a similar contribution (see Figure 5.26b). Furthermore, it 
was also found that the second principal component (PC2) represented similar contributions of 
the same four metrics. However, PC2 was found to contrast the peak and RMS amplitude 
metrics with the duration and rise time metrics (see Figure 5.26b). The PCA of Section 5.5.2 
also found that the third principal component (PC3) represented the main frequency content 
metric almost completely. Figure 6.11 reproduces the plot of Figure 5.25b and includes the 
factor scores corresponding to the six squeaking events of Table 6.7 as supplementary 
observations for comparison (See comment in Section 5.5.2 on supplementary observations).  
 
Figure 6.11 Squeaking events from Table 6.7 have been plotted as supplementary PCA points on the PCA factor scores plot 
from Figure 5.25b which showed the noise revision reason group AE events plotted against the first and second 
principal components (PC1 and PC2 respectively). 
 
From Figure 6.11 it was observed that three of the squeaks (Squeaks 2 and 3 from Walk 5 and 
Squeak 3 from Walk 1) were grouped relatively close together. The close grouping of three of 
the squeaks indicated that overall they had similar values for PC1 and PC2. Consequently, the 
close grouping indicated that the three squeaks had relatively similar values for the duration, 
rise time, peak amplitude, and RMS amplitude metrics when considering the overall variation. 
The remaining three squeaks were observed to have considerably more negative PC1 values. 
Walk 5 Squeak 1 
Walk 1 Squeak 1 
Walk 1 Squeak 2 
Cluster of 
3 squeaks 
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However, two of the squeaks (Squeaks 1 and 2 from Walk 1) had PC2 values that were similar 
to the PC2 values of the other three squeaks. Overall, Figure 6.11 showed that three of the 
squeaks (Squeaks 1 and 2 from Walk 1 and Squeak 1 from Walk 5) had characteristics that 
were commonly seen in THR participants that were revised for noisy implants. The 
characteristics of the other three squeaks (Squeaks 2 and 3 from Walk 5 and Squeak 3 from 
Walk 1) had locations in Figure 6.11 that (from the conclusions of Section 5.5.2) did not 
necessarily indicate which revision group of THR participants the AE events could be 
categorised into. 
Since the squeaking events were observed to have occurred at similar stages of the gait cycle 
it was likely that the squeaks were induced by the same underlying mechanisms. However, the 
differences observed from the metrics of the six squeaking events suggest that not all squeaks 
that occur at the same stage of the gait cycle have similar signal properties. Nonetheless, upon 
further investigation, it was found that the frequency content of the squeaks exhibited similar 
trends when considering the temporal behaviour of the frequency content of the squeaks. 
Therefore, while the metrics of duration, rise time, peak amplitude, and RMS amplitude may 
have had a sizeable variance across the squeaks, the frequency responses of the AEs were 
generally comparable.  
The implication of the differing metrics from seemingly similar AEs is that the current event 
detection method and subsequent event metric calculations may be limited in their ability to 
make accurate comparisons of different AE events. However, analysing AE signals according 
to phases of the gait cycle has now been made possible and may help to provide clearer 
discrimination between AEs from different participant groups. By restricting analysis of AE 
signals to specific regions of the gait cycle, better comparisons of the AE parameters are able 
to be made. For example, the metrics of AE events that belong to the subset of events that 
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occurred between 30%-50% of the gait cycle could be compared. As a result, any similarities 
in the AE event parameters may become more apparent since potentially unrelated AE events 
would be ignored. However, a much larger set of combined AE and gait tracking data (beyond 
the three study participants tested to date) is required before this additional analysis can be 
undertaken. 
Furthermore, the event detection algorithm could potentially be disregarded altogether in 
favour of comparing the temporal signal properties of AE signals in particular regions of the 
gait cycle. The thresholding values used in the event detection process were arbitrary. 
Consequently, eliminating the need for an event detection process would remove an element 
of subjectivity from the overall AE analysis. Additionally, inter-participant comparisons of AE 
signals could be made more reliable using comparisons limited to gait cycle stages. Given that 
each participant performs motions at self-selected speeds, AEs from motions performed at 
different rates could now be reliably compared by matching the dynamic loading and 
orientation profiles of implant components. 
6.7 Summary 
A method for detecting THR AEs while simultaneously collecting gait data has been 
developed. The existing AE monitoring hardware and data collection protocols of Chapter 3 
were employed to collect the AE data. In conjunction with the AE data, protocols to collect 
gait data using a BTS Bioengineering motion analysis system have been developed. 
Furthermore, the gait data collection protocol incorporates the use of three IMUs to collect 
inertial data from the lower limb. The inertial data collection will contribute to ongoing and 
future research with the aim of allowing the gait analysis to be conducted solely from IMU 
data. The developed methodology for the combined analysis of AE and gait data has 
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successfully been used to collect simultaneous AE and gait data from three THR participants. 
Methodology has been developed to apply the gait data to a computer musculoskeletal model, 
through OpenSim software, to estimate hip joint motion. The computer modelling process 
ultimately yields joint angle estimates, for all joints of the torso and lower limbs, which are 
synchronised in time with the AE data. Furthermore, the OpenSim software has the capability 
of estimating the corresponding forces at the joints by factoring in contributions from the 
muscles and force plate data. 
The initial results from the combined AE and gait analysis of the three THR participants who 
underwent the testing were promising. Substantial AEs have been observed to occur only 
during the stance phase of the gait cycle in two out of three participants. Repeatable audible 
squeaking was observed from one of these participants during terminal stance (i.e. 30%-50% 
of the gait cycle). The squeaking was observed to occur from approximately 5°-15° extension 
when high joint loading and rapid changes in hip angle were taking place, which is also likely 
to be the conditions which lead to the largest wear rate of the main bearing surfaces of the THR 
implant. Participant 119 was observed to have less AE activity relative to the other participants. 
However, this participant had large amplitude, short duration AEs that consistently occurred 
and seemed to correspond with the heel strike events of the gait cycle. 
The research objectives of Section 1.5 posed the question: Can any correlations be seen 
between implant joint angles and audible AEs? The results from the initial dataset of three 
participants has shown that correlations between audible squeaking and hip joint angles do 
seem to exist. Furthermore, correlations seemed to also exist between overall increased AE 
activity and the load bearing phases of the walking gait cycle. A further question posed in 
Section 1.5 asked if any observed correlations were able to improve the ability of the AE 
technique to categorise AEs into revision reason groups. The answer to this second question is 
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less clear from the results of the three THR participants who underwent combined AE 
monitoring and gait analysis. From the results of the three participants who underwent the 
combined analysis, it was evident that the participant who produced audible squeaking would 
have been categorised into the noise revision group as a result of the presence of squeaks. 
Alternatively, this same categorisation could have been reached without considering the gait 
data. However, the combined technique has shown that being able to compare AE signals by 
restricting them to specific stages of the gait cycle will likely result in clearer identification of 
AEs with similar characteristics. Nevertheless, further data is required before meaningful 
conclusions can be drawn that relate AEs with stages of the gait cycle and associated implant 
loading. Since the groundwork has now been laid for further THR participants to be tested with 
the combined AE monitoring and gait analysis, it is anticipated that ongoing research will 
verify the observations presented in this chapter and continue to show promise of the diagnostic 
potential of the AE monitoring technique.  
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Chapter 7 Conclusions & Future Work 
7.1 Conclusions 
This thesis presented an analysis of the AE monitoring technique as a potential diagnostic tool 
for the assessment and early diagnosis of THR implant complications. The research hypothesis 
was that THR implant complications would have unique and identifiable AE characteristics 
that could be used to assist orthopaedic surgeons in making more informed and prompt implant 
complication diagnoses. Analysis of the AE data showed promise that the AE monitoring 
technique could be a potential diagnostic tool. Some distinctions were found in the distributions 
of AE event metric values between different sets of study participants grouped by implant 
revision reasons. However, the AE data analysis was not able to conclusively show that AEs 
from THR participants could be reliably categorised by their characteristics and be associated 
with distinct implant revision reasons. 
A procedure was also developed to collect AE data of THR participants concurrently with gait 
tracking data. Data was collected from three THR study participants using the combined AE 
and gait tracking methodology. Initial results from the combined testing found that some AEs 
occurred repeatedly at specific stages of the gait cycle. In particular, audible squeaking was 
observed to occur consistently during the terminal stance phase of the gait cycle. Consequently, 
the preliminary results of the combined AE monitoring and concurrent gait analysis 
strengthened the evidence supporting the AE monitoring technique as a potential diagnostic 
tool of implant complications. Nevertheless, more data is required to verify the outcomes from 
combined AE monitoring and gait analysis. 
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An initial analysis on the in-vivo and in-vitro AE signals that investigated time and frequency 
domain behaviour of the AEs showed that the majority of the AE activity in the in-vivo signals 
was from short duration (<20 ms) AE events. However, a number of long duration AE events 
were observed from THR participants that were generally associated with audible squeaking. 
The in-vivo non-squeaking AEs (from both the THR participants and the control participants) 
were generally found to have main frequency content in the 1-4 kHz range. The frequency 
responses of AE signals containing squeaking typically had main frequency content in the same 
the range of 1-4 kHz and could exhibit distinct narrow-band peaks or more broad-band noisy 
peaks. Additionally, many of the squeaking AEs were found to exhibit strong harmonic signals 
and transient frequency content.  
In-vitro testing on implant components investigated the AEs from the interaction of the main 
bearing interface in addition to the interaction of the femoral components at the trunnion Morse 
taper (TMT) interface. The in-vitro main bearing interaction AE signals primarily contain long 
duration squeaking AE events. Consequently, it is likely that a substantial amount of the short 
duration AE events detected in-vivo are a result of interactions between other components of 
the overall joint system (such as muscle, soft tissue, bone, ligaments, fascia, tendons, bone to 
implant interactions, and possibly even indirect contributions from the knee joint). 
Furthermore, the in-vitro main bearing interface AEs had frequency content in the same range 
as the in-vivo AEs. Conversely, the in-vitro AEs from the TMT interactions had frequency 
content upwards of 12 kHz, with the primary content typically in the 18-22 kHz range. 
Consequently, it was concluded that squeaking observed from THR participants in-vivo was 
much more likely to have been induced by interactions of the main bearing interface than 
having been caused directly by interactions at the TMT. 
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An event detection algorithm was developed to automate the detection of regions of interest 
from the large dataset of AE signals. The event detection algorithm performed well at 
identifying THR AE events and provided good distinction between events that occurred closely 
in time. Event metrics of duration, rise time, RMS amplitude, peak amplitude, and main 
frequency content was determined for each AE event. The AE events were then grouped using 
the control participants and the clinical revision reasons. Results from the statistical analysis 
indicated that the single metrics alone were not sufficient to categorise participant AE data. 
Therefore, two separate multidimensional metric analyses was carried out, in the form of two-
dimensional scatter plot comparisons and a principal component analysis (PCA), to investigate 
if combining multiple metrics would result in more distinct differences between revision reason 
groupings. 
The two-dimensional event metric analysis showed that it may be possible to categorise a THR 
AE event into the noise revision group but it was more likely that a random AE event would 
have event metrics that are common to all participant groupings. However, correlations 
between metrics were observed that were unable to be noticed from the statistical distribution 
analysis. The PCA showed that a definite difference in the distributions of different groups of 
AE events was apparent, particularly contrasting the loosening group of THR participants. The 
PCA result suggests it is likely that particular AE events may be more (or less) prevalent in 
THR patients with particular implant complications such as loosening. The PCA results offered 
the strongest support of the potential diagnostic capability of the AE monitoring technique. 
However, further research is needed to identify and examine the AE event which had the most 
influence on the differing PCA results as those events are likely to be characteristic to particular 
implant failure modes. 
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Overall, the initial results from the AE analysis show some promise in the diagnostic potential 
of the AE monitoring technique. However, the results fell well short of being able to lead to a 
reliable failure diagnosis in their current state. Consequently, a system was developed to collect 
concurrent AE, gait, IMU, and force plate data to allow the synchronisation of AE data with 
specific motions and loadings of the implant. Three THR study participants have been tested 
using the combined AE and gait analysis system. The initial data from the combined system 
has shown promising intra- and inter-participant consistency of the AE and gait analysis results. 
Substantial AE activity was observed to occur repeatedly during the stance phase of the gait 
cycle. Furthermore, audible squeaking was observed to occur consistently during the terminal 
stance phase of one participant. Consequently, the occurrence of the audible squeaking was 
shown to correspond well with large vertical ground reaction forces and high rates of change 
of hip joint angle.  
This study has indicated that the AE device shows promise as a potential diagnostic tool for 
assessing the condition of THR implants. While a large amount of AE data has been shown to 
be common across the control and various implant revision reason participant groups, results 
have shown that some noticeably different AE characteristics did exist between participant 
groups. Initial testing from combined AE and gait analysis has indicated relationships likely 
exist between AEs and particular implant motions and loadings. However, more research is 
needed to verify the findings of this study and provide more conclusive evidence regarding the 
diagnostic capability of the AE monitoring technique. 
7.2 Future Work 
A number of specific areas of future research related to this thesis have been identified and are 
presented in this section. The most obvious and important next step of this study is to collect 
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more data from THR patients using the combined AE monitoring and gait analysis. The 
developed sensing system with AE and gait tracking, along with a detailed data collection 
protocol has been developed and is now available to allow the combined AE and gait data to 
be collected easily. Therefore, recruitment of more study participants who have THR implants 
is required. Due to the limited availability of suitable THR patients within the Canterbury 
region, an average of one or two study participants are usually recruited per month. 
Consequently, the collection of data from large amount of study participants happens over a 
large period of time. However, since detailed data collection protocols for the combined AE 
monitoring and gait analysis have now been developed in the work of this thesis, it would be 
beneficial to direct more focus on the recruitment of suitable study participants and possibility 
of expanding the region that participants are recruited from. 
A major limitation of the in-vitro testing that was conducted was the use of manual implant 
manipulations for the trunnion Morse taper (TMT) rotations. The nature of the manual 
manipulation meant that the force, speed, and rotation that was applied to manipulate the 
implant components was not able to be controlled as accurately as with the flexion-extension 
manipulations that used robotic control. Therefore, it would be desirable to conduct further 
TMT rotation testing using robotic manipulation. The main challenge with performing these 
tests robotically is finding an effective method to grip the femoral head and femoral stem in 
order to apply the desired rotations. 
The analysis of the in-vitro data of this study found that there was consistency in the occurrence 
of some sequential AE events. For example, some in-vitro audible squeaking AE events were 
found to be followed by a short duration AE event with a consistent timing gap between the 
events. Since the study now has the ability to synchronise in-vivo AE signals with the motion 
of the hip joint, it would be interesting to investigate the occurrences of sequential AE events 
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from the in-vivo environment. This additional analysis will be enabled as more data is collected 
using the combined AE-gait analysis system, where AEs can be linked to temporal gait motion, 
limb angles and implant loads. 
Another important aspect of the AE analysis presented in this thesis was that the event detection 
method that was applied to the data incorporated arbitrarily chosen voltage thresholds for event 
detection. While these voltage and time threshold values were iteratively tested and manually 
optimised, there is no indication that these are necessarily optimal values. Therefore, it would 
be desirable to perform a more comprehensive study that investigates the effect of different 
threshold values used in the event detection thresholds on the subsequent event metric analysis. 
Additionally, the event metric analysis that was performed in this thesis was developed in such 
a way that it can somewhat easily be applied to AE events from any alternative AE event 
detection methods. Furthermore, since the combined AE monitoring and gait analysis allows 
AEs to be temporally matched to the gait cycle, a gait based event detection or signal analysis 
could be implemented as an alternative to methods that incorporate arbitrary voltage thresholds. 
For example, once a larger dataset with gait analysis is developed, the event metric 
comparisons could be re-created, where only events within the terminal stance phase of gait 
could be included (or any other subset of the gait cycle could be included or excluded). Such 
gait-stage selection of a subset of data has the potential to remove AEs unrelated to implant 
mechanics and could potentially lead to improved distinction between revision reason groups. 
In addition, a useful improvement of the current AE monitoring system would be to develop 
an on-patient or wireless data logging method. Currently, the AE sensors are required to be 
tethered to a laptop computer for the data acquisition. The tethering of the AE sensors limits 
the distance the study participants can move away from the data acquisition laptop. 
Consequently, motions like walking can only be performed in a limited space. Furthermore, 
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the cables from the AE sensors occasionally obstruct the line-of-sight of the motion capture 
cameras to the reflective markers positioned on the study participant. This obstruction 
introduces error to the marker positions and occasionally the marker positions cannot be 
tracked for a small number of data frames. The development of an on-patient or wireless AE 
and IMU data collection method would allow a more streamlined testing procedure. One of the 
major challenges with developing such a system is that the high sampling rate of the AE data 
(100 kHz) generates large amounts of data in a short time span. Therefore, any wireless or on-
patient system must be able to reliably and quickly transfer or store the data during the testing. 
From observing the results of this thesis, it would be possible to reduce the sampling rate of 
the AE sensors and still capture important AEs. However, given that some AE content was 
detected up to 50 kHz, a high sample rate is desirable for the AE monitoring. In the longer 
term, it would be desirable to have a system that could be incorporated into a wearable device, 
where patients could undertake AE monitoring over many days during normal life, rather than 
for a short period in a clinical environment. However, significant additional research is needed 
before this could be undertaken. 
Furthermore, a key part of future research would be to develop and implement population based 
inverse kinematics models that predict the gait based on the IMU data only. The current 
combined AE and gait system relies on access to a motion capture facility with trained 
personnel to operate the system. These requirements limit the ability for such systems to be 
used in clinical practice in regional settings, restricting access to the technology. The 
development of a system to track gait based only off the IMUs would allow for a much more 
portable, cheaper, and easily accessible combined AE monitoring and gait analysis to be 
applied to THR patients. 
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A natural extension to the current gait analysis is to perform inverse dynamics using the 
computer musculoskeletal model to estimate the muscle reaction forces of the lower limbs and 
the associated joint loads. The ability to directly compare AE signals and hip joint loadings 
would provide a much greater insight into in-vivo implant biomechanics and the relationship 
between implant AEs and implant loads. In particular, an investigation of the relationship 
between implant squeaking frequencies and implant loading would be of great interest. In-vitro 
studies from literature have suggested a correlation exists between implant load and squeaking 
frequency. While transient squeaking frequencies have been seen in-vivo within this research, 
that data was not linked to any gait tracking, so it is not possible to retrospectively determine 
whther those transient squeaking frequencies are linked to transient implant loads. The 
combined AE monitoring and gait analysis technique of this thesis, especially if combined with 
inverse dynamic modelling, will provide the ability to examine if any such correlation exist 
within the in-vivo environment. 
Finally, the event detection and subsequent event metric comparison methods presented within 
this thesis are only one approach to data analysis. While they make sense as an initial approach 
to understand the characteristics of the AE data, the use of machine learning, neural networks 
and genetic algorithms has the potiental to identify other traits that exist within the datset. 
While such additional analyses could be very complicated and prolonged, and may require a 
much larger dataset than is currently available, there is significant potential for new insight to 
be gained from this approach.  
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Table B.1: Kolmogorov-Smirnov test results for event duration and RMS amplitude of noise group participants. A 
significance level of 1% was used. 












Control-P1: 1 <0.001 0.424 0 0.327 0.142 
Control-P10: 0 0.120 0.133 0 0.809 0.072 
Control-P23: 0 0.057 0.188 0 0.125 0.166 
Control-P25: 0 0.200 0.151 0 0.602 0.108 
Control-P27: 1 <0.001 0.384 1 <0.001 0.216 
Control-P53: 1 <0.001 0.257 1 0.002 0.154 
Control-P58: 1 <0.001 0.232 1 0.004 0.111 
Control-P6: 1 <0.001 0.215 1 <0.001 0.144 
Control-P60: 0 0.029 0.291 1 <0.001 0.438 
Noise-P1: 0 0.032 0.213 0 0.045 0.204 
Noise-P10: 1 <0.001 0.240 0 0.101 0.135 
Noise-P23: 0 0.181 0.152 0 0.992 0.060 
Noise-P25: 1 <0.001 0.287 0 0.012 0.223 
Noise-P27: 1 <0.001 0.104 1 <0.001 0.087 
Noise-P53: 1 <0.001 0.206 1 0.002 0.149 
Noise-P58: 0 0.033 0.085 0 0.010 0.096 
Noise-P6: 1 <0.001 0.172 1 <0.001 0.139 
Noise-P60: 1 0.006 0.338 1 0.008 0.332 
P27-P53: 1 <0.001 0.289 1 <0.001 0.224 
 
Table B.2: Kolmogorov-Smirnov test results for event main frequency content and duration between events of noise group 
participants. A significance level of 1% was used. 












Control-P1: 1 <0.001 0.578 1 0.006 0.289 
Control-P10: 1 <0.001 0.323 1 <0.001 0.288 
Control-P23: 1 <0.001 0.703 0 0.028 0.240 
Control-P25: 1 <0.001 0.615 1 0.003 0.328 
Control-P27: 1 <0.001 0.256 1 <0.001 0.465 
Control-P53: 1 <0.001 0.563 0 0.251 0.095 
Control-P58: 1 <0.001 0.463 1 <0.001 0.231 
Control-P6: 1 <0.001 0.529 1 <0.001 0.319 
Control-P60: 1 <0.001 0.401 1 <0.001 0.882 
Noise-P1: 1 <0.001 0.510 0 0.184 0.182 
Noise-P10: 1 <0.001 0.455 1 <0.001 0.502 
Noise-P23: 1 <0.001 0.538 1 0.002 0.301 
Noise-P25: 1 <0.001 0.685 1 <0.001 0.598 
Noise-P27: 1 <0.001 0.131 1 <0.001 0.153 
Noise-P53: 1 <0.001 0.345 1 <0.001 0.323 
Noise-P58: 1 <0.001 0.251 1 <0.001 0.197 
Noise-P6: 1 <0.001 0.495 0 0.534 0.053 
Noise-P60: 0 0.023 0.298 1 <0.001 0.893 
P27-P53: 1 <0.001 0.393 1 <0.001 0.473 
 
  248 
Table B.3: Kolmogorov-Smirnov test results for event rise time and peak amplitude of noise group participants. A 
significance level of 1% was used. 












Control-P1: 1 <0.001 0.415 0 0.548 0.119 
Control-P10: 0 0.173 0.124 0 0.222 0.118 
Control-P23: 0 0.706 0.099 0 0.029 0.204 
Control-P25: 0 0.530 0.114 0 0.428 0.123 
Control-P27: 1 <0.001 0.319 1 <0.001 0.281 
Control-P53: 1 <0.001 0.199 1 <0.001 0.254 
Control-P58: 1 <0.001 0.312 1 <0.001 0.132 
Control-P6: 1 <0.001 0.257 1 <0.001 0.143 
Control-P60: 0 0.353 0.186 1 <0.001 0.506 
Noise-P1: 0 0.047 0.202 0 0.265 0.148 
Noise-P10: 1 <0.001 0.330 1 <0.001 0.265 
Noise-P23: 1 <0.001 0.280 0 0.387 0.126 
Noise-P25: 1 <0.001 0.292 1 <0.001 0.287 
Noise-P27: 1 <0.001 0.091 1 <0.001 0.089 
Noise-P53: 1 <0.001 0.365 0 0.085 0.100 
Noise-P58: 1 <0.001 0.128 1 0.002 0.112 
Noise-P6: 1 0.009 0.105 0 0.018 0.098 
Noise-P60: 0 0.033 0.286 1 0.003 0.358 
P27-P53: 1 <0.001 0.450 1 0.001 0.159 
 
Table B.4: Kolmogorov-Smirnov test results for number of events per recording duration of noise group participants. A 
significance level of 1% was used. 







Control-P1: 0 0.030 0.441 
Control-P10: 0 0.268 0.190 
Control-P23: 0 0.284 0.205 
Control-P25: 0 0.320 0.176 
Control-P27: 1 <0.001 0.650 
Control-P53: 1 <0.001 0.400 
Control-P58: 1 <0.001 0.513 
Control-P6: 1 <0.001 0.800 
Control-P60: 1 <0.001 0.534 
Noise-P1: 0 0.468 0.260 
Noise-P10: 1 <0.001 0.404 
Noise-P23: 0 0.014 0.331 
Noise-P25: 1 <0.001 0.369 
Noise-P27: 1 <0.001 0.453 
Noise-P53: 1 0.008 0.275 
Noise-P58: 1 0.002 0.293 
Noise-P6: 1 <0.001 0.565 
Noise-P60: 1 <0.001 0.627 
P27-P53: 1 <0.001 0.585 
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Table B.5: Kolmogorov-Smirnov test results for event duration and RMS amplitude of loosening group participants. A 
significance level of 1% was used. 












Control-P14: 1 <0.001 0.396 0 0.368 0.078 
Control-P15: 1 <0.001 0.362 0 0.047 0.111 
Control-P16: 1 0.002 0.139 1 0.001 0.142 
Control-P17: 0 0.145 0.183 0 0.497 0.132 
Control-P18: 1 <0.001 0.348 1 0.007 0.282 
Control-P19: 0 0.060 0.369 0 0.884 0.163 
Control-P36: 0 0.141 0.158 0 0.291 0.134 
Control-P47: 0 0.023 0.188 1 0.006 0.213 
Control-P50: 0 0.895 0.050 0 0.742 0.060 
Control-P52: 1 <0.001 0.334 0 0.165 0.102 
Control-P54: 1 <0.001 0.282 0 0.018 0.141 
Control-P55: 1 <0.001 0.337 0 0.480 0.083 
Control-P59: 1 <0.001 0.267 0 0.151 0.086 
Control-P62: 1 <0.001 0.260 0 0.040 0.113 
Control-P65: 1 <0.001 0.210 1 0.002 0.186 
Control-P69: 1 0.005 0.112 0 0.021 0.097 
Control-P74: 1 <0.001 0.218 0 0.020 0.140 
Control-P76: 0 0.027 0.289 1 <0.001 0.431 
Control-P79: 1 <0.001 0.346 0 0.062 0.227 
Control-P85: 1 <0.001 0.168 0 0.143 0.064 
Control-P90: 1 <0.001 0.287 0 0.133 0.126 
Loose-P14: 1 <0.001 0.353 0 0.823 0.051 
Loose-P15: 1 <0.001 0.329 0 0.186 0.084 
Loose-P16: 1 0.005 0.122 1 <0.001 0.155 
Loose-P17: 0 0.161 0.177 0 0.652 0.116 
Loose-P18: 1 0.003 0.300 1 0.009 0.274 
Loose-P19: 0 0.233 0.287 0 0.899 0.159 
Loose-P36: 0 0.432 0.118 0 0.305 0.131 
Loose-P47: 0 0.256 0.125 0 0.012 0.198 
Loose-P50: 0 0.060 0.111 0 0.666 0.061 
Loose-P52: 1 <0.001 0.255 0 0.028 0.129 
Loose-P54: 1 <0.001 0.245 0 0.016 0.138 
Loose-P55: 1 <0.001 0.262 0 0.156 0.109 
Loose-P59: 1 <0.001 0.252 0 0.040 0.101 
Loose-P62: 1 <0.001 0.207 0 0.087 0.097 
Loose-P65: 0 0.018 0.150 1 0.001 0.187 
Loose-P69: 1 0.001 0.113 0 0.062 0.079 
Loose-P74: 1 <0.001 0.194 0 0.028 0.130 
Loose-P76: 0 0.178 0.215 1 <0.001 0.415 
Loose-P79: 1 0.005 0.297 0 0.069 0.222 
Loose-P85: 1 <0.001 0.108 0 0.061 0.066 
Loose-P90: 1 <0.001 0.254 0 0.027 0.155 
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Table B.6: Kolmogorov-Smirnov test results for event main frequency content and duration between events of loosening 
group participants. A significance level of 1% was used. 












Control-P14: 1 <0.001 0.394 0 0.023 0.140 
Control-P15: 1 <0.001 0.401 0 0.430 0.076 
Control-P16: 1 <0.001 0.205 1 <0.001 0.234 
Control-P17: 1 <0.001 0.468 0 0.163 0.213 
Control-P18: 1 0.009 0.277 0 0.011 0.313 
Control-P19: 0 0.011 0.450 1 <0.001 0.677 
Control-P36: 1 <0.001 0.391 1 0.004 0.293 
Control-P47: 1 <0.001 0.688 1 <0.001 0.312 
Control-P50: 1 <0.001 0.333 0 0.019 0.151 
Control-P52: 1 <0.001 0.209 0 0.025 0.164 
Control-P54: 1 <0.001 0.711 0 0.258 0.112 
Control-P55: 1 <0.001 0.674 0 0.030 0.164 
Control-P59: 1 <0.001 0.535 0 0.052 0.113 
Control-P62: 1 <0.001 0.200 1 <0.001 0.301 
Control-P65: 1 <0.001 0.260 1 0.004 0.210 
Control-P69: 1 <0.001 0.537 1 <0.001 0.417 
Control-P74: 1 <0.001 0.813 0 0.049 0.139 
Control-P76: 1 0.009 0.322 0 0.269 0.279 
Control-P79: 1 <0.001 0.656 0 0.027 0.347 
Control-P85: 1 <0.001 0.570 1 <0.001 0.187 
Control-P90: 1 <0.001 0.295 0 0.219 0.126 
Loose-P14: 1 <0.001 0.435 1 <0.001 0.207 
Loose-P15: 1 <0.001 0.217 0 0.022 0.123 
Loose-P16: 1 <0.001 0.170 1 <0.001 0.161 
Loose-P17: 1 <0.001 0.567 0 0.067 0.245 
Loose-P18: 1 <0.001 0.467 1 0.002 0.354 
Loose-P19: 1 0.004 0.486 1 <0.001 0.698 
Loose-P36: 1 <0.001 0.586 1 <0.001 0.383 
Loose-P47: 1 <0.001 0.527 1 <0.001 0.400 
Loose-P50: 1 <0.001 0.505 0 0.598 0.072 
Loose-P52: 1 <0.001 0.434 1 <0.001 0.252 
Loose-P54: 1 <0.001 0.561 1 0.001 0.206 
Loose-P55: 1 <0.001 0.758 0 0.183 0.119 
Loose-P59: 1 <0.001 0.304 0 0.144 0.090 
Loose-P62: 1 <0.001 0.431 1 <0.001 0.231 
Loose-P65: 1 <0.001 0.409 1 <0.001 0.252 
Loose-P69: 1 <0.001 0.306 1 <0.001 0.339 
Loose-P74: 1 <0.001 0.685 0 0.556 0.077 
Loose-P76: 0 0.015 0.306 0 0.060 0.367 
Loose-P79: 1 <0.001 0.597 0 0.016 0.366 
Loose-P85: 1 <0.001 0.331 1 <0.001 0.131 
Loose-P90: 1 <0.001 0.518 0 0.048 0.159 
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Table B.7: Kolmogorov-Smirnov test results for event rise time and peak amplitude of loosening group participants. A 
significance level of 1% was used. 












Control-P14: 0 0.047 0.115 0 0.054 0.113 
Control-P15: 1 <0.001 0.349 0 0.031 0.116 
Control-P16: 0 0.092 0.093 1 <0.001 0.220 
Control-P17: 0 0.921 0.088 0 0.525 0.130 
Control-P18: 0 0.031 0.243 0 0.187 0.183 
Control-P19: 0 0.151 0.316 0 0.566 0.219 
Control-P36: 0 0.171 0.152 0 0.329 0.130 
Control-P47: 1 0.004 0.221 0 0.550 0.100 
Control-P50: 1 <0.001 0.265 1 <0.001 0.179 
Control-P52: 1 <0.001 0.253 1 0.006 0.157 
Control-P54: 1 <0.001 0.300 0 0.285 0.091 
Control-P55: 1 0.006 0.169 0 0.079 0.126 
Control-P59: 0 0.812 0.048 0 0.920 0.042 
Control-P62: 0 0.088 0.101 1 0.005 0.139 
Control-P65: 1 <0.001 0.219 0 0.022 0.151 
Control-P69: 1 <0.001 0.212 0 0.097 0.079 
Control-P74: 1 <0.001 0.307 0 0.019 0.140 
Control-P76: 0 0.020 0.298 0 0.185 0.215 
Control-P79: 1 0.004 0.302 0 0.028 0.252 
Control-P85: 1 <0.001 0.164 0 0.286 0.055 
Control-P90: 0 0.087 0.136 0 0.094 0.134 
Loose-P14: 0 0.047 0.111 0 0.036 0.115 
Loose-P15: 1 <0.001 0.232 0 0.034 0.110 
Loose-P16: 1 <0.001 0.144 1 <0.001 0.221 
Loose-P17: 0 0.414 0.140 0 0.485 0.132 
Loose-P18: 0 0.747 0.113 0 0.197 0.179 
Loose-P19: 0 0.590 0.214 0 0.557 0.219 
Loose-P36: 0 0.999 0.051 0 0.401 0.121 
Loose-P47: 0 0.279 0.122 0 0.686 0.088 
Loose-P50: 1 <0.001 0.375 1 <0.001 0.169 
Loose-P52: 1 <0.001 0.190 1 0.003 0.158 
Loose-P54: 1 <0.001 0.204 0 0.382 0.080 
Loose-P55: 1 <0.001 0.202 0 0.084 0.121 
Loose-P59: 1 0.006 0.123 0 0.858 0.044 
Loose-P62: 1 0.007 0.129 0 0.015 0.121 
Loose-P65: 0 0.046 0.134 0 0.027 0.143 
Loose-P69: 0 0.023 0.089 0 0.099 0.073 
Loose-P74: 1 <0.001 0.190 1 0.007 0.149 
Loose-P76: 0 0.237 0.202 0 0.192 0.211 
Loose-P79: 0 0.035 0.243 0 0.023 0.255 
Loose-P85: 0 0.175 0.055 0 0.239 0.051 
Loose-P90: 0 0.930 0.057 0 0.064 0.138 
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Table B.8: Kolmogorov-Smirnov test results for number of events per recording duration of loosening group participants. 
A significance level of 1% was used. 







Control-P14: 1 <0.001 0.462 
Control-P15: 1 <0.001 0.497 
Control-P16: 1 <0.001 0.553 
Control-P17: 0 0.946 0.125 
Control-P18: 0 0.210 0.268 
Control-P19: 1 <0.001 0.561 
Control-P36: 0 0.216 0.197 
Control-P47: 0 0.204 0.218 
Control-P50: 1 0.001 0.330 
Control-P52: 1 <0.001 0.332 
Control-P54: 1 <0.001 0.363 
Control-P55: 0 0.157 0.191 
Control-P59: 1 <0.001 0.414 
Control-P62: 1 <0.001 0.512 
Control-P65: 0 0.059 0.231 
Control-P69: 1 0.007 0.301 
Control-P74: 1 <0.001 0.452 
Control-P76: 1 <0.001 0.450 
Control-P79: 1 <0.001 0.391 
Control-P85: 1 <0.001 0.460 
Control-P90: 0 0.428 0.194 
Loose-P14: 0 0.018 0.294 
Loose-P15: 0 0.018 0.337 
Loose-P16: 1 <0.001 0.415 
Loose-P17: 0 0.212 0.251 
Loose-P18: 0 0.035 0.357 
Loose-P19: 1 <0.001 0.645 
Loose-P36: 1 0.002 0.344 
Loose-P47: 0 0.034 0.288 
Loose-P50: 0 0.191 0.184 
Loose-P52: 0 0.050 0.207 
Loose-P54: 0 0.029 0.213 
Loose-P55: 0 0.650 0.123 
Loose-P59: 0 0.031 0.249 
Loose-P62: 1 0.002 0.381 
Loose-P65: 0 0.211 0.182 
Loose-P69: 0 0.043 0.245 
Loose-P74: 0 0.038 0.279 
Loose-P76: 1 <0.001 0.533 
Loose-P79: 1 <0.001 0.516 
Loose-P85: 1 <0.001 0.338 
Loose-P90: 0 0.039 0.309 
 
 






Appendix C: Data Collection Instructions 
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Appendix D: Motion Capture Instructions 
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